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FSP Section 11,000
Checklists and Illustrative Financial
Statements for Health Care Organizations
Description
.01 Health care organizations may be classified by sponsorship or legal structure within the following
broad categories:

Not-for-profit business-oriented: These are essentially self-sustaining from fees charged for goods and
services. The fees charged by such organizations generally are intended to help the organization
maintain its self-sustaining status rather than to maximize profits for the owner's benefit. Such
organizations often are exempt from federal income taxes and may receive contributions of relatively
small amounts from resource providers that do not expect commensurate or proportionate pecuniary
returns.
Not-for-profit non-business-oriented: These are voluntary health and welfare organizations as defined
in FASB Statement of Financial Accounting Standards (SFAS) No. 117, Financial Statements of Not-forProfit Organizations. Such organizations are within the scope of the AICPA Audit and Accounting
Guide Not-for-Profit Organizations rather than that of the Health Care Organizations Guide.

Governmental: Often called public health care entities, the entities are owned and operated by federal,
state, city, or county governments or other political subdivisions.
Investor- (or operator-) owned: These organizations operate as stock corporations, partnerships, or sole
proprietorships.

.02 Health care organizations include, but are not limited to, the following:
•

Clinics, medical group practices, individual practitioners and practice associations, and other ambu
latory care organizations

•

Continuing care retirement communities (CCRCs)

•

Health maintenance organizations and similar prepaid health care plans

•

Home health agencies

•

Hospitals

•

Nursing homes that provide skilled, intermediate, and less intensive levels of health care

•

Parent companies, holding companies, and other organizations that primarily plan, organize, and
oversee health care services

Applicability of This Checklist
.03 This checklist, and the illustrative financial statements included herein, follow the guidance con
tained in the AICPA Audit and Accounting Guide Health Care Organizations (with conforming changes as of
May 1,1998), referred to as "the Guide." The checklist and illustrative financial statements should be used
for not-for-profit business-oriented and investor-owned health care organizations. Not-for-profit health care pro
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viders that receive federal financial assistance may be required to have an audit conducted in accordance
with Office of Management and Budget (OMB) Circular A-133, Audits of States, Local Governments, and
Non-Profit Organizations. Section 11,300 includes guidance for auditors' reports for audits performed under
OMB Circular A-133.

.04 Although the Guide also applies to state and local government-owned health care providers, this
checklist does not include disclosures or sample financial statements of government-owned providers. Chapter
1 of the Guide discusses the application of generally accepted accounting principles (GAAP) to governmental
health care providers.
.05 In addition, this checklist does not apply to not-for-profit non-business-oriented health care organiza
tions. For these types of organizations, follow the guidance in the AICPA Audit and Accounting Guide
Not-for-Profit Organizations, and the AICPA's disclosure checklist entitled Not-for-Profit Organizations.

Legislation and Regulation
.06 Significant aspects of health care organization operations are affected by government legislation and
regulation with many states adopting laws governing the granting of licenses, as well as scope of services to
be rendered. In addition, many independent organizations and governmental agencies, including Medicare
and Medicaid, evaluate programs and services of health care organizations to determine compliance with
set standards.

Basic Financial Statements
.07 The financial reporting for not-for-profit business-oriented organizations and investor-owned health
care enterprises generally is consistent except for transactions that clearly are not applicable. For example,
not-for-profit business-oriented organizations, by their nature, do not have shareholders' equity. On the
other hand, investor-owned health care enterprises typically do not receive contributions. Throughout this
checklist, disclosure/presentation questions are preceded by certain symbols. Not-for-profit businessoriented organizations should complete all disclosure items denoted with a star (★). Investor-owned health
care enterprises should complete all disclosure items denoted with a diamond (♦).
.08 The basic financial statements of health care providers generally consist of a statement of financial
position or balance sheet, a statement of activities or income statement or statement of operations, a statement
of changes in net assets (equity), a statement of cash flows, and notes to the financial statements. The titles
of the financial statements will depend upon the business form of the provider (i.e., not-for-profit, investorowned, etc.). See the chart below.

Basic Financial Statements

Not-for-Profit
Business-Oriented Organization

Investor-Owned Organization

Balance Sheet/Statement of Financial Position
Statement of Operations/Statement of Activities
Statement of Changes in Net Assets (Fund Balance)*

Balance Sheet
Statement of Operations/Income Statement
Statement of Changes in Equity*

Statement of Cash Flows

Statement of Cash Flows

* May be combined with the Statement of Operations.

Note: This publication was extracted from sections 11,000 through 11,500 of the AICPA Financial Statement
Preparation Manual (FSP).
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FSP Section 11,100
Instructions
Purpose
.01 The checklists and illustrative financial statements included in this section have been developed by
the staff of the Accounting and Auditing Publications Team of the AICPA as nonauthoritative technical
practice aids to be used as a memory jogger to aid in the audit of financial statements of health care
organizations.

The checklists have been updated to include guidance relevant to health care organizations
contained in official pronouncements through:
•

FASB Statement of Financial Accounting Standards No. 135, Rescission of FASB
Statement No. 75 and Technical Corrections

•

FASB Interpretation No. 42, Accountingfor Transfers ofAssets in Which a Not-for-Profit
Organization Is Granted Variance Power

•

FASB Technical Bulletin No. 97-1, Accounting under Statement 123 for Certain Employee
Stock Purchase Plans with a Look-back Option

•

AICPA Statement on Auditing Standards No. 87, Restricting the Use of an Auditor's
Report

•

AICPA Statement of Position No. 98-9, Modification of SOP 97-2, Software
Revenue Recognition, With Respect to Certain Transactions

•

AICPA Statement on Standards for Accounting and Review Services No. 7, Omnibus
Statement on Standards for Accounting and Review Services—1992

•

AICPA Audit and Accounting Guide Health Care Organizations (with conforming
changes as of May 1,1999)

•

AICPA Practice Bulletin No. 15, Accounting by the Issuer of Surplus Notes

•

FASB EITF consensuses adopted up to and including the January 1999 Emerging
Issues Task Force meeting

The checklists and illustrative financial statements should be modified, as appropriate, for
subsequent pronouncements. In determining the applicability of a pronouncement, its effective
date should also be considered.

Instructions
.02 The checklists consist of a number of questions or statements that are accompanied by references to
the applicable authoritative pronouncements. The checklists provide for checking off or initialing each
question or point to show that it has been considered. Users should check: "yes" if the disclosure has been
appropriately made, "no" if the disclosure has not been made, or "n/a" if the disclosure is not applicable to
the organization. The auditor should consider the effect of a "no" answer on his/her report. A "no" answer
that is material to the financial statements may warrant a departure from an unqualified opinion. (See paragraphs
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20-63 of SAS No. 58, Reports on Audited Financial Statements, as amended [AICPA, Professional Standards, vol.
1, AU sec. 508.20-.63].) If a "no" answer is checked, the authors recommend that a note be made in the right
margin to explain why the disclosure was not made (for example, if the disclosure was not made because it
was not material to the financial statements, write "not material" in the right margin). The right margin may
be used for other remarks or comments as appropriate, including cross-referencing to applicable workpapers
where the support to a disclosure may be found. Use of the checklists requires the exercise of individual
professional judgment and may likely require some modification based on the circumstances of individual
engagements.

.03 This checklist is applicable to not-for-profit business-oriented and investor-owned health care organiza
tions. While financial reporting for these types of organizations is generally consistent, there are requirements
that apply to only not-for-profit business-oriented organizations and those that apply to only investor-owned
enterprises. Symbols have been used to indicate the applicability of presentation and disclosure requirements
to these types of organizations. Not-for-profit business-oriented organizations should complete all disclosure
items denoted with a star (★). Investor-owned organizations should complete all disclosure items denoted
with a diamond (♦).

.04 The checklist is not a substitute for the authoritative pronouncements. Users of the checklists and
illustrative financial statements are urged to refer directly to applicable authoritative pronouncements
when appropriate. The checklists and illustrative financial statements do not include all disclosures and
presentation items promulgated nor do they represent minimum requirements. Disclosures prescribed
by pronouncements deemed remote for health care organizations are not included in this document. The
checklists and illustrative financial statements are "tools" and in no way represent official positions or
pronouncements of the AICPA.
.05 If you have further questions, call the AICPA Technical Hotline at 1-888-777-7077.
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FSP Section 11,200
Financial Statements and
Notes Checklist
.01 This checklist has been developed by the staff of the Accounting and Auditing Publications Team of
the AICPA as a nonauthoritative practice aid. The checklists and illustrative financial statements do not
include all disclosures and presentation items required by GAAP; as a result, pronouncements deemed
unlikely to be encountered in financial statements of health care providers are not included.

.02 Explanation of References:

★=

Disclosure applicable for not-for-profit organizations

♦=

Disclosure applicable for investor-owned organizations

AAG =

AICPA Audit and Accounting Guide Health Care Organizations (with conform
ing changes as of May 1,1998)

AC =

Reference to section number in FASB Accounting Standards—Current Text

APB =

Accounting Principles Board Opinion

ARB =

Accounting Research Bulletin

AU =

Reference to section number in AICPA Professional Standards (vol. 1)

EITF =

FASB Emerging Issues Task Force consensus

FASBI =

FASB Interpretation

FASCON =

FASB Statement of Financial Accounting Concepts

SAS =

AICPA Statement on Auditing Standards

SFAS =

FASB Statement of Financial Accounting Standards

SOP =

AICPA Statement of Position

TB =

FASB Technical Bulletin

.03 Checklist Questionnaire:

This checklist is organized into the sections listed below. Carefully review the topics listed and consider
whether they represent potential disclosure items for the health care provider. Place a check mark by the
topics or sections considered not applicable; these sections need not be completed. For example, if the entity
does not have any extraordinary items, place a check by "Extraordinary Items" and skip this section when
completing the checklist.
Place by
Sections Not Applicable
•

General
A.
Titles and References
B.
Comparative Financial Statements

•

Statement of Financial Position/Balance Sheet

A.

General
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Place by
Sections Not Applicable

B.
C.
D.
E.
F.
G.
H.
I.
J.
K.
•

Cash and Cash Equivalents
Investments
Receivables
Property and Equipment, Supplies, and Other Assets
Current Liabilities, Notes Payable, and Other Debt
Other Liabilities and Deferred Credits
Lessor Leases
Lessee Leases
Net Assets
Restricted Resources

Statement of Activities / Income Statement/Statement of
Operations/Statement of Changes in Net Assets

A.
B.
C.
D.
E.
F.
G.
H.
I.
J.
K.
L.
M.
N.
O.

General
Revenue
Income Taxes
Discontinued Operations
Extraordinary Items
Unusual or Infrequent Items
Advertising Costs
Donated or Contributed Services
Fund Raising
Contributions/Pledges
Expenses
Wills
Endowments
Earnings Per Share
Comprehensive Income

•

Statement of Cash Flows

•

Other Financial Statement Disclosures

A.
B.
C.
D.
E.
F.
G. 1.
/G
H.
I.
J.
K.
L.
M.
•

Accounting Changes
Accounting Policies
Business Combinations
Commitments and Contingencies
Costs to Exit an Activity
Derivatives
Financial Instruments
Nonmonetary Transactions
Pension and Other Postretirement Benefit Plans
Related Organizations and Economic Dependency
Risks and Uncertainties
Segment Information
Subsequent Events

Continuing Care Retirement Communities (CCRCs)

A.
B.
C.

Refundable Advance Fees
Fees Refundable to Residents Only From Reoccupancy
Proceeds of a Contract Holder's Unit
Nonrefundable Advance Fees
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Place by
Sections Not Applicable
D.
E.
F.

Obligation to Provide Future Services and Use of Facilities
to Current Residents
Costs of Acquiring Initial Continuing-Care Contracts
Other

•

OMB Circular A-133 Presentation Requirements

•

Exhibit A—Stock-Based Compensation

•

Auditors' Reports

•

Auditors' Reports on Audits Performed Under Government Auditing
Standards and Under OMB Circular A-133

Yes

No

____

___

____

___

a. Statement of financial position (balance sheet)?

____

___

b. Statement of activities (statement of operations/income statement)?

____

___

c. Statement of cash flows?

____

___

d. Statement of changes in net assets (equity)? [Note that this state
ment may be combined with the statement of activities.]
[SFAS 117, pars. 1 and 6 (AC No5.104); AAG, par. 1.05]

____

___

____

___

____

___

____

___

General
A. Titles and References

1.

Are the financial statements suitably titled?
[SFAS 62, par. 7 (AU 623.07)]

2.

Does each statement include a general reference that the notes are an
integral part of the financial statement presentation?
[Generally Accepted]

★ 3.

Do the basic financial statements of the health care organization
include:

B. Comparative Financial Statements

★♦1.

Has presentation of comparative statements been considered?
[SFAS 117, par. 69; ARB 43, Ch. 2A, pars. 1 and 2 (AC F43.101 and
■ 102)]

2.

Are the disclosures included in the prior year's financial statements
repeated, or at least referred to, to the extent that they continue to be
of significance?
[ARB 43, Ch. 2A, par. 2 (AC F43.102)]

★♦3.

If changes have occurred in the manner of or basis for presenting
corresponding items for two or more periods, are appropriate expla
nations of the changes disclosed?
[ARB 43, Ch. 2A, par. 3 (AC F43.103)]
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N/A

Yes

★ 4.

If comparative annual financial statements are presented for earlier
periods, are those financial statements reclassified (or restated) to
reflect retroactive application of the provisions of SFAS116 and SFAS
117?
[SFAS 116, par. 30; SFAS 117, par. 31]

____

Statement of Financial Position/Balance Sheet
A. General

★♦1.

2.

★ 3.

★4.

For classified statements of financial position/balance sheets, are
assets and liabilities segregated into current and noncurrent classifi
cations, with totals presented for current assets and current liabilities?
[ARB 43, Ch. 3A, par. 3; SFAS 78, pars. 5 and 13 (AC B05.102-.109B);
SFAS 6, par. 15 (AC B05.118); FASBI 8, par. 3 (AC B05.117); TB 79-3,
par. 2 (AC B05.501-.503); SFAS 117, par. 12 (AC No5.110)]
Are assets not expected to be realized during the current operating
cycle classified as noncurrent?
[ARB 43, Ch. 3A, pars. 5 and 6 (AC B05.106 and .107)]

Does the statement of financial position/balance sheet report total
assets, liabilities, and net assets as well as separate amounts for each
of three classes of net assets with captions used to describe their
meaning as explained in SFAS 117?
[SFAS 117, pars. 10,13, and 100 (AC No5.108, .111, and .131, fn. a)]

★♦6.

____

____

Does the entity provide information about liquidity by one or more
of the following presentations:

a. Sequencing assets according to their nearness of conversion to
cash and sequencing liabilities according to the nearness of their
maturity and resulting use of cash?

____

b. Classifying assets and liabilities as current and noncurrent?

____

c. Disclosing in notes to financial statements relevant information
about the liquidity or maturity of assets and liabilities, including
restrictions on the use of particular assets?
[SFAS 117, par. 12 (AC No5.110)]

★♦5.

____

Are valuation allowances for assets shown as deductions from their
related assets with appropriate disclosure?
[APB 12, par. 3 (AC V18.102)]
Is the need for disclosure of the impact of a new FASB Statement,
issued but not yet effective where restatement of prior periods is
required, considered?
[SAS 1, secs. 9410.13-18 (AU 9410.13-.18)]

____

____

____

B. Cash and Cash Equivalents

★♦1.

2.

Is restricted cash appropriately segregated from cash available for
current operations?
[ARB 43, Ch. 3A, par. 6 (AC B05.107); AAG, par. 3.01]

____

Are restrictions on cash (such as for plant acquisition, debt reduction
or working capital maintenance) appropriately disclosed?
[SFAS 5, pars. 18 and 19 (AC C59.120)]

____
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No

N/A

Yes
3.

Are personal funds of patients, residents and others under an agency
arrangement reported as unrestricted assets and corresponding li
abilities in the balance sheet/statement of financial position?
[AAG, par. 3.02]

★♦4.

If a concentration of credit risk arises from deposits in excess of
federally insured limits, is it disclosed?
[SFAS 105, par. 20 (AC F25.115)]

Note: SFAS 133, Accountingfor Derivative Instruments and Hedging Activi
ties, which is effective for all fiscal quarters of fiscal years beginning after
June 15,1999, supersedes SFAS 105. If SFAS 133 has been adopted, refer
to the disclosure requirements listed in the Other Financial Statement
Disclosures section G1 of this checklist.

The FASB has issued an exposure draft dated May 20,1999 of a proposed
Statement titled "Accounting for Derivative Instruments and Hedging
Activities—Deferral of the Effective Date of FASB Statement No. 133, an
amendment of FASB Statement No. 133," which would amend SFAS 133
to defer its effective date to all fiscal quarters of all fiscal years beginning
after June 15,2000. The comment deadline was June 19,1999. Users of this
checklist should be alert to the issuance of a final pronouncement.

5.

If the organization has material bank overdrafts or material balance
of undelivered checks as of the statement-of-financial-position/bal
ance-sheet date, are:

a. Bank overdrafts presented as a separate caption within current
liabilities?
b. Undelivered checks classified as accounts payable?
[Generally Accepted]

6.

Are internally designated funds reported separately from externally
designated funds?
[AAG, par. 3.01]

7.

Is the policy for determining cash equivalents disclosed?
[SFAS 95, par. 10 (AC C25.108)]

C. Investments
1.

Are investments reported as current or noncurrent assets in conform
ity with GAAP?
[AAG, par. 4.14]

★♦2.

Are the appropriate disclosures made for investments in common
stock accounted for by the equity method?
[APB 18, par. 20 (AC I82.110)]

3.

Are other investments (such as real estate) reported at amortized cost,
or at lower of cost or market if an impairment in value is deemed to
be other than temporary?
[AAG, par. 4.02]

♦ 4.

Are debt and equity securities classified as (a) held-to-maturity, (b)
available-for-sale, or (c) trading?
[SFAS 115, par. 6 (AC I80.103)]
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No

NIA

Yes
Note: SFAS 133, Accounting for Derivative Instruments and Hedging Activi
ties, which is effective for all fiscal quarters of fiscal years beginning after
June 15, 1999, modifies the disclosure requirements of SFAS 115, para
graphs 19,20,21, and 22. If SFAS 133 has been adopted, replace Questions
5,6,7,9, and 10 below with those shown in the Other Financial Statement
Disclosures section G1 of this checklist.

The FASB has issued an exposure draft dated May 20,1999 of a proposed
Statement titled "Accounting for Derivative Instruments and Hedging
Activities—Deferral of the Effective Date of FASB Statement No. 133, an
amendment of FASB Statement No. 133," which would amend SFAS 133
to defer its effective date to all fiscal quarters of all fiscal years beginning
after June 15,2000. The comment deadline was June 19,1999. Users of this
checklist should be alert to the issuance of a final pronouncement.

♦ 5.

For debt and marketable equity securities classified as available-forsale or held-to-maturity, are the following disclosures made, by ma
jor-security type, for each balance sheet presented:

a. Aggregate fair value?
b. Gross unrealized holding gains or losses?
c. Amortized cost basis?

♦ 6.

For investments in debt securities classified as available-for-sale or
held-to-maturity is:

a. Disclosure made about their contractual maturities, as of the date
of the latest balance-sheet date presented (maturity information
may be combined in appropriate groupings)?
[SFAS 115, par. 20 (AC I80.119)]

♦ 7.

Is consideration given to separate disclosure for securities not due
at a single date and the basis for allocation if such securities are
allocated?
[SFAS 115, par. 20 (AC I80.119)]

♦ 8.

If an option (to purchase securities that will be accounted for under SFAS
115) is classified as held-to-maturity or available-for-sale, is the account
ing policy for the premium paid to acquire the option disclosed?
[EITF 96-11]

♦ 9.

For each period for which an earnings statement is presented, are the
following disclosures made:

a. The proceeds from sales of available-for-sale securities and gross
realized gains and losses on those sales?
b. The basis on which cost was determined in computing realized
gain or loss (i.e., specific identification, average cost, or other
method used)?

c. The gross gains and losses included in earnings from transfers
of securities from the available-for-sale category to the trading
category?

d. The change in net unrealized holding gain or loss on available-forsale securities that is included in other comprehensive income
during the period?
10

No

N/A

Yes
e. The change in net unrealized holding gain or loss on trading
securities that is included in earnings during the period?
[SFAS 115, par. 21 (AC I80.120)]

♦ 10. For any sales of or transfers from securities classified as held-to-maturity, are the following disclosed for each period for which an earn
ings statement is presented:
a. Amortized cost amount of the sold or transferred security?
b. Related realized or unrealized gain or loss?
c. The circumstances leading to the decision to sell or transfer the
security?
[SFAS 115, par. 22 (AC I80.121)]

★♦11. Are significant concentrations of credit risk arising from concentra
tions of securities of a particular issuer disclosed?
[SFAS 105, par. 20 (AC F25.115)]
Note: SFAS 133, Accounting for Derivative Instruments and Hedging Activi
ties, which is effective for all fiscal quarters of fiscal years beginning after
June 15,1999, supersedes SFAS 105. If SFAS 133 has been adopted, refer
to the disclosure requirements listed in the Other Financial Statement
Disclosures section G1 of this checklist.

The FASB has issued an exposure draft dated May 20, 1999 of a
proposed Statement titled "Accounting for Derivative Instruments and
Hedging Activities—Deferral of the Effective Date of FASB Statement
No. 133, an amendment of FASB Statement No. 133," which would
amend SFAS 133 to defer its effective date to all fiscal quarters of all
fiscal years beginning after June 15, 2000. The comment deadline was
June 19, 1999. Users of this checklist should be alert to the issuance of
a final pronouncement.

★ 12. Are realized gains and losses; unrealized gains and losses; dividend,
interest, and other similar investment income; and other than tempo
rary impairment losses reported in the statement of activities as
increases or decreases in unrestricted net assets or in temporarily
restricted net assets or in permanently restricted net assets, depending
on the existence of or lack of donor restrictions or law?
[SFAS 124, pars. 8 and 9 (AC No5.154 and .155); AAG, pars. 4.07 and
4.08]

★ 13. Are realized gains and losses; dividend, interest and other similar invest
ment income; and other than temporary impairment losses included in
the performance indicator within the statement of activities?
[SFAS 124, par. 49; AAG, par. 4.07]

★ 14. Are unrealized gains and losses on trading securities (as defined in
SFAS 115) included in the performance indicator within the statement
of activities?
[SFAS 124, par. 49; AAG, par. 4.07]
★ 15. Are unrealized gains and losses on available-for-sale and held-to-ma
turity securities excluded from the performance indicator within the
statement of activities?
[SFAS 124, par. 49; AAG, par. 4.07]
11

No

N/A

Yes

★ 16. If a provider reports gains and investment income that are limited to
specific uses by donor-imposed restrictions as increases in unre
stricted net assets because the restrictions are met in the same report
ing period as the gains and income are recognized, does the provider:
a. Have a similar policy for reporting contributions received?
b. Report consistently from period to period?

c.

Disclose its accounting policy?
[SFAS 124, par. 10 (AC No5.156); AAG, par. 4.09]

★ 17. For each period that a statement of activities is presented, are the
following disclosures made on the face of the financial statements or
in the notes thereto:
a. The composition of investment return including, at a minimum,
investment income, net realized gains or losses on investments
reported at other than fair value, and net gains or losses on
investments reported at fair value?
b. A reconciliation of investment return to amounts reported in the
statement of activities, if investment return is separated into oper
ating and nonoperating amounts?

c. A description of the policy used to determine the amount of invest
ment return included in the measure of operations, if investment
return is separated into operating and nonoperating amounts?

d. A discussion of circumstances leading to a change, if any, in the
policy referred to in Step 17c above?
[SFAS 124, par. 14 (AC No5.161); AAG, par. 4.11]

★ 18. For each period for which a statement of financial position is pre
sented, are the following disclosures made on the face of the financial
statements or in the notes thereto:
a. The aggregate carrying amount of investments by major types
(e.g., equity securities, corporate debt securities, etc.)?
b. The basis for determining the carrying amount for investments
other than equity securities with readily determinable fair values
and all debt securities?
c. The methods and assumptions used to estimate the fair values of
investments other than financial instruments, if those other invest
ments are reported at fair value?

d. The aggregate amount of the deficiencies for all donor-restricted
endowment funds, for which the fair value of the assets at the
reporting date is less than the level required by donor stipulations
or law?
[SFAS 124, par. 15 (AC No5.162); AAG, par. 4.11]

★ 19. For the most recent period for which a statement of financial position
is presented, does the provider disclose the nature of and carrying
amount for every individual investment or group of investments that
represents a significant concentration of market risk (market risk may
result from the nature of the investments, a lack of diversity of
industry, currency, or geographic location)?
[SFAS 124, pars. 16 and 86 (AC No5.163); AAG, par. 4.11]
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No

N/A

Yes

No

N/A

★ 20. In the period that SFAS 124 is first applied, does the provider disclose
the nature of any restatements and its effect on the change in net assets
and on each class of net assets for each period presented?
[SFAS 124, par. 19]

★ 21. If SFAS 124 is not applied retroactively, is the cumulative effect of the
change in accounting on each class of net assets reported in the
statement of activities between the captions "extraordinary items," if
any, and "change in unrestricted net assets," "change in temporarily
restricted net assets," and "change in permanently restricted net
assets"?
[SFAS 124, par. 18]

22. Are significant net realized and net unrealized gains and losses that
arose after the latest statement of financial position date, but before
issuance of the financial statements, disclosed?
[SAS 1, sec. 560, pars. 5 and 7 (AU 560.05 and .07)]
D. Receivables
1.

Are charity care revenue and receivables excluded from the financial
statements?
[AAG, par. 5.03]

2.

Are differences between the estimates originally reported and sub
sequent revisions, including final settlements:
a. Included in the statement of activities/income statement in the
period the revisions are made and disclosed, if material?
b. Reported in the current period unless they meet the criteria for
prior-period adjustments?
[AAG, par. 5.07; SFAS 16 (AC A35)]

3.

Are advances from third-party payors reported as a liability (unless
the right of setoff against a related receivable applies)?
[AAG, par. 7.01]

★♦4.

Are deposits received from individuals reported as a liability (to the
extent that a right of setoff does not exist)?
[AAG, par. 7.01]

5.

Are receivables (less an allowance for uncollectibles, discounts, and
contractual adjustments) reported as current assets?

a. If the terms of payment are extended beyond one year from the
balance-sheet date, is that portion classified as noncurrent?
b. Are amounts due from third-party payors for retroactive adjust
ments of items (such as final settlements or appeals) reported
separately in the financial statements?
[AAG, pars. 5.17 and 5.18]

★ 6.

When displaying total assets and total liabilities, are interfund assets
and liabilities eliminated?1

1 The display of interfund items in a statement of financial position is not prohibited by SFAS 117. However, since interfund items are
not organizational assets or liabilities, those interfund items must be clearly labeled and arranged in the statement of financial position
to eliminate their amounts when total assets and liabilities are displayed.
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Yes

★ 7.

Do entities that receive unconditional promises to give disclose the
following:

a. The amounts of promises receivable in less than one year, in one
to five years, and in more than five years?
b. The amount of any allowance for uncollectible promises receivable?
[SFAS 116, par. 24 (AC C67.121)]

★ 8.

____
____

Do entities that receive conditional promises to give disclose the
following:
a. The total of the amounts promised?

____

b. A description and amount for each group of promises having
similar characteristics (such as amount of promises conditioned
on establishing new programs, completing a new building, and
raising matching gifts by a specified date)?
[SFAS 116, par. 25 (AC C67.122)]

____

Are all receivables reported net of any related allowance for uncol
lectible amounts, with appropriate disclosure?
[AAG, par. 5.17; APB 12, par. 3 (AC V18.102)]

____

10. Are accounts and notes receivable from officers, employees, and affili
ated organizations shown separately with appropriate disclosures?
[ARB 43, Ch. 1A, par. 5 (AC R36.105)]

____

★♦11. Are significant concentrations of credit risk arising from receivables
disclosed?
[SFAS 105, par. 20 (AC F25.115)]

____

9.

Note: SFAS 133, Accounting for Derivative Instruments and Hedging Activi
ties, which is effective for all fiscal quarters of fiscal years beginning after
June 15,1999, supersedes SFAS 105. If SFAS 133 has been adopted, refer
to the disclosure requirements listed in the Other Financial Statement
Disclosures section G1 of this checklist.

The FASB has issued an exposure draft dated May 20,1999 of a proposed
Statement titled "Accounting for Derivative Instruments and Hedging
Activities—Deferral of the Effective Date of FASB Statement No. 133, an
amendment of FASB Statement No. 133," which would amend SFAS 133
to defer its effective date to all fiscal quarters of all fiscal years beginning
after June 15,2000. The comment deadline was June 19,1999. Users of this
checklist should be alert to the issuance of a final pronouncement.
E. Property and Equipment, Supplies, and Other Assets

★ 1.

Is property and equipment that is donor-restricted reported as tem
porarily or permanently restricted assets?
[SFAS 116, par. 14]

★♦ 2.

Are donor or legal restrictions on the proceeds from the disposition
of property and equipment disclosed?
[AAG, par. 6.07]

★♦ 3.

For depreciable assets, do the financial statements or notes disclose:

a. Depreciation expense for each period?
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No

N/A

Yes

★♦4.

♦ 5.

b. Balances of major classes of depreciable assets by nature or function?

____

c. Accumulated depreciation, either by major classes of assets or in
total?

____

d. The method or methods used in computing depreciation with
respect to major classes of depreciable assets?
[APB 12, par. 5 (AC D40.105)]

____

Do disclosures include the method and period of amortization of
intangible assets?
[APB 22, par. 13 (AC A10.106)]

____

In a classified balance sheet:
a. Are deferred tax assets and deferred tax liabilities classified as
current or noncurrent based on the classification of the related
asset or liability for financial reporting?
[SFAS 109, par. 41 (AC I27.140)]
b. Are deferred tax assets or liabilities not related to an asset or
liability for financial reporting (including those related to carry
forwards) classified according to the expected reversal date of the
temporary difference?
[SFAS 109, pars. 41 and 288p (AC I27.140)]

c. Is the valuation allowance for a particular tax jurisdiction allocated
between current and noncurrent deferred tax assets for that tax
jurisdiction on a pro rata basis?
[SFAS 109, par. 41 (AC I27.140)]

____

____

____

d. Are the following items offset and presented as a single amount
for a particular taxpaying component and within a particular
taxpaying jurisdiction:

♦ 6.

♦ 7.

8.

★♦9.

(1)

All current deferred tax liabilities and assets?

____

(2)

All noncurrent deferred tax liabilities and assets?
[SFAS 109, par. 42 (AC I27.141)]

____

Are the totals of (a) all deferred tax liabilities, (b) all deferred tax assets,
and (c) the related valuation allowance recognized in the balance sheet
disclosed?
[SFAS 109, par. 43 (AC I27.142)]
Is the net change during the year in the total valuation allowance
disclosed?
[SFAS 109, par. 43 (AC I27.142)]
Is the amount of interest cost incurred and charged to expense during
the period disclosed for an accounting period in which no interest cost
is capitalized?
[SFAS 34, par. 21a (AC I67.118)]

Is the amount of interest cost incurred during the period and the
amount that has been capitalized disclosed for an accounting period
in which some interest cost is capitalized?
[SFAS 34, par. 21b (AC I67.118)]

10. Are material commitments for property expenditures disclosed?
[SFAS 5, pars. 18 and 19 (AC C59.120)]
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____

____

____

____
____

No

N/A

Yes

★♦11. For an existing property with an asbestos problem, are the costs
incurred to treat the problem, if charged to expense, not classified as
an extraordinary item?
[EITF 89-13]

★♦ 12. If an impairment loss is recognized for assets to be held and used, are
the following disclosures made in financial statements that include
the period of the impairment write-down:
a. A description of the impaired assets and the facts and circum
stances leading to the impairment?
b. The amount of the impairment loss and how fair value was
determined?

c. The caption in the income statement or statement of activities in
which the impairment loss is aggregated if that loss has not been
presented as a separate caption or reported parenthetically on the
face of the statement?
[SFAS 121, par. 14 (AC I08.133)]

★♦13. If assets to be disposed of are accounted for in accordance with
paragraphs 15-17 of SFAS 121, are all of the following disclosed in
financial statements that include a period during which those assets
are held:
a. A description of assets to be disposed of, the facts and circum
stances leading to the expected disposal, the expected disposal
date, and the carrying amount of those assets?
b. The loss resulting from the application of paragraph 15 of SFAS
121?

c. The gain or loss, resulting from changes in the carrying amounts
of assets to be disposed of that arises from application of para
graph 17 of SFAS 121?
d. The caption in the statement of activities/income statement in
which the gains or losses in b. and c. are aggregated if those gains
or losses have not been presented as a separate caption or reported
parenthetically on the face of the statement?

e. The results of operations for assets to be disposed of to the extent
that those results are included in the entity's results of operations
for the period and can be identified?
[SFAS 121, par. 19 (AC I08.138)]

★♦ 14. If an impairment loss is recognized, is it reported as a component of
income from continuing operations before income taxes, or similar
caption, in the statement of activities or income statement?
[SFAS 121, pars. 13 and 18]
F. Current Liabilities, Notes Payable, and Other Debt
1.

Current liabilities:

★♦ a. For classified balance sheets and classified statements of financial
position, do current liabilities include:
(1)

Obligations for items that entered the operating cycle?

(2)

Collections received in advance of the performance of services?

(3)

Debts that arise from operations directly related to the oper
ating cycle?

16

No

N/A

Yes

(4)
(5)

Other liabilities whose regular and ordinary liquidation is
likely to occur within a relatively short time period?

Obligations that, by their terms, are due on demand or will
be due within one year (or operating cycle, if longer) from the
balance-sheet date, even though liquidation may not be ex
pected within that period?
[ARB 43, Ch. 3A, pars. 7 and 8 (AC B05.108 and .109); SFAS
78, par. 5 (AC B05.109A)]

b. Do current liabilities exclude short-term obligations that the
provider intends to refinance on a long-term basis, provided the
provider has demonstrated the ability to consummate the long
term financing?
[SFAS 6, pars. 8-14 (AC B05.113-.116); FASBI 8, pars. 2-4 (AC
B05.117, .138, and .139)]

c. In classified statements of financial position and in classified bal
ance sheets, are current portions of debt obligations presented as
current liabilities?
[ARB 43, Ch. 3A, pars. 7 and 8 (AC B05.108 and .109)]

____

____

____

____

2. Notes payable and other debt:

a. Is there adequate disclosure of interest rates, maturities, and other
terms and conditions provided in loan agreements and bond
indentures (such as assets pledged as collateral, and covenants to
reduce debt, and maintain working capital)?
[FASCON 5, par. 11; SFAS 5, par. 18 (AC C59.120)]
b. Are the combined aggregate amounts of maturities and sinking
fund requirements for all long-term borrowings disclosed for each
of the five years following the date of the latest balance sheet
presented?
[SFAS 47, par. 10b (AC C32.105b)]
c. For unconditional purchase obligations that have been recorded
in accordance with SFAS 47, paragraph 6, is the amount of pay
ments due in the aggregate and for every year during the five years
following the date of the latest statement of financial position/bal
ance sheet presented disclosed?
[SFAS 47, par. 10a (AC C32.105a)]

____

____

____

d. If a note is non-interest-bearing or has an inappropriate stated
interest rate:
(1) Is the discount or premium presented as a deduction from or
addition to the face amount of the note?

____

Does the disclosure include the effective interest rate and face
amount of the note?

____

(3)

Is amortization of the discount or premium reported as interest?

____

(4)

Are issue costs reported in the balance sheet/statement of
financial position as deferred charges?
[APB 21, par. 16 (AC I69.109)]

____

Are debt conversion features (such as rates and pertinent dates)
disclosed?
[FASCON 5, par. 11; APB 14 (AC D10)]

____

(2)

e.
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No

NLA

Yes
If a short-term obligation is to be excluded from current liabilities
in a classified balance sheet/statement of financial position, do
disclosures include:

(1)

General description of the financing agreement?

(2)

Terms of any new obligation incurred or expected to be
incurred, or equity securities issued or expected to be issued
as a result of the refinancing?
[SFAS 6, par. 15 (AC B05.118)]

g. For troubled debt restructuring occurring during the current pe
riod, do disclosures include:
(1)

Description of the principal changes in terms and/or the
major features of settlement?

(2)

Aggregate gain on restructuring of payables and the related
income tax effect?

(3)

Aggregate net gain or loss on transfers of assets recognized
during the period?

(4)

Per-share amount, if applicable, of the aggregate gain on
restructuring of payables, net of related income tax effect?
[SFAS 15, par. 25 (AC D22.121)]

h. For periods after a troubled debt restructuring, do disclosures include:
(1)

Extent to which amounts contingently payable are included
in the carrying amount of restructured payables?

(2)

Total amounts contingently payable, if applicable, and con
ditions under which those amounts would become payable
or forgiven?
[SFAS 15, par. 26 (AC D22.122)]

i.

Are the gains and losses from extinguishment(s) of debt aggre
gated and, if material, shown as an extraordinary item, net of
related income tax effect? (Note: Does not apply to gains and
losses from extinguishments of debt made to satisfy sinking fund
requirements that the reporting entity must meet within one year
of the date of the extinguishment.)
[SFAS 4, par. 8, as amended by SFAS 64, par. 4 (AC L35.107)]

j.

Are gains or losses from extinguishment(s) made to satisfy sinking
fund requirements that the reporting entity must meet within one
year of the date of the extinguishment aggregated and identified
as a separate item?
[SFAS 4, par. 8, as amended by SFAS 64, par. 4 (AC L35.107)]

k. Do disclosures related to gains and losses classified as extraordi
nary include the following:
(1)

A description of the extinguishment transactions, including
the sources of any funds used to extinguish debt if it is
practicable to identify the sources?

(2)

The income tax effect in the period of extinguishment?

(3)

The per-share amount of the aggregate gain or loss net of
related income tax effect?
[SFAS 4, par. 9 (AC L35.109)]
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No

N/A

Yes

l.

If debt was considered to be extinguished under the provisions of
SFAS 76 prior to the effective date of SFAS 125, do disclosures
include:

(1)

A general description of the transaction?

(2)

The amount of debt that is considered extinguished at the end
of the period as long as the debt remains outstanding?
[SFAS 125, par. 17b (AC L35.109)]

m. If assets are set aside after the effective date of SFAS 125 solely for
satisfying scheduled payments of a specific obligation, is disclo
sure made describing the nature of restrictions placed on those
assets?
[SFAS 125, par. 17c (AC L35.109)]
n. Are long-term obligations that are or will be callable by the credi
tor, either because the debtor's violation of the debt agreement at
the balance-sheet/statement-of-financial-position date makes the
obligation callable, or because the violation (if not cured within a
specified grace period) will make the obligation callable, classified
as current unless one of the following conditions is met:
(1)

The creditor waives or subsequently loses the right to de
mand repayment for more than one year (or operating cycle,
if longer) from the balance-sheet date?

(2)

The obligation contains a grace period within which the
debtor may cure the violation and it is probable that the
violation will be cured within that period, thus preventing
the violation from becoming callable?
[SFAS 78, par. 5 (AC B05.109A)]

o. If an obligation under Question n(2) above is included in long
term liabilities (or in the case of an unclassified balance sheet is
included as a long-term liability in the disclosure of debt maturi
ties), are the circumstances disclosed?
[SFAS 78, par. 5 (AC B05.118); see also EITF 86-30]

★ p. Does the not-for-profit provider report tax-exempt obligations
that were issued for its benefit as liabilities if the provider is
responsible for repayment?
[AAG, par. 7.15]
q. Is consideration given to the effects, if any, of current and prior tax
examinations on the financial statements and disclosures related
to the existence of contingent liabilities for unrelated business
income tax, additional payroll tax liabilities, or penalties and
interest on delinquent taxes?
[AAG, par. 7.11]

r. Is disclosure considered for any changes in the provider's activi
ties that could affect its tax-exempt status?
[AAG, par. 7.11]

s.

Are disclosures appropriate regarding the provider's tax-exempt
status and any other significant tax matters?
[AAG, par. 7.11]

t.

Is appropriate disclosure made if unrelated business income tax
has not been accrued on income from:

19

No

N/A

Yes
Debt-financed investments that are not functionally related
to the exempt purpose?

____

(2)

Certain related entities not engaged in an exempt activity?

____

(3)

Pharmacy operations in a medical building for the conven
ience of physicians' private patients?

____

A gift shop, cafeteria or food shop that the provider encour
ages the general public (except patients, visitors and employ
ees) to use?

____

(1)

(4)

(5)

A parking lot available to the general public (except patients,
visitors, and employees)?
[AAG, pars. 7.10 and 7.11]

____

G. Other Liabilities and Deferred Credits
1.

2.

If the reporting entity has not accrued compensated absences (SFAS
43) because the amount cannot be reasonably estimated, is that fact
disclosed?
[SFAS 43, par. 6 (AC C44.104)]

If an obligation for postemployment benefits is not accrued in accord
ance with SFAS 5 or SFAS 43 only because the amount cannot be
reasonably estimated, is the fact that the benefits have not been
accrued disclosed in the financial statements?
[SFAS 112, par. 7 (AC P32.105)]

____

____

H. Lessor Leases
1.

For sales-type and direct financing leases, do disclosures include:

a. Appropriate components of the net investment in the leases as of
the date of each balance sheet/statement of financial position
presented?
[SFAS 91, par. 25d (AC L10.119a)]
b. Future minimum lease payments to be received for each of the five
succeeding fiscal years as of the latest balance-sheet/statement-offinancial-position date presented?
[SFAS 13, par. 23a (AC L10.119a)]

2.

____

____

c. Total contingent rentals included in income for each period for
which an income statement/statement of activities is presented?
[SFAS 13, par. 23a (AC L10.119a)]

____

d. For direct financing leases, the amount of initial direct costs as part
of the investment?
[SFAS 91, par. 25d (AC L10.119a(1))]

____

For operating leases, do disclosures include:

a. Cost and carrying amount of property on lease or held for leasing
by major classes and the amount of accumulated depreciation as
of the date of the latest balance sheet/statement of financial posi
tion presented?

____

b. Minimum future rentals on noncancelable leases as of the date of
the latest balance sheet presented in the aggregate and for each of
the five succeeding fiscal years?

____
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No

N/A

Yes

c. Total contingent rentals included in income for each period for
which an income statement/statement of operations is presented?
[SFAS 13, par. 23b (AC L10.119b)]

★♦3.

4.

Do disclosures include a general description of the lessor's leasing
arrangements?
[SFAS 13, par. 23 (AC L10.119c)]
For investments in leveraged leases, do disclosures include:
a. In the balance sheet, the amount of deferred taxes presented
separately from the remainder of the net investment?
b. In the income statement or the notes thereto, separate presentation
(from each other) of pretax income from the leveraged lease, the
tax effect of pretax income, and the amount of investment tax
credit recognized as income during the period?

c. When leveraged leasing is a significant part of the lessor's business
activities in terms of revenue, net income, or assets, the compo
nents of the net investment balance in leveraged leases in the notes
to the financial statements?
[SFAS 13, par. 47 (AC L10.149)]
5.

I.

For leasing transactions with related parties, are the nature and extent
of the transaction disclosed?
[SFAS 13, par. 29 (AC L10.125)]

Lessee Leases
1.

For capital leases do disclosures include:

a. Gross amounts of assets recorded by major classes, as of the date
of each balance sheet/statement of financial position presented?
[SFAS 13, par. 16a.i. (AC L10.112a(1))]
b. Future minimum lease payments, as of the date of the latest
balance sheet/statement of financial position presented, in total
and for each of the next five years, with separate deductions for
executory costs and imputed interest to reduce net minimum lease
payments to present value?
[SFAS 13, pars. 10 and 16a.ii. (AC L10.106 and .112a(2))]

c. Total future minimum sublease rentals under noncancelable sub
leases as of the date of the latest balance sheet/statement of
financial position presented?
[SFAS 13, par. 16a.iii (AC L10.112a(3))]

d. Total contingent rentals actually incurred for each period presented?
[SFAS 13, par. 16a.iv (AC L10.112a(4))]
e. Assets recorded under capital leases and the related accumulated
amortization, and obligations under those leases identified sepa
rately in the balance sheet/statement of financial position or a
note?
[SFAS 13, pars. 13 and 16 (AC L10.112a)]
2.

For operating leases that have initial or remaining noncancelable lease
terms in excess of one year, do disclosures include:
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No

N/A

Yes

a. Future minimum rental payments required as of the latest balance
sheet/statement of financial position presented in total and for
each of the next five years?
b. Total future minimum rentals under noncancelable subleases as
of the date of the latest balance sheet/statement of financial posi
tion presented?
[SFAS 13, par. 16b (AC L10.112b)]

3.

★♦4.

5.

★♦6.

J.

For all operating leases, do disclosures include rental expense for each
period presented, with separate amounts for minimum rentals, con
tingent rentals, and sublease rentals?
[SFAS 13, par. 16c (AC L10.112c)]

____

____

____

Do disclosures include a general description of the lessee's leasing
arrangements including, but not limited to:
a. Bases for determination of contingent rentals?

____

b. Terms of any renewal or purchase options or escalation clauses?

____

c. Restrictive covenants?
[SFAS 13, par. 16d (AC L10.112d)]

____

Is the nature and extent of leasing transactions with related parties
disclosed?
[SFAS 13, par. 29 (AC L10.125)]
If material, is the accounting policy used in recognizing amounts
related to a modification of an operating lease (that does not change
the lease classification) disclosed?
[EITF 95-17]

____

____

Net Assets
♦ 1.

2.

♦ 3.

★4.

♦ 5.

Are the equity accounts of investor-owned providers presented in a
similar fashion as other investor-owned businesses?
[AAG, par. 9.01]

Is the nature of restrictions on donor-restricted resources disclosed?
[AAG, par. 9.07]

Are limits on the use of unrestricted net assets (such as loan covenants
and board-designated endowments) and information about the na
ture and amounts of different types of permanent and temporary
restrictions disclosed?
[SFAS 117, par. 16 (AC No5.114); AAG, pars. 9.03 and 9.04]
Are net assets released from restriction, such as those related to the
fufillment of time or purpose restrictions, reported separately in the
financial statements or disclosed in the notes?
[AAG, par. 10.07]

____
____

____

____

Shareholders' equity (corporations):

a. For each class of stock, do disclosures include the number of shares
authorized, issued and outstanding, and par or stated value per
share and changes therein?
[Generally Accepted]
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____

No

N/A

Yes
b. Do the financial statements include a description, in summary
form, sufficient to explain the pertinent rights and privileges of the
various securities outstanding, (e.g., dividend and liquidation
preferences, participation rights, call prices and dates, conversion
or exercise prices or rates and pertinent dates, sinking fund re
quirements, unusual voting rights, significant terms of contracts
to issue additional shares)?
[SFAS 129, par. 4 (AC C24.102)]

c.

Do disclosures include the number of shares issued upon conver
sion, exercise, or satisfaction of required conditions during at least
the most recent annual fiscal period and any subsequent interim
period presented?
[SFAS 129, par. 5 (AC C24.103)]

d. Are the following disclosed on the face of the statement of financial
position or in the notes:

(1)

The aggregate or per-share amounts at which preferred stock
may be called or is subject to redemption through sinkingfund operations or otherwise?

(2)

The aggregate and per-share amounts of arrearages in cumu
lative preferred dividends?
[SFAS 129, par. 7 (AC C24.105)]

e.

For preferred stock that has a preference in involuntary liquida
tion considerably in excess of par or stated value of the shares, is
the liquidation preference disclosed? [Note: Disclosure shall be
made in the equity section of the statement offinancial position
in the aggregate, either parenthetically or "in short," rather than
on a per-share basis or through disclosure in the notes.]
[SFAS 129, par. 6 (AC C24.104)]

f.

For redeemable stock, do disclosures include the amount of re
demption requirements, separately by issue or combined, for all
issues of capital stock that are redeemable at fixed or determinable
prices on fixed or determinable dates in each of the five years
following the date of the latest statement of financial position
presented?
[SFAS 129, par. 8 (AC C24.106)]

g. Are any appropriations of retained earnings for loss contingencies
clearly identified and included in stockholders' equity?
[SFAS 5, par. 15 (AC R70.103)]
h. Are restrictions on payment of dividends disclosed?
[SFAS 5, pars. 18 and 19 (AC C59.120)]

i.

Are receivables for stock issued or subscribed appropriately iden
tified and presented as a deduction from capital or, if presented as
an asset, stated separately, clearly labeled, and their status clearly
described to distinguish them from any other type of assets?

♦ j.

Are the carrying basis, the cost and the number of shares disclosed
for treasury stock?
[Generally Accepted]

k. Are preferred stock dividends in arrears and dividend restrictions
disclosed?
[SFAS 5, par. 18 (AC C59.120)]
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No

N/A

Yes

♦ I.

After completion of a quasi-reorganization, is a new retained
earnings account established and dated with the date being dis
closed in subsequent financial statements until it is no longer
deemed significant?
[ARB 43, Ch. 7A, par. 10; ARB 46, par. 2 (AC Q15.111)]

♦ m. Are the nature and extent to which retained earnings is restricted
indicated?
[APB 6, par. 13 (AC C23.104)]
6.

Changes in net assets:
a. When both financial position and results of operations are
presented:
(1)

Are changes in the separate component accounts of equity
disclosed?
[APB 12, par. 10 (AC C08.102)]

(2)

Are changes in the number of shares of capital stock disclosed
for at least the latest year and any subsequent interim periods
presented (for-profit only)?
[APB 12, par. 10 (AC C08.102)]

b. Are prior-period adjustments and their resulting effects (both
gross and net of applicable income taxes) appropriately presented
and disclosed?
[APB 9, par. 26 (AC A35.107)]

c. For a correction of an error, is the nature of the error disclosed in
the period in which the error was discovered and corrected?
(1)

Nature of the error in previously issued financial statements?

(2)

Effect of its correction on income before extraordinary items,
net income, and related per-share amounts, if applicable?
[APB 20, par. 37 (AC C35.105)]

K. Restricted Resources

★ 1.

Are cash or other assets received with a donor-imposed restriction
that limits their use to long-term purposes reported separately from
assets that are unrestricted and available for current use?
[SFAS 117, par. 11 (AC No5.109)]

★ 2.

Does the entity provide information about the nature and amounts of
different types of permanent restrictions and temporary restrictions by
reporting their amounts on the face of the statement of financial position
or by including relevant details in notes to financial statements?
[SFAS 117, par. 14 (AC No5.112)]

Statement of Activities/Income Statement/Statement of
Operations/Statement of Changes in Net Assets
A. General

★ 1.

Does the statement of activities/operations or statement of changes
in net assets report the amount of change in net assets for the period
for the provider as a whole (using a descriptive term such as "change
in net assets" or "change in equity"), and does that amount articulate
to the net assets reported in the statement of financial position?
[SFAS 117, par. 18 (AC No5.116)]
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No

N/A

Yes

★ 2.

★ 3.

Does the statement of activities/operations or the statement of
changes in net assets report the amount of change in permanently
restricted net assets, temporarily restricted net assets, and unre
stricted net assets for the period?
[SFAS 117, par. 19 (AC No5.117)]

Does the statement of activities/operations report the following:
a. Revenues as increases in unrestricted net assets unless the use of
the assets received is limited by donor-imposed restrictions?

____

b. Expenses as decreases in unrestricted net assets?

____

c. Events that simultaneously increase one class of net assets and
decrease another (reclassifications), including expiration of donorimposed restrictions, separately from revenues, expenses, gains,
and losses?
[SFAS 117, pars. 19 and 20 (AC No5.117 and .118); SFAS 116, par.
17 (AC No5.147)]

★ 4.

★ 5.

★ 6.

★ 7.

★ 8.

★ 9.

____

Are revenues and expenses (arising from ongoing activities associated
with health care services) classified as operating and displayed as
gross amounts?
[SFAS 117, par. 24 (AC No5.121)]
If the provider elects to report investment revenues net of related
expenses, does the provider disclose the amount of expenses, either
on the face of the statement of activities or in the notes to the financial
statements?
[SFAS 117, par. 24 (AC No5.121)]
If the entity reports an intermediate measure of operations (for exam
ple, excess or deficit of operating revenues over expenses), is this
intermediate measure reported only in a financial statement that, at a
minimum, reports the change in unrestricted net assets for the period?
[SFAS 117, par. 23 (AC No5.120)]

If the entity's use of the term operations is not apparent from the details
provided on the face of the statement of activities, does a note to
financial statements describe the nature of the reported measure of
operations or the items excluded from operations?
[SFAS 117, par. 23 (AC No5.120)]
If the entity reports net gains and losses or revenue and expense on
its statement of activities/operations, do these net amounts result
from peripheral or incidental transactions or from events largely
beyond the control of the entity and its management?
[SFAS 117, pars. 25 and 138 (AC No5.122)]

Does the not-for-profit provider report total income or loss in a
statement that, at a minimum, also presents the total changes in
unrestricted net assets?
[AAG, par. 10.17]

10. Is management's policy for providing charity care, as well as the level
of charity care provided, disclosed?
[AAG, par. 10.21]
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____

____

____

____

____

____

____

____

No

N/A

Yes

★ 11. Does the statement of activities/operations include a performance
indicator that reports results of operations and that is clearly labeled
with a descriptive term such as revenues over expenses, revenues and
gains over expenses and losses, earned income, or performance earnings?
[AAG, par. 10.17]
★ 12. Do the notes to the financial statements include a description of the
nature and composition of the performance indicator?
[AAG, par. 10.17]

★♦ 13. Does the organization report the following items separately from the
performance indicator:

a. Transactions with owners acting in that capacity?
b. Equity transfers involving other entities that control the reporting
entity, are controlled by the reporting entity, or are under common
control with the reporting entity?

c. Receipt of restricted contributions, including temporary restric
tions (such as time or purpose) or permanent restrictions?
d. Contributions of (and assets released from donor restrictions re
lated to) long-lived assets?

e. Unrealized gains and losses on investments not restricted by
donors or by law, except for those investments classified as trading
securities?
f.

Investment returns restricted by donors or by law?

g. Other items that are required by GAAP to be reported separately
(such as extraordinary items, the effect of discontinued operations,
or the cumulative effect of accounting changes)?
[AAG, par. 10.18]

★♦14. For investments in common stock accounted for by the equity
method, is the investor's share of earnings shown as a single amount
except for investee extraordinary items and prior-period adjustments
that are material to the investor?
[APB 18, pars. 19c and d (AC 182.109c and d)]
★♦ 15. Are total research and development costs charged to expenses dis
closed for each period for which a statement of activities/income
statement is presented?
[SFAS 2, pars. 12 and 13 (AC R50.108 and .109); FASBI4, par. 5 (AC
B50.152); FASBI 6, par. 8 (AC R50.117); SFAS 86, par. 3 (AC Co2.102)]
★♦ 16. If the provider accounts for its obligation under a research and devel
opment arrangement as a contract to perform research and develop
ment for others, is there disclosure of:
a. The terms of significant agreements under the research and develop
ment arrangement as of the date of each balance sheet presented?
b. The amount of compensation earned or costs incurred under such
contracts for each period for which a statement of revenues and
expenses (statement of operations) is presented?
[SFAS 68, par. 14 (AC R55.112)]
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No

N/A

Yes
♦ 17. Are the following excluded from the determination of net income or
results of operations under all circumstances:

a. Adjustments or charges or credits resulting from transactions in
the provider's own capital stock?
b. Transfers to and from accounts properly designated as appropri
ated retained earnings?

c. Adjustments made pursuant to a quasi-reorganization?
[APB 9, par. 28 (AC C08.101)]

★ 18. Are net assets released from restriction, such as those related to the
fulfillment of time or purpose restrictions, reported separately in the
financial statements or disclosed in the notes?
[AAG, par. 10.07]
B. Revenue

★♦ 1.

Is revenue classified based on the type of service (such as patient or
resident) rendered or contracted to be rendered?
[AAG, par. 10.04]

★♦ 2.

Are gains, losses, and interest earned properly classified and reported?
[AAG, par. 10.07]

★♦ 3.

Is patient service revenue reported net of provisions for contractual
charity care and other adjustments?
[AAG, par. 10.20]

★♦4.

Do disclosures include methods of revenue recognition?
[AAG, par. 10.20]

★♦5.

With regard to contractual adjustments and third-party settlements,
does the provider identify and explain the estimated amounts payable
or receivable?
[AAG, par. 10.20]

★ 6.

Is significant revenue earned under capitation arrangements reported
separately?
[AAG, par. 10.20]

C.

Income Taxes

♦ 1.

Are the types of significant temporary differences and carryforwards
disclosed?
[SFAS 109, par. 43 (AC I27.142)]

♦ 2.

Are the following significant components of income tax expense
attributable to continuing operations for each year presented dis
closed in the financial statements or notes thereto:

a. Current tax expense or benefit?
b. Deferred tax expense or benefit (exclusive of the effects of other
components listed below)?
c.

Investment tax credits?
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____
____

____

No

N/A

Yes

d. Government grants (to the extent recognized as a reduction of
income tax expense)?
e. The benefits of operating loss carryforwards?

f.

Tax expense that results from allocating certain benefits, either
directly to contributed capital or to reduce goodwill or other
noncurrent intangible assets of an acquired entity?

g. Adjustments of a deferred tax liability or asset for enacted changes
in tax laws or rates or a change in the tax status of the provider?

h. Adjustments of the beginning-of-the-year balance of a valuation
allowance because of a change in circumstances that causes a
change in judgment about the realizability of the related deferred
tax asset in future years?
i.

Any portion of the valuation allowance for deferred tax assets for
which subsequently recognized tax benefits will be allocated to
reduce goodwill or other noncurrent intangible assets of an ac
quired entity or directly to contributed capital?
[SFAS 109, pars. 45 and 48 (AC I27.144 and .147)]

♦ 3.

Is the amount of income tax expense or benefit allocated to continuing
operations and the amounts separately allocated to other items dis
closed for each year for which those items are presented?
[SFAS 109, pars. 35-39 and 46 (AC I27.134-.138 and .145)]

♦ 4.

a.

Is a reconciliation for public enterprises disclosed by the use of
percentages or dollars of (i) the reported amount of income tax
expense attributable to continuing operations for the year to date
to (ii) the amount of income tax expense that would result from
applying domestic federal statutory rates to pretax income from
operations?

b. Is the nature of significant reconciling items (omission of numerical
reconciliation is permitted) for a non-public enterprise disclosed?

c. If not otherwise evident, are the nature and effect of any other
significant matters affecting comparability of information for all
periods present?
[SFAS 109, par. 47 (AC 127.145)]

♦ 5.

Are the amounts and expiration dates of operating loss and tax credit
carryforwards for tax purposes disclosed?
[SFAS 109, par. 48 (AC I27.147)]

♦ 6.

If the provider is a member of a group that files a consolidated tax
return, are the following items disclosed in its separately-issued finan
cial statements:

a. The aggregate amount of current and deferred tax expense for
each period presented, and the amount of any tax-related balances
due to or from affiliates as of the date of each balance sheet
presented?
b. The method by which the consolidated amount of current and de
ferred tax expense is allocated to members of the group and the
nature and effect of any changes in that method (and in determining
related balances to or from affiliates) for each period presented?
[SFAS 109, par. 49 (AC I27.148)]
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No

N/A

Yes
♦ 7.

Are the amounts of income taxes applicable to the results of discon
tinued operations disclosed on the income statement or in related
notes?
[APB 30, par. 8 (AC I13.105)]

♦ 8.

Are the income taxes applicable to extraordinary events disclosed on
the face of the income statement or in related notes?
[APB 30, par. 11 (AC I17.102)]

D. Discontinued Operations
1.

Are operations of a segment that are discontinued or are the subject
of a formal plan for disposition:
a. Reported separately from continuing operations and as a compo
nent (including applicable income taxes) of income before extraor
dinary items and the cumulative effect of accounting changes (if
any)?
b. Accompanied by disclosure in the notes of revenue applicable to
the discontinued operations?
[APB 30, par. 8 (AC I13.105)]

★♦2.

Is gain or loss from disposal of a discontinued segment reported
separately (including applicable income taxes) in conjunction with
results of discontinued operations as a component of income before
extraordinary items and the cumulative effect of accounting changes
(if any)?
[APB 30, pars. 8,13, and 15-18 (AC I13.101-.103, .105, .106, .108, and
.109)]

3.

If a provider has accounted for the discontinuance of a segment in
accordance with APB 30 and subsequently decides to retain the seg
ment, is any impairment write-down of the individual assets classi
fied in continuing operations?
[EITF 90-16]

4.

If the entity plans to dispose of two segments of a business, and a net
gain is expected (one has a net gain and the other a net loss), is that
gain shown net?
[EITF 85-36]

5.

Are the revenues applicable to the discontinued operations disclosed
in the notes to the financial statements?
[APB 30, par. 8 (AC I13.105)]

★♦6.

For the period encompassing the measurement date, do notes to
financial statement disclose:

a. Identity of the segment discontinued?
b. Expected disposal date, if known?

c. Expected manner of disposal?
d. Description of the remaining assets and liabilities of the discontin
ued segment at the balance-sheet date?

e. Results of operations and any proceeds from disposal of the
discontinued segment during the period from the measurement
date to the balance-sheet date?
[APB 30, par. 18 (AC I13.108)]
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No

N/A

Yes
7.

If the loss on disposal cannot be estimated within reasonable limits,
is that fact disclosed?
[APB 30, par. 18, fn. 7 (AC I13.109)]

8.

For periods subsequent to the measurement date and including the
period of disposal, do notes to the financial statements disclose the
information listed in Questions 6a, b, c, and d above as well as the
information in 6e compared with prior estimates?
[APB 30, par. 18 (AC I13.108)]

★♦9.

If the entity decides to dispose of a segment of a business and the
measurement date occurs after the balance-sheet/statement-of-financial-position date but before the financial statements for the prior
period have been issued:

a. Are the segment's operating results presented as discontinued
operations in the income statement/statement of operations of the
not-yet-released financial statements?
b. Is the estimated loss on disposal recognized in the period that
includes the measurement date, if the decision to dispose of the
segment results from a discrete and identifiable event that occurs
unexpectedly after the balance-sheet date?

c. Is the estimated loss on disposal recognized in the period prior to
the measurement date, if the decision to dispose of the segment
does not result from a discrete and identifiable event that occurs
unexpectedly after the balance-sheet date?
[EITF 95-18]
E. Extraordinary Items
1.

Are extraordinary items segregated and shown (including applicable
income taxes) after income before extraordinary items and before net
income?
[APB 30, pars. 10-12 (AC I17.102 and .103)]

2.

Are descriptive captions and amounts (including applicable income
taxes) presented for individual extraordinary events or transactions,
preferably on the face of the statement of operations/income state
ment, if practicable?
[APB 30, par. 11 (AC I17.102)]

★♦3.

Do disclosures include descriptions of extraordinary events or trans
actions and the principal items entering into determination of extraor
dinary gains or losses?
[APB 30, par. 11 (AC I17.102)]

4.

For an adjustment of an extraordinary item reported in a prior period
(except for correction of an error):

a. Is the adjustment classified separately as an extraordinary item in
the current period?
b. Are the nature, origin, and amount of the item disclosed?
[SFAS 16, par. 16(c) (AC I17.119)]

F. Unusual or Infrequent Items
1.

Are material events or transactions that are either unusual in nature
or of infrequent occurrence, but not both (and therefore not meeting
criteria for extraordinary items):
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No

N/A

Yes

No

____

___

____

___

a. The accounting policy selected from the two alternatives in the
beginning of paragraph 26 of SOP 93-7 for reporting advertising,
indicating whether such costs are expensed as incurred or the first
time the advertising takes place?

____

___

b. A description of the direct-response advertising reported as assets
(if any), the accounting policy for it, and the amortization period?

____

___

c. The total amount charged to advertising expense for each state
ment of activities/income statement presented, with separate dis
closure of amounts, if any, representing a write-down to net
realizable value?

____

___

____

___

a. A description of the programs or activities for which those services
were used, including the nature and extent of contributed services
received for the period and the amount recognized as revenues for
the period?

____

___

b. The fair value of contributed services received but not recognized,
if practicable (optional)?

____

___

c. Nonmonetary information such as the number and trends of
donated hours received or service outputs provided by volunteer
efforts (optional)?

____

___

____

___

a. Reported as a separate component of income from continuing
operations?
b. Accompanied by disclosure of the nature and financial effects of
each event?
[APB 30, par. 26 (AC I22.101)]

G. Advertising Costs
1.

Do disclosures for advertising costs include:

d. The total amount of advertising reported as assets in each balance
sheet/statement of financial position presented?
[SOP 93-7, par. 49]

H. Donated or Contributed Services

★ 1.

If the provider receives contributed services, does it disclose the
following:

d. Dollar amount of contributions raised by volunteers (optional)?
[SFAS 116, pars. 10 and 123 (AC C67.110)]

I.

Fund Raising

Note: SOP 98-2, Accounting for Costs ofActivities ofNot-for-Profit Organiza
tions and State and Local Governmental Entities That Include Fund Raising, is
effective for financial statements for years beginning on or after December
15,1998. Earlier application is encouraged in fiscal years for which finan
cial statements have not been issued. If comparative financial statements
are presented, retroactive application is permitted but not required.

★ 1.

Do financial statement disclosures include:

a. The types of activities for which joint costs have been incurred?
b. A statement that such costs have been allocated?

31

N/A

Yes
c. The total amount allocated during the period and the portion
allocated to each functional expense category?
[SOP 98-2, par. 18]

Note: SOP 98-2 encourages, but does not require, that the amount of joint
costs for each kind of joint activity be disclosed, if practical.
J.

Contributions/Pledges

★ 1.

Does the provider distinguish between contributions received with per
manent restrictions, those received with temporary restrictions, and
those received without donor-imposed restrictions, so that they are
reported as support increasing permanently restricted net assets, tempo
rarily restricted net assets, or unrestricted net assets, respectively?
[SFAS 116, par. 14 (AC No5.143)]

★ 2.

If donor-restricted contributions whose restrictions are met in the
same reporting period are reported as unrestricted support, is such
treatment consistent from period to period and is the policy disclosed?
[SFAS 117, par. 21; SFAS 116, par. 14 (AC No5.143)]

★ 3.

Does the provider report receipt of unconditional promises to give
with payments due in future periods as restricted support, unless
explicit donor stipulations or circumstances surrounding the receipt
of the promise make clear that the donor intended the contribution to
be used to support activities of the current period?
[SFAS 116, par. 15 (AC No5.144)]

★4.

Does an entity that receives gifts of long-lived assets without donor
stipulation about how long the donated asset must be used:

a. Disclose its accounting policy of implying or not implying a time
restriction that expires over the useful life of the asset?
b. Report such support as restricted if it is the provider's policy to
imply a time restriction that expires over the useful life of the
donated asset?

c. Report such support as unrestricted in the absence of such a
policy?
[SFAS 116, par. 16 (AC No5.145)]

★ 5.

Does a provider that receives unconditional promises to give, in
which cash promised will be received in future periods, measure the
fair value of the contribution as the present value of estimated future
cash flows, using a discount rate commensurate with the risks in
volved, and report subsequent accruals of the interest element as
contribution income increasing either the temporarily or permanently
restricted class of net assets if the underlying promise to give is donor
restricted?
[SFAS 116, par. 20 (AC C67.116)]

★ 6.

In discounting unconditional promises to give (as described in Step
5), are the provisions of APB 21 applied?
[SOP 94-2, par. 20]

7.

Are unrestricted pledges/contributions reported in the statement of
operations?
[AAG, par. 10.08]
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No

N/A

Yes

K. Expenses

L.

★ 1.

Does the provider provide information about expenses reported by
their functional classification (such as major classes of program serv
ices and supporting services) either in the statement of activities or in
notes to financial statements?
[SFAS 117, par. 26 (AC No5.123)]

★ 2.

For deferred compensation agreements, are estimated amounts to be
paid properly accrued?
[APB 12, pars. 6 and 7 (AC C38.101 and .102)]

Wills

★♦1.

If the entity receives a promise to give conditioned on a future
uncertain event that is contained in a will and the will has been
declared valid by the probate court, has the provider disclosed the
conditional promise to give?
[SFAS 116, par. 208 (AC C67.160)]

M. Endowments

★ 1.

Does the provider report gains and losses on endowments in the
following manner:

a. As an increase or decrease in permanently restricted net assets if the
governing board has determined that the relevant law requires the
entity to retain permanently some portion of gains on investments?
[SFAS 117, pars. 22 and 129 (AC No5.119)]
b. As an increase or decrease in unrestricted or temporarily restricted
net assets, whichever is consistent with the reporting of the en
dowment's income in the absence of such a law noted in Step a.?
[SFAS 117, par. 129 (AC No5.119, fn. 8)]

N. Earnings Per Share
Note: SFAS 128, Earnings per Share, applies only to entities with publicly
held common stock or potential common stock.

♦ 1.

Are earnings per share (EPS) data presented for all periods for which
an income statement or summary of earnings is presented?
[SFAS 128, par. 38 (AC E11.133)]

♦ 2.

If diluted EPS data are reported for at least one period, are they reported
for all periods presented, even if they are the same amounts as basic EPS?
[SFAS 128, par. 38 (AC E11.133)]

♦ 3.

For entities with only common stock outstanding, are basic EPS
amounts for income from continuing operations and for net income
presented on the face of the income statement?
[SFAS 128, par. 36 (AC E11.131)]

♦ 4.

For entities with potential common stock, are basic and diluted EPS
amounts for income from continuing operations and for net income
presented on the face of the income statement with equal prominence?
[SFAS 128, par. 36 (AC E11.131)]

♦ 5.

If discontinued operations, extraordinary items, or the cumulative
effect of accounting changes are reported in a period, are the basic and
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No

N/A

Yes

diluted per share amounts for those line items presented on the face
of the income statement or in the notes?
[SFAS 128, par. 37 (AC E11.132)]

♦ 6.

♦ 7.

If per share amounts not required to be presented by SFAS 128 are
disclosed, are they disclosed only in the notes and do the disclosures
indicate whether the per share amounts are pretax or net of tax?
[SFAS 128, par. 37 (AC E11.132)]

____

Are the following disclosed for each period for which an income
statement is presented:

a. A reconciliation of the numerators and denominators of the basic
and diluted per share computations for income from continuing
operations?

____

b. The effect that has been given to preferred dividends in arriving at
income available to common stockholders in computing basic EPS?

____

c. Securities (including those issuable pursuant to contingent stock
agreements) that could potentially dilute basic EPS in the future
that were not included in the computation of diluted EPS because
to do so would have been antidilutive for the period(s) presented?
[SFAS 128, par. 40 (AC E11.135)]

♦ 8.

____

For the latest period for which an income statement is presented, do
disclosures include a description of any transaction that occurs after
the end of the most recent period but before issuance of the financial
statements that would have changed materially the number of com
mon shares or potential common shares outstanding at the end of the
period if the transaction had occurred before the end of the period?
[SFAS 128, par. 41 (AC E11.136)]

____

____

O. Comprehensive Income
♦ 1.

♦ 2.

♦ 3.

♦ 4.

If there are components of other comprehensive income (SFAS 130,
paragraphs 5 and 10) for the period presented, is comprehensive
income reported?
[SFAS 130, par. 15 (AC C49.109)]

Is total comprehensive income displayed in the financial statement in
which the components of other comprehensive income are reported?
[SFAS 130, par. 14 (AC C49.108)]
Is other comprehensive income classified separately into foreign cur
rency items, minimum pension liability adjustments, and unrealized
gains and losses on certain investments in debt and equity securities?
[SFAS 130, par. 17 (AC C49.111)]

Are reclassification adjustments presented on the face of the financial
statement in which comprehensive income is reported or disclosed in
the notes?
[SFAS 130, par. 20 (AC C49.114)]

♦ 5.

Is net income displayed as a component of comprehensive income?
[SFAS 130, par. 22 (AC C49.116)]

♦ 6.

(Not required, but encouraged) Are the components of other compre
hensive income and total comprehensive income displayed below the
total for net income?
[SFAS 130, par. 23 (AC C49.117)]
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____

____

____

____
____

____

No

N/A

Yes
7.

Are the components of other comprehensive income displayed either
net of related tax effects, or before related tax effects with one amount
shown for the aggregate tax effect related to the total of other compre
hensive income items?
[SFAS 130, par. 24 (AC C49.118)]

♦ 8.

Is the amount of income tax expense or benefit allocated to each
component of other comprehensive income (including reclassifica
tion adjustments) disclosed in the notes?
[SFAS 130, par. 25 (AC C49.119)]

♦ 9.

Is the total of other comprehensive income for a period transferred to a
component of equity that is displayed separately from retained earnings
and additional paid-in-capital in a statement of financial position with a
descriptive title such as accumulated other comprehensive income?
[SFAS 130, par. 26 (AC C49.120)]

♦ 10. Are accumulated balances for each classification within accumulated
other comprehensive income disclosed on the face of the statement of
financial position, in a statement of changes in equity, or in the notes?
[SFAS 130, par. 26 (AC C49.120)]
♦ 11. If condensed interim financial statements are issued, is total compre
hensive income reported?
[SFAS 130, par. 27 (AC C49.121)]

♦ 12. Are unrealized holding gains and losses for available-for-sale securi
ties, including those classified as current assets, reported in other
comprehensive income?
[SFAS 115, par. 13, as amended by SFAS 130 (AC I80.110)]

★♦ 13. If an additional pension liability is required to be recognized and
exceeds unrecognized prior service cost, is the excess (which would
represent a net loss not yet recognized as net periodic pension cost)
reported in other comprehensive income net of any tax benefits that
result from considering such losses as temporary differences?
[SFAS 87, par. 37, as amended by SFAS 130 (AC P16.131)]
Note: Questions 14 and 15 apply only if SFAS 133, Accountingfor Derivative
Instruments and Hedging Activities, has been adopted. SFAS 133 is effective for
all fiscal quarters of fiscal years beginning after June 15,1999.
The FASB has issued an exposure draft dated May 20, 1999 of a
proposed Statement titled "Accounting for Derivative Instruments and
Hedging Activities—Deferral of the Effective Date of FASB Statement
No. 133, an amendment of FASB Statement No. 133," which would
amend SFAS 133 to defer its effective date to all fiscal quarters of all
fiscal years beginning after June 15, 2000. The comment deadline was
June 19, 1999. Users of this checklist should be alert to the issuance of
a final pronouncement.

♦ 14. Has the entity displayed as a separate classification within other
comprehensive income the net gain or loss on derivative instruments
designated and qualifying as cash flow hedging instruments that are
reported in comprehensive income pursuant to paragraphs 30 and 41
of SFAS 133?
[SFAS 133, par. 46 (AC D50.143)]
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No

N/A

Yes

No

N/A

♦ 15. As part of the disclosures of accumulated other comprehensive in
come, pursuant to paragraph 26 of SFAS 130, Reporting Comprehensive
Income, has the entity separately disclosed the beginning and ending
accumulated derivative gain or loss, the related net change associated
with current period hedging transactions, and the net amount of any
reclassification into earnings?
[SFAS 133, par. 47 (AC D50.144)]

Statement of Cash Flows2
1.

Is a statement of cash flows presented as a basic financial statement for
each period for which both a statement of financial position/balance
sheet and a statement of activities/income statement is presented?
[SFAS 95, par. 3, as amended by SFAS 117, par. 30a (AC C25.101);
AAG, par. 1.07]

2.

Does the statement of cash flows show the change in cash and cash
equivalents?
[SFAS 95, par. 7 (AC C25.105)]

3.

Is the policy for defining cash equivalents disclosed?
[SFAS 95, par. 10 (AC C25.108)]

Note: Any change in policy for determining which items are treated as
cash equivalents is a change in accounting principle.

★♦4.

5.

If the direct method is used, is a separate schedule provided to
reconcile net income of an investor-owned provider or change in net
assets (or excess of revenue and support over expenses) of a not-forprofit provider to net cash flow from operating activities?
[SFAS 95, par. 30, as amended by SFAS 117, par. 30f (AC C25.128)]

If the indirect method is used:

a. Is the same amount for net cash flow from operating activities
reported indirectly by adjusting net income of an investor-owned
provider or change in net assets (or excess of revenue and support
over expenses) of a not-for-profit provider to reconcile it to net
cash flow from operating activities?
[SFAS 95, par. 28, as amended by SFAS 117, par. 30f (AC C25.126)]
b. Is the reconciliation of net income of an investor-owned provider or
change in net assets (or excess of revenue and support over expenses)
of a not-for-profit provider to net cash flows from operating activities
reported, either within the statement of cash flows or provided in a
separate schedule, with the statement of cash flows reporting only
the net cash flow from operating activities?
[SFAS 95, par. 30, as amended by SFAS 117, par. 30f (AC C25.128)]
2 SFAS 95, Statement of Cash Flows, and GASB Statement 9, Reporting Cash Flows of Proprietary and Nonexpendable Trust Funds and
Governmental Entities That Use Proprietary Fund Accounting, established standards for cash flow reporting for investor-owned
organizations and governmental entities, respectively. SFAS 95 excludes not-for-profit organizations from its scope; however, not-forprofit health care entities should apply the provisions of SFAS 95 to ensure that their financial statements are comparable with those of
investor-owned entities. The statement of cash flows may be prepared using the direct or indirect method of reporting cash flows.
(SFAS 117 amends SFAS 95 to extend its provisions to not-for-profit organizations and to extend its description of cash flows from
financing activities to include certain donor-restricted cash that must be used for long-term purposes.)
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Yes

★♦ 6.

Are cash receipts and cash payments from operating activities shown
separately on the statement of cash flows?
[SFAS 95, par. 27 (AC C25.125)]

7.

Are cash receipts and cash payments for the following transactions
classified as cash flows from operating activities:

a. Interest received on loans?
b. Insurance proceeds except those directly related to investing or
financing activities?

c. Interest paid to creditors?

d. Payments to suppliers and employees?
e. Payments to governments for taxes, duties, fines, and other fees
or penalties?
f.

Payments to settle lawsuits?

g. Contributions to charities?
[SFAS 95, pars. 22 and 23 (AC C25.120 and .121)]
h. Cash flows from purchases, sales, and maturities of trading secu
rities?
[SFAS 115, par. 18 (AC I80.117); AAG, par. 4.15]

8.

Are cash receipts and cash payments from investing activities shown
separately on statement of cash flows?
[SFAS 95, par. 31 (AC C25.129)]

9.

Are cash receipts and cash payments for the following transactions
classified as cash flows from investing activities:

a. Receipts from collections or sales of loans?
b. Receipts from sales of property?

c. Loans to others?
d. Payments to acquire property?

e. Purchases of and proceeds from sales of available-for-sale securi
ties?
f.

Proceeds from maturities of available for sale and held-to-matur
ity securities?

g. Purchases of held-to-maturity securities?
[SFAS 95, pars. 16 and 17 (AC C25.114 and .115); SFAS 115, par. 18
(AC I80.117)]

★♦ 10. Are cash receipts and cash payments from financing activities shown
separately on the statement of cash flows?
[SFAS 95, par. 31 (AC C25.129)]

★♦11. Are cash receipts and cash payments for the following transactions
classified as cash flows from financing activities:
a. Proceeds from issuing debt?
b. Repayments for amounts borrowed?
[SFAS 95, pars. 19 and 20 (AC C25.117 and .118)]

c. Cash payments for debt issue costs?
[EITF 95-13]
37

No

N/A

Yes

12. Are investing and financing activities that affect recognized assets or
liabilities but that do not result in cash receipts or cash payments
disclosed?
[SFAS 95, par. 32, as amended by SFAS 117, par. 30g (AC C25.134)]
13. In its statement of cash flows, does the organization include in cash
flows from financing activities any amounts received with donor-im
posed stipulations that they must be used for long-term purposes?
[SFAS 117, par. 30c (AC C25.116)]

14. Are the following classes of operating cash receipts and payments for
providers using the direct method, at a minimum, separately disclosed:
a. Cash received from service recipients?
b. Cash received from contributors?

c. Interest and dividends received?

d. Cash collected on contributions receivables?
e. Other operating cash receipts, if any?
f.

Cash paid to employees and suppliers?

g. Interest paid?
h. Income taxes paid?

i.

Grants paid?

j.

Other operating cash payments, if any?
[SFAS 95, par. 27, as amended by SFAS 117, par. 30e (AC C25.125)]

Note: SFAS 95 encourages enterprises to provide further breakdowns of
operating cash receipts and payments that they consider meaningful and
feasible.
15. Is the reconciliation of net income to net cash flow from operating
activities, including separate reporting of all major classes of reconcil
ing items, presented?
[SFAS 95, par. 29 (AC C25.127)]

★♦16. If the indirect method of reporting net cash flow from operating
activities is used, are amounts of interest paid (net of amounts capi
talized) and income taxes paid during the period provided in related
disclosures?
[SFAS 95, par. 29 (AC C25.127)]

Other Financial Statement Disclosures
A. Accounting Changes

★ 1.

In the initial year of application of SFAS 117, is the nature of any
restatement and its effect on the change in net assets for each period
presented disclosed?
[SFAS 117, par. 31]

★ 2.

For a not-for-profit health care organization, in the initial year of
application of SFAS 116, is the nature of any restatement and its effect
on the change in net assets for each period presented disclosed?
[SFAS 116, par. 30]
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No

N/A

Yes
♦ 3.

For an investor-owned health care organization, in the initial year of
application of SFAS 116, is the restatement accounted for as a change
in accounting principle applied retroactively in accordance with APB
20, paragraphs 27 and 28?
[SFAS 116, par. 30]

♦ 4.

For a not-for-profit health care organization, if SFAS 116 is not applied
retroactively, is the cumulative effect of the change in accounting on
each class of net assets reported in the statement of activities between
the captions "extraordinary items," if any, and "change in unre
stricted net assets," "change in temporarily restricted net assets," and
"change in permanently restricted net assets"?
[SFAS 116, par. 29]

♦ 5.

For an investor-owned health care organization, if SFAS 116 is not
applied retroactively, is the cumulative effect of the change in ac
counting reported in the income statement between the captions
"extraordinary items," if any, and "net income"?
[SFAS 116, par. 29]

♦ 6.

For a not-for-profit health care organization, in the initial year of appli
cation of the June 1996 Guide, is the nature of any restatement and its
effect on the change in net assets for each period presented disclosed?
[AAG, Preface]

♦ 7.

For an investor-owned health care organization, in the initial year of
application of the June 1996 Guide, is the restatement accounted for
as a change in accounting principle applied retroactively in accord
ance with APB 20, paragraphs 27 and 28?
[AAG, Preface]

♦ 8.

For a not-for-profit health care organization, if the June 1996 Guide is
not applied retroactively, is the cumulative effect of the change in
accounting on each class of net assets reported in the statement of
activities between the captions "extraordinary items," if any, and
"change in unrestricted net assets," "change in temporarily restricted
net assets," and "change in permanently restricted net assets"?
[AAG, Preface]

♦ 9.

For an investor-owned health care organization, if the June 1996
Guide is not applied retroactively, is the cumulative effect of the
change in accounting reported in the income statement between the
captions "extraordinary items," if any, and "net income"?
[AAG, Preface]

10. For an accounting change, does disclosure in the period of the change
include:
a. Nature of the change?
b. Justification for the change, including a clear explanation of why
the newly adopted principle is preferable?

c.

Effect on income?
[APB 20, par. 17 (AC A06.113)]

★♦11. For other changes in accounting principle (excluding specific excep
tions related to an initial public offering, change in the reporting entity,
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No

N/A

Yes

or adoption of certain authoritative pronouncements), is the presen
tation and disclosure guidance in APB 20 properly applied?
[APB 20, pars. 17-22 and 24-26 (AC A06.113-.118, .121, and .122);
FASBI 20, par. 5, as amended by SFAS 111 (A06.127)]
12. Is the correction of an error shown as a prior-period adjustment
with disclosure of the following in the period of its discovery and
correction:
a. Nature of the error in previously issued financial statements?
b. Effect of its correction on revenue and gains in excess of expenses
and losses (income) before extraordinary items and net revenue
and gains in excess of expenses and losses (net income) (and
related per share amounts if applicable)?
[APB 20, par. 37 (AC A35.105); SFAS 109, par. 288n (AC A35.103)]

B. Accounting Policies

★♦1.

Is a description of all pertinent accounting policies of the provider
presented as an integral part of the financial statements?
[APB 22, pars. 8 and 9 (AC A10.102 and .103)]

2.

Does disclosure of significant accounting policies encompass impor
tant judgments as to the appropriateness of principles concerning
recognition of revenue and allocation of asset costs to current and
future periods?
[APB 22, par. 12 (AC A10.105)]

3.

Does disclosure of significant accounting policies include appropriate
reference to details presented elsewhere (in the statements and notes
thereto) so duplication of details is avoided?
[APB 22, par. 14 (AC A10.107)]

C. Business Combinations

Note: EITF 97-2, Application of FASB Statement No. 94 and APB Opinion No.
16 to Physician Practice Management Entities and Certain Other Entities with
Contractual Management Arrangements, provides guidance to assist physi
cian practice management companies (PPMs) in applying APB 16 when
PPMs acquire a physician practice.

★♦1.

If a business combination occurred during the period and met the
specified conditions for a pooling-of-interests, do the statements and
notes include the required disclosures?
[APB 16, pars. 63-65 (AC B50.122-.124)]

Note: Not-for-profit organizations are, under certain circumstances, per
mitted to use the pooling-of-interests method, even though they generally
do not issue common stock. [AAG, pars. 1.33 and 1.34]

2.

If a business combination occurred during the period and is to be
accounted for under the purchase method, do the statements and
notes include the required disclosures?
[APB 16, pars. 95 and 96 (AC B50.164 and .165); SFAS 79, par. 6 (AC
B50.165); SFAS 38, par. 10 (AC B50.166)]
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No

N/A

Yes

D. Commitments and Contingencies
1.

Uninsured medical malpractice claims:

a. If a minimum amount of a probable loss (usually associated with
litigating or settling malpractice claims) is accrued, is there disclo
sure as to a reasonable possibility of an additional potential loss
in excess of the amount accrued?
[AAG, par. 8.07; SFAS 5 (AC C59)]
b. If a range of loss cannot be reasonably estimated, is a contingency
disclosed?
[AAG, par. 8.11; SFAS 5 (AC C59)]

c. Is the program of medical malpractice coverage and basis for loss
accruals disclosed?
[AAG, par. 8.11]
d. If the provider discounts accrued malpractice claims, are the fol
lowing disclosed:

2.

(1)

The carrying amount of the claims?

(2)

The interest rates or other rates used to discount the claims?
[AAG, par. 8.12]

Retrospectively rated premiums:

a. If the provider cannot estimate losses from asserted or unasserted
malpractice claims, is the existing contingency disclosed?
[AAG, par. 8.14; SFAS 5 (AC C59)]
b. Does the provider disclose that it is insured under a retrospec
tively rated policy?
[AAG, par. 8.15]

c. Does the provider disclose that premiums are accrued based on
the ultimate cost of the experience to date of a group of entities?
[AAG, par. 8.15]

3.

Medical malpractice claims insured with captive insurance compa
nies (controlled by a parent entity for the main purpose of providing
insurance for the parent):
a. Does the provider disclose that it is insured under a retrospec
tively rated policy of a multiprovider captive?
[AAG, par. 8.18]
b. Does the provider disclose that premiums are accrued based on
the captive's experience to date?
[AAG, par. 8.18]
c. Is the provider's ownership percentage in the captive disclosed?
[AAG, par. 8.19]

d. Is the method of accounting for its investment in and the opera
tions of the captive disclosed?
[AAG, par. 8.19]

e. If the provider cannot make the necessary estimates of losses
from asserted or unasserted claims, does it disclose the existing
contingency?
[AAG, par. 8.19; SFAS 5 (AC C59)]
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N/A

Yes

4.

Trust funds:

a. If trust funds (revocable or irrevocable) are included in the
provider's financial statements:

5.

(1)

Is a portion of the funds (the amount of assets expected to be
liquidated to pay malpractice claims classified as current
liabilities) classified as a current asset in a classified balance
sheet/statement of financial position?
[AAG, par. 8.20]

(2)

Is the balance of the funds, if any, classified as a noncurrent
asset in a classified balance sheet/statement of financial po
sition?
[AAG, par. 8.20]

(3)

Are trust fund revenue and administrative expenses included
in the statement of activities (statement of operations)?
[AAG, par. 8.20]

(4)

Are estimated losses from asserted and unasserted claims
reported?
[AAG, par. 8.21]

(5)

Is the existence of trust funds and whether they are irrevoca
ble disclosed?
[AAG, par. 8.22]

Prepaid health care services:

a. Health care costs:
(1)

Is the basis for accruing health care costs disclosed?

(2)

Are significant business and contractual arrangements with
hospitals, physicians, and other associated entities disclosed?
[AAG, par. 13.04]

b. Stop-loss insurance:
(1)

Are receivables representing amounts recoverable from in
surers reported as assets net of any valuation allowance?

(2)

Are the nature, amounts, and effects of significant stop-loss
insurance contracts disclosed?
[AAG, par. 13.08]

c. Loss contracts:
(1)

Are losses recognized, in accordance with SFAS 5, when it is
probable that expected future health care costs and mainte
nance costs under a group of existing contracts will exceed
anticipated future premiums and stop-loss insurance on
those contracts?
[AAG, par. 13.06]

d. Contract acquisition costs:
(1)

Are acquisition costs of providers of prepaid health care serv
ices, other than costs of advertising, expensed as incurred?
[AAG, par. 13.10]
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No

N/A

Yes
6.

Other disclosures:
a. Are the nature and, if applicable, amount (or a statement that no
loss estimate can be made) disclosed for loss contingencies (includ
ing guarantees)?
[SFAS 5, pars. 9-12 and FASBI 34, pars. 2 and 3 (AC C59.108-.114)]
b. If exposure to loss exists in excess of the amount accrued for a loss
contingency, do disclosures include the excess amount or state that
no estimate is possible?
[SFAS 5, par. 10 (AC C59.109)]
c. Are gain contingencies adequately disclosed with care to avoid
misleading implications as to the likelihood of realization?
[SFAS 5, par. 17 (AC C59.118)]

d. Are the nature, term, amount and other required information
disclosed for long-term unconditional purchase obligations?
[SFAS 47, pars. 7 and 10a (AC C32.102 and .105a)]
e. Are the nature and amount of guarantees disclosed (for example,
of indebtedness of others)?
[SFAS 5, par. 12 (AC C59.113); FASBI 34, pars. 2 and 3 (AC
C59.114)]
Is there adequate disclosure of commitments such as those for
plant acquisition or an obligation to reduce debts, maintain work
ing capital, or restrict dividends?
[SFAS 5, pars. 18 and 19 (AC C59.120)]
g. If an obligation for postemployment benefits (other than pensions)
is not accrued in accordance with SFAS 5 (AC C59) or SFAS 43 (AC
C44) only because the amount cannot reasonably be estimated, is
the fact of nonaccrual disclosed in the financial statements?
[SFAS 112, par. 7 (AC P32.105)]

h. Are environmental remediation obligations reported and dis
closed in accordance with SOP 96-1?
[SOP 96-1]

E. Costs to Exit an Activity
1.

If a material liability is recognized for certain employee termination
benefits in accordance with Section A of EITF 94-3, Liability Recognition
for Certain Employee Termination Benefits and Other Costs to Exit an
Activity (including Certain Costs Incurred in a Restructuring), are the
following disclosures made in all periods until the plan of termination
is completed:
a. The amount of termination benefits accrued and charged to ex
pense and the classification of those costs in the income state
ment/ statement of activities?
b. The number of employees to be terminated?

c. A description of the employee group(s) to be terminated?
d. The amount of actual termination benefits paid and charged
against the liability and the number of employees actually termi
nated as a result of the plan to terminate employees?

e. The amount of any adjustment(s) to the liability?
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No

N/A

Yes

★♦2.

If management commits to an exit plan that meets the criteria in
Section B of EITF 94-3, are the following reporting requirements
followed:
a. Reporting the income statement effect of recognizing a liability at
the commitment date in income from continuing operations and
not on the face of the income statement net of taxes?

b. No disclosure made on the face of the income statement for
earnings per share effect?
c. Revenue and related costs and expenses of activities that will not
be continued should not be combined and reported as a separate
component of income?
[EITF 94-3, Section B]

3.

If the activities that will not be continued are significant to the enter
prise's revenue or operating results, or if the exit costs recognized at
the commitment date are material, are the following disclosures made
in all periods until the exit plan is completed:
a. A description of the major actions comprising the exit plan, activi
ties that will not be continued, including the method of disposi
tion, and the anticipated date of completion?
b. A description of the type and amount of exit costs recognized as
liabilities and the classification of those costs in the income state
ment/statement of activities?
c. A description of the type and amount of exit costs paid and
charged against the liability?

d. The amount of any adjustment(s) to the liability?
e. For all periods presented, the revenue and net operating income
or losses from activities that will not be continued if those activities
have separately identifiable operations?
[EITF 94-3, Section B]
F. Derivatives
Note: If SFAS 133, Accounting for Derivative Instruments and Hedging Ac
tivities, has been adopted, the following Questions do not apply. See
Section G1 for the required disclosures. SFAS 133 is effective for all fiscal
quarters of fiscal years beginning after June 15,1999.

The FASB has issued an exposure draft dated May 20,1999 of a proposed
Statement titled "Accounting for Derivative Instruments and Hedging
Activities—Deferral of the Effective Date of FASB Statement No. 133, an
amendment of FASB Statement No. 133," which would amend SFAS 133
to defer its effective date to all fiscal quarters of all fiscal years beginning
after June 15,2000. The comment deadline was June 19,1999. Users of this
checklist should be alert to the issuance of a final pronouncement.
1.

For options held and other derivative financial instruments not within
the scope of SFAS 105 that do not have off-balance-sheet risk, are the
following disclosures made by category of financial instrument:
a. The face or contract amount (or notional principal amount if there
is no face or contract amount)?
b. The nature and terms, including a discussion of:
(1) Credit and market risk?

(2)

Cash requirements?
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N/A
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(3)

Related accounting policy as required by APB 22?

c. Do disclosures in Steps a. and b. above distinguish between finan
cial instruments held or issued for:

★♦2.

(1)

Trading purposes, including dealing and other trading activi
ties measured at fair value with gains and losses recognized
in earnings?

(2)

Purposes other than trading?
[SFAS 119, pars. 8 and 9 (AC Appendix E, F25.115L-.115M)]

Does the provider that holds or issues derivative financial instru
ments for trading purposes disclose:
a. The average fair value during the reporting period and the related
end-of-period fair value, distinguishing between assets and li
abilities?
b. The net gains or losses (net trading revenue) arising from trading
activities during the reporting period disaggregated by class, busi
ness activity, risk or other category consistent with management
of those activities and where those net trading gains or losses are
reported in the income statement?

(1)

If the disaggregation is other than by class, did the provider
also disclose for each category the classes of derivative finan
cial instruments, other financial instruments, and nonfinan
cial assets and liabilities from which the net trading gains and
losses arose?

c. The average fair value for assets and liabilities from the trading of
other types of financial instruments or non financial assets? (This
disclosure is encouraged but not required.)
[SFAS 119, par. 10 (AC Appendix E, F25.115N)]
3.

Does a provider that holds or issues derivative financial instruments
for purposes other than trading disclose:

a. A description of:

(1)

The objectives for holding or issuing?

(2)

The context needed to understand those objectives?

(3)

The strategies for achieving those objectives?

(4) The classes of derivative financial instruments used?
b. A description of how each class of derivative financial instrument
is reported in the financial statements, including:

(1)

The policies for recognition and measurement or nonrecog
nition of the derivative financial instruments?

(2)

When recognized, where the instruments and related gains
and losses are reported?

c. For derivative financial instruments that are held or issued and
accounted for as hedges of anticipated transactions, both firm and
forecasted transactions for which there is no firm commitment,
including:
(1)

A description of the anticipated transactions whose risks are
hedged, including the expected time period of occurrence?

(2)

A description of the classes of derivative financial instru
ments used to hedge?
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4.

(3)

The amount of explicitly deferred hedging gains and losses?

(4)

A description of the transaction or events that result in recog
nition in earnings of the deferred gains or losses?
[SFAS 119, par. 11 (AC Appendix E, F25.115O)]

Are the following encouraged, but not required, quantitative disclo
sures made:
a. Interest rate?
b. Foreign exchange?

c. Commodity price?
d. Other market risks consistent with management's strategies?

e. Information of the risk of other financial instruments or nonfinan
cial assets and liabilities related by risk management strategy
pertaining to the objectives for holding or issuing derivative finan
cial instruments?
[SFAS 119, pars. 12 and 13 (AC Appendix E, F25.115P-.115Q)]
G. Financial Instruments

Note: If SFAS 133, Accounting for Derivative Instruments and Hedging Ac
tivities, has been adopted, the following Questions do not apply. See
Section G1 for the required disclosures. SFAS 133 is effective for all fiscal
quarters of fiscal years beginning after June 15,1999.
The FASB has issued an exposure draft dated May 20,1999 of a proposed
Statement titled "Accounting for Derivative Instruments and Hedging
Activities—Deferral of the Effective Date of FASB Statement No. 133, an
amendment of FASB Statement No. 133," which would amend SFAS 133
to defer its effective date to all fiscal quarters of all fiscal years beginning
after June 15,2000. The comment deadline was June 19,1999. Users of this
checklist should be alert to the issuance of a final pronouncement.

★♦1.

Except for certain excluded items (SFAS 105, pars. 14 and 15 (AC
F25.104 and .105)), are the following disclosed in the financial state
ments or notes for each category of financial instruments with
off-balance-sheet risk (health care organizations that enter into certain
types of receivable financing arrangements should disclose their offbalance-sheet risk):
a. The face or contract amount, or notional principal amount if there
is no face or contract amount?
b. The nature and terms, including, at a minimum, a discussion of:
(1) Credit and market risk of those instruments?

(2)

Cash requirements of those instruments?

Related accounting policy, as required by APB 22, Disclosure
of Accounting Policies (AC A10)?
[SFAS 105, par. 17, as amended by SFAS 119, par. 14 (AC
Appendix E, F25.112-.112A); AAG, par. 5.20]
c. For the disclosures in a. and b. above, distinguish between financial
instruments with off-balance-sheet risk held or issued for trading
purposes, and financial instruments with off-balance-sheet risk
held or issued for purposes other than trading?
For financial instruments with off-balance-sheet credit risk (except for
the items excluded in SFAS 105 (AC Appendix E, F25)), are the following

(3)

2.
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N/A
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disclosed, either in the financial statements or in the notes, by category
of financial instrument:
a. The amount of accounting loss the entity would incur if any party
to the financial instrument failed completely to perform according
to the terms of the contract and if the collateral or other security,
if any, for the amount due proved to be of no value to the entity?
b. Regarding collateral or other security to support financial instru
ments subject to credit risk:
(1) The entity's policy of requiring such collateral or other security?

(2)

(3)

★♦3.

Information about the entity's access to that collateral or other
security?
The nature and a brief description of the collateral or other
security supporting those financial instruments?
[SFAS 105, par. 18, as amended by SFAS 119, par. 14 (AC
Appendix E, F25.113)]

Do disclosures of all significant concentrations of credit risk arising
from all financial instruments, whether from an individual counter
party or groups of counterparties (except for certain excluded items
[SFAS 105, par. 14 (AC Appendix E, F25.104)]), include:

Note: Health care providers that enter into certain types of receivable
financing arrangements should disclose their off-balance-sheet risk.
a. Information about the (shared) activity, region, or economic char
acteristic that identifies the concentration?
b. The amount of the accounting loss due to credit risk the entity
would incur if any party to the financial instruments that make up
the concentration failed completely to perform according to the
terms of the contracts and if the collateral or other security, if any,
for the amount due proved to be of no value to the entity?
c. Regarding collateral or other security to support financial instru
ments subject to credit risk:
(1) The entity's policy of requiring such collateral or other security?
(2) Information about the entity's access to that collateral or other
security?
(3) The nature and a brief description of the collateral or other
security supporting those financial instruments?
[SFAS 105, pars. 14 and 20 (AC Appendix E, F25.104 and .115)]
4.

Is disclosure made of the primary geographic sources of patients?
[AAG, par. 5.19]

Note: SFAS 126, Exemptionfrom Certain Required Disclosures about Financial
Instruments for Certain Nonpublic Entities, states that disclosures about the
fair value of financial instruments prescribed in SFAS 107 shall be optional
for an entity that meets all of the following criteria:
a. The entity is a nonpublic company.
b. The entity's total assets are less than $100 million on the date of the
financial statements.
c. The entity has not held or issued any derivative financial instru
ments as defined in SFAS 119 other than loan commitments, during
the reporting period.
Consider this exemption when reviewing items 5 through 10 below.

47

No

Yes

5.

Is the fair value of financial instruments for which it is practicable to
estimate that value (except for those excluded in paragraphs 8 and 13
of SFAS 107) disclosed, together with the related carrying amount in
a form that makes it clear whether the fair value and carrying amount
represent assets or liabilities and how the carrying amounts relate to
what is reported in the statement of financial position? [Note: If
disclosed in more than a single note, one of the notes should include
a summary table containing the fair value and related carrying
amounts and cross-references to the location(s) of the remaining
disclosures required by SFAS 107, as amended.]
[SFAS 107, par. 10, as amended by SFAS 119, par. 15 (AC Appendix
E, F25.115C)]

★♦6.

Do the disclosures in Step 5 distinguish between financial instruments
held or issued for trading purposes, including dealing and other
trading activities measured at fair value with gains and losses recog
nized in earnings, and financial instruments held or issued for pur
poses other than trading?
[SFAS 107, par. 10, as amended by SFAS 119, par. 15 (AC Appendix
E, F25.115C)]

7.

Are the methods and significant assumptions used to estimate the fair
value of financial instruments disclosed?
[SFAS 107, par. 10 (AC Appendix E, F25.115C)]

8.

If it is not practicable to estimate the fair market value of a financial
instrument, do disclosures include:
a. Information pertinent to estimating the fair value of the financial
instrument or class of financial instruments, such as the carrying
amount, effective interest rate, and maturity?
b. The reasons why it is not practicable to estimate fair value?
[SFAS 107, par. 14 (AC F25.115J)]

9.

If the offsetting of derivative financial instruments against nonderi
vative financial instruments is not permitted under FASBI39, Offset
ting of Amounts Related to Certain Contracts, does the organization, in
disclosing the fair value of a derivative financial instrument, not:

a. Combine, aggregate, or net the fair value with the fair value of a
nonderivative financial instrument?
b. Net the fair value with the fair value of other derivative financial
instruments?
[SFAS 107, par. 13, as amended by SFAS 119, par. 15 (AC Appendix
E, F25.115I)]

10. For all fiscal years subsequent to the year of transition, are SFAS 107
disclosures included for each year for which a statement of financial
position is presented for comparative purposes?
[SFAS 107, par. 17]
11. For a written put option involving a reporting entity's own stock that
gives the reporting entity a choice of settlement methods, is the
classification within equity based on the settlement method that
required the written put option to be initially classified as equity
under the EITF 94-7 framework?
[EITF 96-13]
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No

N/A

Yes
12. Are the classification guidelines under EITF 96-13 followed for writ
ten put options involving a reporting entity's own stock that give the
reporting entity a choice of settlement methods?
[EITF 96-13]

Gl. Financial Instruments
Note: The following disclosures apply only if SFAS 133, Accountingfor Deriva
tive Instruments and Hedging Activities, has been adopted. SFAS 133 is effective
for all fiscal quarters of fiscal years beginning after June 15,1999.

The FASB has issued an exposure draft dated May 20,1999 of a proposed
Statement titled "Accounting for Derivative Instruments and Hedging
Activities—Deferral of the Effective Date of FASB Statement No. 133, an
amendment of FASB Statement No. 133," which would amend SFAS 133
to defer its effective date to all fiscal quarters of all fiscal years beginning
after June 15,2000. The comment deadline was June 19,1999. Users of this
checklist should be alert to the issuance of a final pronouncement.

Derivative Instruments and Hedging Activities
1.

2.

3.

4.

5.

6.

If an entity holds or issues derivative instruments (or nonderivative instru
ments that are designated and qualify as hedging instruments pursuant to
paragraphs 37 and 42 of SFAS 133) has disclosure been made of its objectives
for holding or issuing those instruments, the context needed to under
stand those objectives, and its strategies for achieving those objectives?
[SFAS 133, par. 44 (AC D50)]

Does the description distinguish between derivative instruments (and
nonderivative instruments) designated as fair value hedging instruments,
derivative instruments designated as cash flow hedging instruments,
derivative instruments (and nonderivative instruments) designated as
hedging instruments for hedges of the foreign currency exposure of a net
investment in a foreign operation, and all other derivatives?
[SFAS 133, par. 44 (AC D50)]
Does the description also indicate the entity's risk management policy
for each of those types of hedges, including a description of the items
or transactions for which risks are hedged?
[SFAS 133, par. 44 (AC D50)]
For derivative instruments not designated as hedging instruments,
does the description indicate the purpose of the derivative activity?
[SFAS 133, par. 44 (AC D50)]
Qualitative disclosures about an entity's objectives and strategies for
using derivative instruments may be more meaningful if such objec
tives and strategies are described in the context of an entity's overall
risk management profile. If appropriate, an entity is encouraged, but
not required, to provide such additional qualitative disclosures. Have
such disclosures been made?
[SFAS 133, par. 44 (AC D50)]

Do the entity's disclosures for every reporting period for which a com
plete set of financial statements is presented also include the following:
Fair Value Hedges

a. For derivative instruments, as well as nonderivative instruments
that may give rise to foreign currency transaction gains or losses
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____

____

____

____

____

No

N/A

Yes
under SFAS 52, that have been designated and have qualified as
fair value hedging instruments and for the related hedged items:

(1)

(2)

The net gain or loss recognized in earnings during the report
ing period representing(a) the amount of the hedges' ineffec
tiveness and (b) the component of the derivative instruments'
gain or loss, if any, excluded from the assessment of hedge
effectiveness, and a description of where the net gain or loss
is reported in the statement of income or other statement of
financial performance?

The amount of net gain or loss recognized in earnings when
a hedged firm commitment no longer qualifies as a fair value
hedge?
[SFAS 133, par. 45a (AC D50)]

____

____

Cash Flow Hedges
b. For derivative instruments that have been designated and have
qualified as cash flow hedging instruments and for the related
hedged transactions:

The net gain or loss recognized in earnings during the report
ing period representing (a) the amount of the hedges' ineffec
tiveness and (b) the component of the derivative instruments'
gain or loss, if any, excluded from the assessment of hedge
effectiveness, and a description of where the net gain or loss
is reported in the statement of income or other statement of
financial performance?

____

A description of the transactions or other events that will
result in the reclassification into earnings of gains and losses
that are reported in accumulated other comprehensive in
come, and the estimated net amount of the existing gains or
losses at the reporting date that is expected to be reclassified
into earnings within the next 12 months?

____

(3) The maximum length of time over which the entity is hedging
its exposure to the variability in future cash flows for fore
casted transactions excluding those forecasted transactions
related to the payment of variable interest on existing finan
cial instruments?

____

(1)

(2)

(4)

The amount of gains and losses reclassified into earnings as a
result of the discontinuance of cash flow hedges because it is
probable that the original forecasted transactions will not occur?
[SFAS 133, par. 45b (AC D50)]

Note: SFAS 133, paragraph 43, states that an entity that does not report
earnings as a separate caption in a statement of financial performance (for
example, a not-for-profit organization) shall recognize the gain or loss on
a hedging instrument and a nonhedging derivative instrument as a
change in net assets in the period of change unless the hedging instrument
is designated as a hedge of the foreign currency exposure of a net invest
ment in a foreign operation. Entities that do not report earnings shall
recognize the changes in the carrying amount of the hedged item pursuant
to paragraph 22 of SFAS 133 in a fair value hedge as a change in net assets
in the period of change. Those entities are not permitted to use cash flow
hedge accounting because they do not report earnings separately.
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____

No

N/A

Yes
Hedges of the Net Investment in a Foreign Operation

c. For derivative instruments, as well as nonderivative instruments
that may give rise to foreign currency transaction gains or losses
under SFAS 52, that have been designated and have qualified as
hedging instruments for hedges of the foreign currency exposure
of a net investment in a foreign operation, the net amount of gains
or losses included in the cumulative translation adjustment during
the reporting period?
[SFAS 133, par. 45c (AC D50)]
7.

The quantitative disclosures about derivative instruments may be
more useful, and less likely to be perceived to be out of context or
otherwise misunderstood, if similar information is disclosed about
other financial instruments or nonfinancial assets and liabilities to
which the derivative instruments are related by activity. Accordingly,
in such situations, has the entity presented a more complete picture
of its activities by disclosing that information? (Encouraged, but not
required.)
[SFAS 133, par. 45 (AC D50)]

Disclosures About Fair Value of Financial Instruments

8.

Has the entity disclosed, either in the body of the financial statements
or in the accompanying notes, the fair value of financial instruments
(except for those excluded in paragraphs 8 and 13 of SFAS 107) for
which it is practicable to estimate fair value?
[SFAS 107, par. 10 (AC F25)]

Note: If disclosed in more than a single note, one of the notes shall include
a summary table. The summary table shall contain the fair value and
related carrying amounts and cross-references to the location(s) of the
remaining disclosures required by SFAS 107 as amended.
9.

Has the fair value disclosed in the notes been presented together with
the related carrying amount in a form that makes it clear whether the
fair value and carrying amount represent assets or liabilities and how
the carrying amounts relate to what is reported in the statement of
financial position?
[SFAS 107, par. 10 (AC F25)]

10. In disclosing the fair value of a financial instrument, has the entity
taken care not to net that fair value with the fair value of other financial
instruments—even if those financial instruments are of the same class
or are otherwise considered to be related, for example, by a risk
management strategy—except to the extent that the offsetting of
carrying amounts in the statement of financial position is permitted
under the general principle in paragraphs 5 and 6 of FASBI 39,
Offsetting of Amounts Related to Certain Contracts, or the exceptions for
master netting arrangements in paragraph 10 of 39 and for amounts
related to certain repurchase and reverse repurchase agreements in
paragraphs 3 and 4 of FASBI 41, Offsetting ofAmounts Related to Certain
Repurchase and Reverse Repurchase Agreements?
[SFAS 107, par. 14 (AC F25)]
11. If it is not practicable to estimate the fair value of a financial instru
ment or a class of financial instruments, are the following disclosed:
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No

N/A

Yes

a. Information pertinent to estimating the fair value of that financial
instrument or class of financial instruments, such as the carrying
amount, effective interest rate, and maturity?
b. The reasons why it is not practicable to estimate fair value?
[SFAS 107, par. 14 (AC F25)]

Note: SFAS 126, Exemptionfrom Certain Required Disclosures about Financial
Instruments for Certain Nonpublic Entities, makes the disclosures about fair
values of financial instruments prescribed in SFAS 107 optional for report
ing entities that:
• Are nonpublic entities,
• Have total assets of less than $100 million on the date of the financial
statements, and
• Have no instrument that, in whole or in part, is accounted for as a
derivative instrument under SFAS 133, Accounting for Derivative In
struments and Hedging Activities, during the reporting period.

Disclosure About Concentrations of Credit Risk ofAll Financial Instruments
12. Except as indicated in paragraph 15B of SFAS 107, has the entity
disclosed all significant concentrations of credit risk arising from all
financial instruments, whether from an individual counterparty or
groups of counterparties (Group concentrations of credit risk exist if a
number of counterparties are engaged in similar economic charac
teristics that would cause their ability to meet contractual obligations
to be similarly affected by changes in economic or other conditions)?
[SFAS 107, par. 15A (AC F25)]

Note: SFAS 107, paragraph 15B provides that these disclosure require
ments do not apply to the following financial instruments, whether writ
ten or held:
a. Financial instruments of a pension plan, including plan assets, when
subject to the accounting and reporting requirements of SFAS 87
(Financial instruments of a pension plan, other than the obligations
for pension benefits, when subject to the accounting and reporting
requirements of SFAS 35, Accounting and Reporting by Defined Benefit
Pension Plans, are subject to the reporting of paragraph 15A).
b. The financial instruments described in paragraphs 8(a), 8(c), 8(e),
and 8(f) of SFAS 107, as amended by SFAS 112, Employers' Accounting
for Postemployment Benefits, SFAS 123, Accounting for Stock Based
Compensation, and SFAS 125, Accounting for Transfers and Servicing
of Financial Assets and Extinguishments of Liabilities, except for rein
surance receivables and prepaid reinsurance premiums.
13. Has the entity made the following disclosures about each significant
concentration:
a. Information about the (shared) activity, region, or economic char
acteristic that identifies the concentration?

b. The maximum amount of loss due to credit risk that, based on the
gross fair value of the financial instrument, the entity would incur
if parties to the financial instruments that make up the concentra
tion failed completely to perform according to the terms of the
contracts and the collateral or other security, if any, for the amount
due proved to be of no value to the entity?
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____

No

N/A

Yes

c. The entity's policy of requiring collateral or other security to
support financial instruments subject to credit risk, information
about the entity's access to that collateral or other security, and the
nature and a brief description of the collateral or other security
supporting those financial instruments?
d. The entity's policy of entering into master netting arrangements
to mitigate the credit risk of financial instruments, information
about the arrangements for which the entity is a party, and a brief
description of the terms of those arrangements, including the
extent to which they would reduce the entity's maximum amount
of loss due to credit risk?
[SFAS 107, par. 15A (AC F25)]

14. Has the entity disclosed quantitative information about the market
risks of financial instruments that is consistent with the way it man
ages or adjusts those risks? (Encouraged, but not required.)
[SFAS 107, par. 15C (AC F25)]
Note: Appropriate ways of reporting the quantitative information en
couraged will differ for different entities and will likely evolve over time
as management approaches and measurement techniques evolve. Possi
bilities include disclosing (a) more details about current positions and
perhaps activity during the period, (b) the hypothetical effects on compre
hensive income (or net assets), or annual income, of several possible
changes in market prices, (c) a gap analysis of interest rate repricing or
maturity dates, (d) the duration of the financial instruments, or (e) the
entity's value at risk from derivatives and from other positions at the end
of the reporting period and the average value at risk during the year. This
list is not exhaustive, and an entity is encouraged to develop other ways
of reporting quantitative information.

15. For a written put option involving a reporting entity's own stock that
gives the reporting entity a choice of settlement methods, is the
classification within equity based on the settlement method that
required the written put option to be initially classified as equity
under the EITF 94-7 framework?
[EITF 96-13]
16. Are the classification guidelines under EITF 96-13 followed for writ
ten put options involving a reporting entity's own stock that give the
reporting entity a choice of settlement methods?
[EITF 96-13]

Note: If SFAS 133 has been adopted, replace questions 5,6,7,9, and 10 in
Section C of the Balance Sheet section with the following Questions:

♦ 5.

For securities classified as available-for-sale, has the reporting entity
made the following disclosures by major-security type as of each date
for which a statement of financial position is presented:

a. Aggregate fair value?
b. Total gains for securities with net gains in accumulated other
comprehensive income?

c. Total losses for securities with net losses in accumulated other
comprehensive income?
[SFAS 115, par. 19 (AC I80.118)]
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No

N/A

Yes

♦ 6.

For securities classified as held-to-maturity, has the reporting entity
made the following disclosures by major-security type as of each date
for which a statement of financial position is presented:

a. Aggregate fair value?
b. Gross unrecognized holding gains or losses?

c. Net carrying amount?
d. Gross gains and losses in accumulated other comprehensive in
come for any derivatives that hedged the forecasted acquisition of
the held-to-maturity securities?
[SFAS 115, par. 19 (AC I80.118)]

♦ 7.

For investments in debt securities classified as available-for-sale or
held-to-maturity:

a. Is disclosure made about their contractual maturities as of the date
of the latest balance sheet presented (maturity information may be
combined in appropriate groupings)?
b. If securities not due at a single date (such as mortgage-backed
securities) are allocated over several maturity groupings, is the
basis for allocation disclosed?
[SFAS 115, par. 20 (AC I80.119)]

♦ 8.

For each period for which an income statement is presented, are the
following disclosed:

a. The proceeds from sales of available-for-sale securities and gross
realized gains and losses that have been included in earnings as a
result of those sales?
b. The basis on which the cost of a security sold or the amount
reclassified out of accumulated other comprehensive income into
earnings was determined (i.e., specified identification, average
cost, or other method used)?

c. The gross gains and losses included in earnings from transfers of
securities from the available-for-sale category to the trading category?
d. The amount of the net unrealized holding gain or loss on avail
able-for-sale securities for the period that has been included in
accumulated other comprehensive income and the amount of
gains and losses reclassified out of accumulated other comprehen
sive income into earnings for the period?

e. The portion of trading gains and losses for the period that relates
to trading securities still held at the reporting date?
[SFAS 115, par. 21 (AC I80.120)]

♦ 9.

For any sales of or transfers from securities classified as held-tomaturity, are the following disclosed for each period for which an
earnings statement is presented:
a. Net carrying amount of the sold or transferred security?
b. The net gain or loss in accumulated other comprehensive income
for any derivative that hedged the forecasted acquisition of the
held-to-maturity security?
c. Related realized or unrealized gain or loss?

d. The circumstances leading to the decision to sell or transfer the
security?
[SFAS 115, par. 22 (AC I80.121)]
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No

N/A

Yes
H. Nonmonetary Transactions
1.

Do disclosures include:

a. Nature of the transactions?
b. Basis of accounting for the assets transferred?

c. Gains or losses recognized on the transfers?
[APB 29, par. 28 (AC C11.102 and N35.120)]
I.

Pension and Other Postretirement Benefit Plans
Note: The disclosures required by SFAS 132 may be aggregated for all of
an employer's defined benefit pension plans and may be aggregated for
all of an employer's defined benefit postretirement plans or may be
disaggregated in groups if that is considered to provide the most useful
information or is otherwise required by paragraph 7 of the Statement.
Disclosures about pension plans with assets in excess of the accumulated
benefit obligation generally may be aggregated with disclosures about
pension plans with accumulated benefit obligations in excess of assets.
The same aggregation is permitted for postretirement plans. An employer
may combine disclosures about pension or postretirement benefit plans
outside the United States with those for U.S. plans unless the benefit
obligations of the plans outside the United States are significant relative
to the total benefit obligation and those plans use significantly different
assumptions. A nonpublic entity, as defined by SFAS 132, may elect the
reduced disclosure requirements permitted by the Statement.

1.

If there is a defined benefit pension plan or a defined benefit postre
tirement plan, do disclosures include:

a. A reconciliation of beginning and ending balances of the benefit
obligation showing separately, if applicable, the effects during the
period attributable to each of the following: service cost, interest
cost, contributions by plan participants, actuarial gains and losses,
foreign currency exchange rate changes, benefits paid, plan
amendments, business combinations, divestitures, curtailments,
settlements, and special termination benefits?
b. A reconciliation of beginning and ending balances of the fair value
of plan assets showing separately, if applicable, the effects during
the period attributable to each of the following: actual return on
plan assets, foreign currency exchange rate changes, contributions
by the employer, contributions by plan participants, benefits paid,
business combinations, divestitures, and settlements?

c. The funded status of the plans, the amounts not recognized in the
statement of financial position, and the amounts recognized in the
statement of financial position, including:

(1)

The amount of any unamortized prior service cost?

(2)

The amount of any unrecognized net gain or loss (including
asset gains and losses not yet reflected in market-related
value)?

(3)

The amount of any remaining unamortized, unrecognized
net obligation or net asset existing at the initial date of appli
cation of SFAS 87 or SFAS 106?
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No

N/A

Yes

(4)

The net pension or other postretirement benefit prepaid as
sets or accrued liabilities?

(5)

Any intangible asset and the amount of accumulated other
comprehensive income recognized pursuant to paragraph 37
of SFAS 87, as amended?

d. The amount of net periodic benefit cost recognized, showing
separately the service cost component, the interest cost compo
nent, the expected return on plan assets for the period, the amor
tization of the unrecognized transition obligation or transition
asset, the amount of recognized gains and losses, the amount of
prior service cost recognized, and the amount of gain or loss
recognized due to a settlement or curtailment?

e. The amount included within other comprehensive income for the
period arising from a change in the additional minimum pension
liability recognized pursuant to paragraph 37 of SFAS 87, as
amended?

f.

On a weighted-average basis, the following assumptions used in
the accounting for the plans: assumed discount rate, rate of com
pensation increase (for pay-related plans), and expected long-term
rate of return on plan assets?

g. The assumed health care cost trend rate(s) for the next year used
to measure the expected cost of benefits covered by the plan (gross
eligible charges) and a general description of the direction and
pattern of change in the assumed trend rates thereafter, together
with the ultimate trend rate(s) and when that rate is expected to
be achieved?

h. The effect of a one-percentage-point increase and the effect of a
one-percentage-point decrease in the assumed health care cost trend
rates on (1) the aggregate of the service and interest cost components
of net periodic postretirement health care benefit cost and (2) the
accumulated postretirement benefit obligation for health care bene
fits (For purposes of this disclosure, all other assumptions shall be
held constant, and the effects shall be measured based on the sub
stantive plan that is the basis for the accounting.)?
i.

If applicable, the amounts and types of securities of the employer
and related parties included in plan assets, the approximate
amount of future annual benefits of plan participants covered by
insurance contracts issued by the employer or related parties, and
any significant transactions between the employer or related par
ties and the plan during the period?

j.

If applicable, any alternative amortization method used to amor
tize prior service amounts or unrecognized net gains and losses
pursuant to paragraphs 26 and 33 of SFAS 87 or paragraphs 53 and
60 of SFAS 106?

k. If applicable, any substantive commitment, such as past practice
or a history of regular benefit increases, used as the basis for
accounting for the benefit obligation?
l.

If applicable, the cost of providing special or contractual termina
tion benefits recognized during the period and a description of the
nature of the event?
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No

N/A

Yes
m. An explanation of any significant change in the benefit obligation
or plan assets not otherwise apparent in the other disclosures
required by SFAS 132?
[SFAS 132, par. 5 (AC P16.150)]

2.

For employers that sponsor more than one defined benefit pension
plan or more than one defined benefit postretirement plan, are the
disclosures required by Step I.2 above aggregated for all of the em
ployer's defined benefit pension plans and for all of the employer's
defined benefit postretirement plans or disaggregated in groups if
that is considered to provide the most useful information or is other
wise required by paragraph 7 of SFAS 132?
[SFAS 132, par. 6 (AC P16.153)]

3.

For employers that have aggregated disclosures about postretirement
plans with assets in excess of the accumulated benefit obligations with
disclosures about postretirement plans with accumulated benefit ob
ligations in excess of assets, do disclosures include:
a. The aggregate benefit obligation and aggregate fair value of plan
assets for plans with benefit obligations in excess of plan assets?

b. The aggregate pension accumulated benefit obligation and aggre
gate fair value of plan assets for pension plans with accumulated
benefit obligations in excess of plan assets?
c. Amounts recognized separately in the statement of financial posi
tion as prepaid benefit costs and accrued benefit liabilities?
[SFAS 132, par. 6 (AC P16.153)]

4.

Are disclosures about pension or postretirement benefit plans outside
the United States separate from those for U.S. plans when the plans
outside the United States have benefit obligations that are significant
relevant to the total benefit obligation and use significantly different
assumptions?
[SFAS 132, par. 7 (AC P16.153A)]

5.

For a nonpublic entity that has elected the reduced disclosure require
ments for its pension and other postretirement benefit plans in lieu of
the disclosures required by paragraph 5 of SFAS 132 (Step I.2.), do
disclosures include:

a. The benefit obligation, fair value of plan assets, and funded status
of the plan?
b. Employer contributions, participant contributions, and benefits
paid?
c. The amounts recognized in the statement of financial position,
including the net pension and other postretirement benefit pre
paid assets or accrued liabilities and any intangible asset and the
amount of accumulated other comprehensive income recognized
pursuant to paragraph 37 of SFAS 87, as amended?

d. The amount of net periodic benefit cost recognized and the
amount included within other comprehensive income arising
from a change in the minimum pension liability recognized pur
suant to paragraph 37 of SFAS 87, as amended?
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No

N/A

Yes
e. On a weighted-average basis, the following assumptions used in
the accounting for the plans: assumed discount rate, rate of com
pensation increase (for pay-related plans), and expected long-term
rate of return on plan assets?
f.

The assumed health care cost trend rate(s) for the next year used
to measure the expected cost of benefits covered by the plan (gross
eligible charges) and a general description of the direction and
pattern of change in the assumed trend rates thereafter, together
with the ultimate trend rate(s) and when that rate is expected to
be achieved?

g. If applicable, the amounts and types of securities of the employer
and related parties included in plan assets, the approximate
amount of future annual benefits of plan participants covered by
insurance contracts issued by the employer or related parties, and
any significant transactions between the employer or related par
ties and the plan during the period?
h. The nature and effect of significant nonroutine events, such as
amendments, combinations, divestitures, curtailments, and
settlements?
[SFAS 132, par. 8 (AC P16.150A)]
6.

If there are one or more defined contribution plans:

a. Is the amount of cost recognized for the defined contribution
pension or other postretirement benefit plans during the period
disclosed separately from the amount of cost recognized for de
fined benefit plans?
b. Do disclosures include a description of the nature and effect of any
significant changes during the period affecting comparability,
such as a change in the rate of employer contributions, a business
combination, or a divestiture?
[SFAS 132, par. 9 (AC P16.162)]

7.

If there are one or more multiemployer plans:

a. Do disclosures include the amount of contributions to the mul
tiemployer plan(s) during the period?
b. If the employer discloses total contributions to multiemployer
plans without disaggregating the amounts attributable to pen
sions and other postretirement benefits, do the disclosures include
a description of the nature and effect of any changes affecting
comparability, such as a change in the rate of employee contribu
tions, a business combination, or a divestiture?
[SFAS 132, par. 10 (AC P16.166)]

c. If the situation arises where the withdrawal from a multiemployer
plan may result in the employer having an obligation to the plan for
a portion of its unfunded benefit obligations that is either probable or
reasonably possible, are the provisions of SFAS 5 (AC C59) applied?
[SFAS 87, par. 70 (AC P16.167)]

8.

Are the provisions of SFAS 5 (AC C59) applied if the situation arises
where withdrawal from a multiemployer plan may result in an em
ployer's having an obligation to the plan for a portion of the plan's
unfunded accumulated postretirement benefit obligation and it is
probable or reasonably possible that:
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No

N/A

Yes

a. An employer would withdraw from the plan under circumstances
that would give rise to an obligation?
or
b. An employer's contribution to the fund would be increased during
the remainder of the shortfall in the funds necessary to maintain
the negotiated level of benefit coverage?
[SFAS 106, par. 83 (AC P40.179)]
J.

Related Organizations and Economic Dependency
1.

Consolidation and combination:

a. If the provider and another entity are related and they meet the
criteria for consolidation or combination ("consolidation"), are
consolidated or combined ("consolidated") financial statements
presented?
[AAG, pars. 11.10 and 11.11; ARB 51 (AC C51); SFAS 94 (AC C51)]
b. If consolidated statements are presented:

(1)

Is the consolidation policy disclosed?
[ARB 51, par. 5 (AC C51.108); APB 22, par. 13 (AC A10.106)]

(2)

When the financial reporting periods of consolidated entities
differ, is recognition given, by disclosure or otherwise, to the
effect of intervening events that materially affect financial
position or results of operations?
[ARB 51, par. 4 (AC C51.107)]

c. Do disclosures about formerly unconsolidated subsidiaries that
are now consolidated include summarized information about the
assets, liabilities, and results of operations (or separate statements)
in the consolidated financial statements or notes?
[SFAS 94, par. 14 (AC C51.120A)]
2.

Related parties and economic dependency:

a. If the reporting entity controls a separate not-for-profit entity
through a form other than majority ownership or voting interest,
has an economic interest in that other entity, and consolidated
financial statements are not presented, is identification of the other
entity and the nature of its relationship with the reporting entity
disclosed; and is summarized financial data of the related organi
zation disclosed?
[AAG, par. 11.12]
b. If the reporting entity has control over a related party, or has an
economic interest in a related party, but the related party is not
consolidated, are the following disclosures made:

(1)

The nature of the relationship between the entity and the
related party?

(2)

If there are material transactions between the entity and the
related party:
(i)

A description of the transactions, including transactions
to which nominal or no amounts were ascribed?

(ii) The amount of such transactions?
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No

Yes
(iii) Amounts due from or to the related party and, if not
apparent, the terms and manner of settlement?
(iv) The information required by paragraph 49 of SFAS 109?
[AAG, par. 11.13; SFAS 13, par. 29 (AC L10.125); SFAS
57, pars. 2-4, as amended by SFAS 109, paragraph 288(s)
(AC R36.102-.104)]

No

N/A

____
____

c. If consolidated financial statements are presented and they in
clude a controlled not-for-profit organization, are the following
disclosed:

(1)

Restrictions made by entities outside of the reporting entity
on distributions from the controlled not-for-profit organiza
tion to the reporting entity?

____

and
(2)

Any resulting unavailability of the net assets of the controlled
not-for-profit organization for use by the reporting entity?
[AAG, par. 11.14]

d. Are significant relationships and transactions not in the ordinary
course of business with directors, management, medical staff, etc.
disclosed in the financial statements?
[AAG, par. 11.25]

____

____

K. Risks and Uncertainties
1.

Are the following disclosed:

a. A description of the principal services performed by the health
care provider and the revenue sources for the entity's services?
b. The fact that financial statements prepared in accordance with
GAAP require the use of management's estimates?
[SOP 94-6, pars. 10 and 11]

★♦2.

b. That a material change in the estimate could occur in the near
term?
[SOP 94-6, pars. 12-14]

★♦4.

____

If (1) it is at least reasonably possible that the estimate(s) used in
preparing the financial statements will change in the near term, and
(2) the effect(s) of the change will be material, are the following
disclosed:

a. The nature of uncertainties inherent in estimates used to deter
mine the carrying amounts of assets and liabilities, or used to
disclose gain or loss contingencies?

3.

____

If the estimate in Step 2 above involves a loss contingency covered by
SFAS 5, Accounting for Contingencies, do disclosures include an esti
mate of the possible loss or range of loss, or state that such an estimate
cannot be made?3
[SOP 94-6, par. 14]

____
____

____

If (1) concentrations exist at the financial statement date, and (2) the
concentrations could cause the provider a near-term severe impact,
are the following disclosed:

3 If risk reduction techniques are used to mitigate losses or the uncertainty that may result from certain events, these disclosures are
encouraged but not required.

60

Yes
a. Concentrations in the volume of the business transacted with a
particular customer (patient), supplier, lender, grantor, or con
tributor?
b. Concentrations in revenue from particular services provided or
fund-raising events?

c. Concentrations in the available sources of supply of labor, serv
ices, or of applicable licenses necessary to provide services?
d. Concentrations in the market or geographical area in which an
entity conducts its operations, including the carrying amounts of
net assets and their locations?
e. Concentrations of labor subject to collective bargaining agree
ments, including the percentage of the labor force covered by a
collective bargaining agreement and the percentage of the labor
force covered by a collective bargaining agreement that will expire
within one year?

f. Information adequate to inform users of the general nature of the
risk associated with the concentration?
[SOP 94-6, pars. 21-24]
L. Segment Information

Note: Public business enterprises are required to provide the disclosures
described in SFAS 131, Disclosures about Segments of an Enterprise and Related
Information, and nonpublic business enterprises are encouraged to do so.
1. Are the following items disclosed for each reportable segment for each
period for which an income statement is presented:

a. General information as described in SFAS 131, paragraph 26?
b. Information about profit or loss (including certain revenues and
expenses included in profit or loss), segment assets, and the basis
of measurement, as described in SFAS 131, paragraphs 27-31?
c. Reconciliations of the totals of segment revenues, reported profit
or loss, assets, and other significant items to corresponding enter
prise amounts as described in SFAS 131, paragraph 32?

d. Interim period information as described in SFAS 131, paragraph
33?
[SFAS 131, pars. 25-33, as amended by SFAS 135, par. 4 (AC
S30.124-.132)]

Note: Reconciliations of balance sheet amounts for reportable segments
to consolidated balance sheet amounts are required only for each year for
which a balance sheet is presented.
2.

If an enterprise changes the structure of its internal organization in a
manner that changes the composition of its reportable segments, has
it disclosed whether it has restated the corresponding items of seg
ment information for earlier periods?
[SFAS 131, par. 34 (AC S30.133)]

3.

If segment information is not restated to reflect a change in the
composition of reportable segments, is current year segment informa
tion under both the old basis and the new basis of segmentation
disclosed, unless it is impracticable to do so?
[SFAS 131, par. 35 (AC S30.134)]
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No

N/A

Yes

4.

For all enterprises subject to SFAS 131, including those that have a
single reportable segment, are the following enterprise-wide items
disclosed:

a. Revenues from external customers for each product and service or
each group of similar products and services unless it is impracti
cable to do so?
b. Geographic information as described in paragraph 38 unless it is
impracticable to do so?

c. Information about the extent of the enterprise's reliance on its
major customers as described in paragraph 39?
[SFAS 131, pars. 36-39 (AC S30.135-.138)]
5.

If the information described in items 4.a. and 4.b. above has not been
disclosed because it is impracticable, is that fact disclosed?
[SFAS 131, pars. 37 and 38 (AC S30.136-.137)]

M. Subsequent Events
1.

Are subsequent events that provide evidence about conditions that
did not exist at the date of the balance sheet, but arose subsequent to
that date, adequately disclosed to keep the financial statements from
being misleading?
[SFAS 5, par. 11 (AC C59.112); APB 16 (AC B50.120); SAS 1, secs.
560.05-.07, .09, and 561.01-.09 (AU 560.05-.07, .09, and 561.01-.09)]

Continuing Care Retirement Communities (CCRCs)
A. Refundable Advance Fees

★♦1.

Is the estimated amount of advance fees expected to be refunded to
current residents reported as a liability?
[AAG, par. 14.22]

★♦2.

Is the remaining amount of advance fees reported in the balance sheet
as deferred revenue?
[AAG, par. 14.22]

★♦3.

Are the following disclosed:

a. The gross amount of contractual refund obligations under existing
contracts?
b. The CCRC's refund policy?
[AAG, par. 14.22]

★♦4.

Are amounts refunded disclosed in the statement of cash flows as a
financing transaction?
[AAG, par. 14.22]

★♦5.

Is the method of accounting, including the amortization method, for
deferred revenue disclosed?
[AAG, par. 14.23]

B. Fees Refundable to Residents Only From Reoccupancy Proceeds of a
Contract Holder's Unit
1.

Are the following reported as deferred revenue:
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No

N/A

Yes

a. The portion of fees to be paid to current residents or their desig
nees, only to the extent of a contract holder's unit reoccupancy
proceeds, if law and management policy and practice support the
withholding of refunds under this condition?
b. Similar amounts received from new residents in excess of the
amount to be paid to previous residents or their designees?
[AAG, par. 14.25]

C. Nonrefundable Advance Fees
1.

★♦2.

Are nonrefundable advance fees reported as deferred revenue?
[AAG, par. 14.26]

Is unamortized deferred revenue reported as revenue upon a resi
dent's death or contract termination?
[AAG, par. 14.23]

D. Obligation to Provide Future Services and Use of Facilities to Current
Residents

★♦1.

If the obligation to provide future services and use of facilities to
current residents under continuing-care contracts results in a liability,
are the following disclosed:

a. The carrying amount of the liability that is presented at present
value in the financial statements (if not separately disclosed in the
balance sheet/statement of financial position)?

b. The interest rate used to discount that liability?
[AAG, par. 14.31]
E.

Costs of Acquiring Initial Continuing-Care Contracts
1.

Are costs of acquiring initial continuing-care contracts capitalized if
they are expected to be recovered from future contract revenues?
[AAG, par. 14.33]

2.

Are continuing-care contract acquisition costs expensed if incurred
after (a) the CCRC is substantially occupied or (b) one year following
completion?
[AAG, par. 14.33]

F. Other

★♦1.

Do the notes to the financial statements of the CCRC include a
description of the CCRC and the nature of the related continuing-care
contracts entered into by the CCRC?
[AAG, par. 14.35]

★♦2.

Do the notes to the financial statements of the CCRC include the
statutory escrow or similar requirements?
[AAG, par. 14.35]

OMB Circular A-133 Presentation Requirements
1.

Does the schedule of expenditures of federal awards disclose the basis
of accounting and the significant accounting policies used in prepar
ing the schedule?
[SOP 98-3, par. 5.5]
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No

N/A

Yes

2.

Did the auditee prepare a schedule of expenditures of federal awards
for the period covered by the auditee's financial statements that, at a
minimum:

a. Lists individual federal programs by federal agency?

____

b. Include, for federal awards received as a subrecipient, the name
of the pass-through entity and the identifying number assigned by
the pass-through entity?

____

c. Provide the total federal awards expended for each individual
federal program and the CFDA number or other identifying num
ber when the CFDA information is not available?

____

d. Include notes that describe the significant accounting policies used
in preparing the schedule?

____

e. Identify, to the extent practical, the total amount provided to
subrecipients by pass-through entities from each federal program?

____

f.

3.

Include, in either the schedule or a note to the schedule, the value
of federal awards expended in the form of noncash assistance, the
amount of insurance in effect during the year, and loans or loan
guarantees outstanding at year end?
[SOP 98-3, par. 5.6]

If nonfederal data are presented in the schedule of expenditures of
federal awards:

a. Are the nonfederal data segregated and clearly designated as
nonfederal?
b. Is the title of the schedule modified to indicate that nonfederal
awards are included?
[SOP 98-3, par. 5.9]

4.

____

____
____

If the auditee is unable to obtain the CFDA number, does the schedule
include:

a. A statement that the CFDA number is not available?

____

b. The program's name and, if available, other identifying numbers?
[SOP 98-3, par. 5.10]

____

Exhibit A

Stock-Based Compensation
♦1.

♦2.

♦3.

If an entity continues to apply APB 25 in accounting for its stock-based
compensation arrangements, is the pro forma net income and, if pre
sented, earnings per share (determined as if the fair value based
method had been applied in measuring compensation cost) disclosed?
[SFAS 123, pars. 11 and 45 (AC C36.110 and .144)]

If an entity has one or more stock-based compensation plans, is a
description of the plan(s), including the general terms of awards
under the plan(s), disclosed?
[SFAS 123, par. 46 (AC C36.145)]

Is the information in paragraph 47 of SFAS 123 disclosed for each year
for which an income statement is presented?
[SFAS 123, par. 47a-f (AC C36.146)]
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____

____

____

No

N/A

Yes
♦4.

♦5.

If an entity grants options under multiple stock-based employee
compensation plans, are the items in paragraph 47 disclosed sepa
rately for different types of awards to the extent that the differences
in the characteristics of the awards make separate disclosure important
to an understanding of the entity's use of stock-based compensation?
[SFAS 123, par. 47 (AC C36.146)]

____

Are the following disclosed for options outstanding at the date of the
latest statement of financial position presented:

a. The range of exercise prices?

____

b. The weighted-average exercise price?

____

c. The weighted-average remaining contractual life?
[SFAS 123, par. 48 (AC C36.147)]

____

♦ 6.

If the range of exercise prices is wide, are they segregated into ranges?
[SFAS 123, par. 48 (AC C36.147)]

____

♦7.

Are the following disclosed for each range identified in Step 6:
a. The number, weighted-average exercise price, and weighted-av
erage remaining contractual life of options outstanding?
b. The number and weighted-average exercise price of options cur
rently exercisable?
[SFAS 123, par. 48 (AC C36.147)]
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____
____

No

N/A

FSP Section 11,300
Auditors' Reports Checklist
.01 This checklist has been developed by the staff of the Accounting and Auditing Publications Team of
the AICPA as a nonauthoritative practice aid.

.02 Explanation of References:

SAS =

AICPA Statement on Auditing Standards

AU =

Reference to section number in AICPA Professional Standards (vol. 1)

SSARS =

AICPA Statements on Standards for Accounting and Review Services

AR =

Reference to section number in AICPA Professional Standards (vol. 2)

.03 Checklist Questionnaire:

1.

2.

Yes

No

N/A

____

____

____

a. Appropriate addressee?
[SAS 58, par. 9 (AU 508.09)]

____

____

____

b. Date (or dual dates) of the report?
[SAS 1, sec. 530.05 (AU 530.05)]

____

____

____

c. A title that includes the word "independent"?
[SAS 58, par. 8a (AU 508.08a)]

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

Is each financial statement audited specifically identified in the intro
ductory paragraph of the auditor's report?
[SAS 58, par. 6 (AU 508.06)]
Does the auditor's report include:

d. A statement that the financial statements identified in the report
were audited?
[SAS 58, par. 8b (AU 508.08b)]
e. A statement that the financial statements are the responsibility of
management and that the auditor's responsibility is to express an
opinion on the financial statements based on his or her audit?
[SAS 58, par. 8c (AU 508.08c)]

f. A statement that the audit was conducted in accordance with
generally accepted auditing standards?
[SAS 58, par. 8d (AU 508.08d)]
g. A statement that generally accepted auditing standards require
that the auditor plan and perform the audit to obtain reasonable
assurance about whether the financial statements are free of ma
terial misstatement?
[SAS 58, par. 8e (AU 508.08e)]
h. A statement that an audit includes examining, on a test basis,
evidence supporting the amounts and disclosures in the financial
statements; assessing the accounting principles used and signifi
cant estimates made by management; and evaluating the overall
financial statement presentation?
[SAS 58, par. 8f (AU 508.08f)]
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Yes
i. A statement that the auditor believes that his or her audit provides
a reasonable basis for his or her opinion?
[SAS 58, par. 8g (AU 508.08g)]

j.

An opinion as to whether the financial statements present fairly,
in all material respects, the financial position of the reporting
entity as of the balance sheet date and the results of its operations
and its cash flows for the period then ended in conformity with
generally accepted accounting principles?
[SAS 58, par.8h (AU 508.08h)]

k. The manual or printed signature of the auditor's firm?
[SAS 58, par.8i (AU 508.08i)]
3.

If the auditor is not independent, is the appropriate disclaimer ex
pressed, regardless of the extent of services provided?
[SAS 26, par. 10 (AU 504.10); SSARS1, pars. 22 and 38 (AR 100.22 and
.38)]

4.

Does the reporting language conform with the auditor's standard
report on:

a. Financial statements of a single year or period?
b. Comparative financial statements?
[SAS 58, par. 8 (AU 508.08)]

5.

Does the report include appropriate language for the following
situations:

a. Only one basic financial statement is presented and there are no
scope limitations?
[SAS 58, pars. 33 and 34, as amended by SAS 79 (AU 508.33 and
.34)]
b. Audited and unaudited financial statements are presented in com
parative form?
[SAS 26, pars. 14-17 (AU 504.14-.17)]

6.

Is an explanatory paragraph (or other explanatory language) added
to the standard report if:

a. There is substantial doubt about the entity's ability to continue as
a going concern for a reasonable period of time and that conclusion
is expressed through the use of the phrase "substantial doubt
about its (the entity's) ability to continue as a going concern"?
[SAS 64, par. 1 (AU 341.12 and .13)]
b. There is a material change between periods in accounting princi
ples or in the method of their application?
[SAS 58, pars. 16-18, as amended by SAS 79 (AU 508.16-.18)]

c. In an updated report on comparative financial statements, the
current opinion on the prior period is different from the one
previously expressed?
[SAS 58, pars. 68,69,72, and 73, as amended by SAS 79 (AU 508.68,
.69, .72, and .73)]
d. The prior period financial statements are audited by a predecessor
auditor whose report is not presented?
[SAS 64, par. 2 (AU 508.74)]
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No

N/A

Yes

No

N/A

e. The auditor's opinion is based in part on the report of another
auditor?
[SAS 1, sec. 543 (AU 543); SAS 58, pars. 12 and 13 (AU 508.12 and .13)]
f.

The financial statements contain a departure from a promulgated
accounting principle when conformity with GAAP would result
in a misleading presentation?
[SAS 58, pars. 14 and 15 (AU 508.14 and .15)]

g. Other information in a document containing audited financial
statements is materially inconsistent with information appearing
in the financial statements?
[SAS 8, par. 4 (AU 550.04)]
h. The auditor decides to emphasize a matter in the report?
[SAS 58, par. 19, as amended by SAS 79 (AU 508.19); Interpretation 3
of SAS 1, sec. 410 (AU 9410.18); Interpretation 1 of SAS 57 (AU9342.03)]
Note: In a going concern paragraph, the auditor should not use condi
tional language in expressing a conclusion concerning the existence of
substantial doubt about the entity's ability to continue as a going concern.
See SAS 77 for an example.

7.

Is a qualified opinion or disclaimer of opinion expressed if scope
limitations preclude application of one or more auditing procedures
considered necessary in the circumstances?1
[SAS 58, pars. 22-27 (AU 508.22-.27); SAS 31, par. 22 (AU 326.23); SAS
84, par. 18 (AU 315.18); SAS 85, par. 13.14 (AU 333.14)]

Note: Consult the Topical Index to the AICPA Professional Standards under
"Scope of Audit—Limitations" for additional references to specific types of
scope limitations that could result in either a qualified or disclaimer of opinion.

8.

Is a qualified opinion or adverse opinion expressed if a lack of conformity
with GAAP (including inadequate disclosure) is present?12
[SAS 58, pars. 35-57, as amended by SAS 79 (AU 508.35-.59); SAS 32,
par. 3 (AU 431.03)]

Note: Consult the Topical Index to the AICPA Professional Standards under
"Departures from Established Principles," "Adverse Opinions," and "Quali
fied Opinions" for additional references to specific types of GAAP departures
that could result in either a qualified or adverse opinion.

9.

If a qualified opinion, adverse opinion, or disclaimer of opinion is
expressed, are all the substantive reasons for the opinion or disclaimer
disclosed and is the reporting language appropriately modified?
[SAS 58, pars. 21, 59, 60, and 62, as amended by SAS 79 (AU 508.21,
.59, .60, and .62)]

1 This includes when the auditor is unable to obtain sufficient, evidential matter to support management's assertions about the
nature of a matter involving an uncertainty and its presentation or disclosure in the financial statements. [SAS 58, par. 31, as amended
by SAS 79]
2 The auditor should express a qualified or an adverse opinion if the auditor concludes that (a) a matter involving a risk or an
uncertainty is not adequately disclosed, (b) the accounting principles used cause the financial statements to be materially misstated
when the inability to make a reasonable estimate raises questions about the appropriateness of the accounting principles used, and (c)
management's estimate is unreasonable and its effect is to cause the financial statements to be materially misstated. [SAS 58, pars.
46-49, as amended by SAS 79]
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Yes

No

N/A

10. If information accompanies the basic financial statements and audi
tor's report in an auditor-submitted document, does the report on the
accompanying information:

a. State that the audit is performed for the purpose of forming an
opinion on the basic financial statements taken as a whole?
b. Specifically identify the accompanying information?

c. State that the accompanying information is presented for purposes
of additional analysis and is not a required part of the basic
financial statements?

d. State whether the accompanying information is subject to the audit
ing procedures applied in the audit of the basic financial statements
and the appropriate expression of opinion or disclaimer?
[SAS 29, pars. 6-11 (AU 551.06-.11)]
11. Is the reporting form and content of SAS 60, paragraphs 9-19, fol
lowed when communicating internal control related matters noted in
an audit?3
[SAS 60, pars. 9-19, as amended by SAS 87 (AU 325.09-.19)]
Note: SAS 87, Restricting the Use ofan Auditor's Report, provides guidance
to auditors in determining whether an engagement requires a restricteduse report and, if so, what elements to include in that report. SAS 87 is
effective for reports issued after December 31,1998.

12. Is the reporting form and content of SAS 72, as amended by SAS 76
and SAS 86, followed for comfort letters submitted to underwriters
and other requesting parties on tax-exempt bond offerings?
[SAS 72, as amended by SAS 76 and SAS 86 (AU 634)]
13. If, during a GAAS audit of the financial statements, the auditor
becomes aware that the entity is subject to an audit requirement of
legal, regulatory, or contracted nature not encompassed in the en
gagement, did the auditor consider the client's actions in response to
such requirement including the potential effect on the financial state
ments and the auditor's report?
[SAS 74, par. 23 (AU 801.22 and .23)]

3 Reportable conditions in internal control structure that have not been corrected must be communicated, preferably in writing, to
senior management and the board of trustees or its audit committee. [SAS 60]
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FSP Section 11,400
Auditors’ Reports on Audits Performed
Under Government Auditing Standards
and Under OMB Circular A-133 Checklist
.01 This checklist, developed by the staff of the Accounting and Auditing Publications Team of the
AICPA as a nonauthoritative practice aid, addresses the auditor's reporting requirements addressed by
AICPA Statement of Position (SOP) 98-3, Audits of States, Local Governments, and Not-for-Profit Organizations
Receiving Federal Awards. SOP 98-3 was issued in March of 1998. It provides guidance on the auditor's
responsibilities when conducting a single audit or program-specific audit in accordance with the Single Audit
Act Amendments of 1996 and OMB Circular A-133.

.02 Explanation of References:

SOP =

AICPA Statement of Position

AU =

Reference to section number in AICPA Professional Standards (vol. 1)

GAAP =

Generally accepted accounting principles

GAAS =

Generally accepted auditing standards

OMB =

Office of Management and Budget

.03 Checklist questionnaire:

Yes

General
Circular A-133 Requirements
1.

Does the auditor's report include:

a. An opinion (or disclaimer of opinion) on whether the financial
statements are presented fairly in all material respects in conform
ity with GAAP and an opinion (or a disclaimer of opinion) on
whether the schedule of expenditures of federal awards is pre
sented fairly in all material respects in relation to the financial
statements taken as a whole?
b. A report on the internal control related to the financial statements
and on the internal control related to major programs?

c. A report on compliance with laws, regulations, and the provisions
of contracts or grant agreements, noncompliance with which
could have a material effect on the financial statements, including
an opinion (or a disclaimer of opinion) on whether the auditee
complied with laws, regulations, and the provisions of contracts
or grant agreements that could have a direct and material effect
on each major program, and, where applicable, refers to the sepa
rate schedule of findings and questioned costs?

d. A schedule of findings and questioned costs?
[SOP 98-3, par. 10.3]
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No

N/A

Yes

Reporting on the Financial Statements and Supplementary
Schedule of Expenditures of Federal Awards in Accordance
With Government Auditing Standards
Government Auditing Standards Requirements
2.

Does the auditor's report on the audit of the financial statements:

a. Include a statement that the audit was made in accordance with
generally accepted government auditing standards?
[SOP 98-3, par. 10.16b]
b. Describe the scope of the auditor's testing of compliance with laws
and regulations and internal control and present the results of
those tests?

or

refer to separate reports containing that information?
[SOP 98-3, par. 10.16c]
c. State the nature of information omitted and the requirement that
makes the omission necessary when certain information is prohib
ited from general disclosure?
[SOP 98-3, par. 10.16d]
3.

Did the auditor communicate certain information related to the con
duct and reporting of the audit to the audit committee or to the
individuals with whom he or she has contracted for the audit, includ
ing the auditor's responsibility in a financial statement audit and the
nature of any additional testing of internal control and compliance
required by laws or regulations?
[SOP 98-3, par. 10.16a]

4.

Were written audit reports:

a. Submitted to the appropriate officials of the auditee and to the
appropriate officials of the organizations requiring or arranging
for the audit (including external funding organizations), unless
legal restrictions prevent it?
b. Sent to other officials who have legal oversight authority or who
may be responsible for acting on audit findings and recommenda
tions and others authorized to receive such reports?

c. Made available for public inspection unless restricted by law or
regulation?
[SOP 98-3, par. 10.16e]
Fraud, Illegal Acts, and Other Noncompliance
5.

If a report presenting fraud, illegal acts, or other noncompliance that are
required to be reported is prepared, have the report contents standards
in chapter 7 of Government Auditing Standards been followed?
[SOP 98-3, par. 10.21]

6.

If the auditor detected fraud, illegal acts, or other noncompliance that
do not meet the criteria for reporting in paragraph 5.18 of Government
Auditing Standards:
a. Did he or she communicate those findings to the auditee, prefer
ably in writing?
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No

N/A

No
b. If those findings were communicated in a management letter, was
the management letter referred to in the report on compliance?
[SOP 98-3, par. 10.22]
7.

If applicable, did the auditor comply with the guidance in paragraphs
5.21 through 5.25 of Government Auditing Standards on direct reporting
of fraud and illegal acts?
[SOP 98-3, par. 10.23]

Internal Control Over Financial Reporting

8.

Does the auditor's report on internal control matters:

a. Describe the extent of the work performed, as required by SAS No.
55?

b. Include the report requirements of SAS No. 60 and separately
identify material weaknesses?

c. Follow the report contents standards in chapter 7 of Government
Auditing Standards when reporting reportable conditions and ma
terial weaknesses?
d. Report to the auditee detected deficiencies in the internal control
that are not reportable conditions, preferably in writing?

e. If a management letter was used to report the nonreportable
conditions, was that letter referred to in the report on internal
control?
[SOP 98-3, pars. 10.27-10.29]
Implementing Regulations of Certain Federal Awarding Agencies May
Define Entity to Be Audited Differently Than GAAP

9.

Where parent-only financial statements have been audited because
the regulations of the federal agency that provides federal awards to
a parent company define the entity for single audit purposes to consist
of only the parent, and consolidated financial statements are not also
prepared as required by GAAP, has the auditor's report been modi
fied due to a material departure from GAAP, if necessary?
[SOP 98-3, par. 10.34]

Opinion on the Financial Statements and on the Supplementary
Schedule of Expenditures of Federal Awards
10. Does the auditor's standard report on the financial statements and on
the supplementary schedule of expenditures of federal awards in
clude the following:

a. Identification of the financial statements audited in an opening
(introductory) paragraph?
b. A description of the nature of an audit in a scope paragraph?

c. An expression of the auditor's opinion on the financial statements
and supplementary schedule of expenditures of federal awards in
separate opinion paragraphs?
[SOP 98-3, par. 10.35]
d. A title that includes the word independent?
[SOP 98-3, par. 10.35a]

e. A statement that the financial statements identified in the report
were audited?
[SOP 98-3, par. 10.35b]
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N/A

Yes

f.

No

N/A

A statement that the financial statements are the responsibility of
the auditee's management and that the auditor's responsibility is
to express an opinion on the financial statements based on his or
her audit?
[SOP 98-3, par. 10.35c]

g. A statement that the audit was conducted in accordance with
GAAS and the standards applicable to financial audits contained
in Government Auditing Standards issued by the Comptroller Gen
eral of the United States?1
[SOP 98-3, par. 10.35d]
h. A statement that those standards require that the auditor plan and
perform the audit to obtain reasonable assurance about whether
the financial statements are free of material misstatement?
[SOP 98-3, par. 10.35e]

i.

j.

A statement that an audit includes—
(1)

Examining, on a test basis, evidence supporting the amounts
and disclosures in the financial statements?

(2)

Assessing the accounting principles used and significant es
timates made by management?

(3)

Evaluating the overall financial statement presentation?
[SOP 98-3, par. 10.35f]

A statement that the auditor believes that the audit provides a
reasonable basis for his or her opinion?
[SOP 98-3, par. 10.35g]

k. An opinion on whether the financial statements for a not-for-profit
organization present fairly, in all material respects, the financial
position of the auditee as of the date of the statement of financial
position, and the changes in its net assets and its cash flows for the
period then ended in conformity with GAAP; or, for a govern
ment, the financial position of the auditee as of the balance sheet
date, and the results of its operations and cash flows for the period
then ended in conformity with GAAP?
[SOP 98-3, par. 10.35h]

Note: If an auditee prepares financial statements in conformity with a
comprehensive basis of accounting other than GAAP, the auditor is still
required to express or disclaim an opinion and should follow the reporting
in SAS 62, Special Reports.
l.

A reference to the separate report on compliance with certain
provisions of laws, regulations, contracts, and grant agreements
and on the internal control over financial reporting prepared in
accordance with Government Auditing Standards, if this reporting
is not included in the report on the financial statement? (SOP 98-3
recommends separate reporting.)
[SOP 98-3, par. 10.35i]

m. A description of the accompanying supplementary information
(for example, the schedule of expenditures of federal awards) by
descriptive title or by page number of the document?
[SOP 98-3, par. 10.35j]
1 The standards applicable to financial audits include the general, fieldwork, and reporting standards described in chapters 3,4, and
5 of Government Auditing Standards.
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Yes
n. A statement that the accompanying supplementary information,
including the schedule of expenditures of federal awards required
by Circular A-133, is presented for purposes of additional analysis
and is not a required part of the financial statements?
[SOP 98-3, par. 10.35k]

o. An opinion on whether the accompanying supplementary infor
mation is fairly stated, in all material respects, in relation to the
financial statements taken as a whole?
[SOP 98-3, par. 10.351]
p. The manual or printed signature of the auditor's firm?
[SOP 98-3, par. 10.35m]
q. The date of the audit report?
[SOP 98-3, par. 10.35n]
11. If a separate single audit package is issued for the schedule of expen
diture of federal awards, is the required reporting on the schedule
incorporated in the report issued to meet the requirements of Circular
A-133?
[SOP 98-3, par. 10.36]

Report on Compliance and on Internal Control Over Financial Reporting
Based on an Audit of Financial Statements Performed in Accordance
With Government Auditing Standards
12. Is the reporting on the scope of the auditor's testing of compliance and
on the internal control over financial reporting based on an audit of
the financial statements as required by Government Auditing Standards
combined in one report? (This is encouraged but not required by SOP
98-3.)
[SOP 98-3, par. 10.38]
13. Does the auditor's standard report on compliance and on the internal
control over financial reporting based on an audit of the financial
statements in accordance with Government Auditing Standards include:

a. A statement that the auditor has audited the financial statements
of the auditee and a reference to the auditor's report on the
financial statements, including a description of any departure
from the standard report?

b. A statement that the audit was conducted in accordance with
GAAS and with the standards applicable to financial audits con
tained in Government Auditing Standards issued by the Comptroller
General of the United States?
c. A statement that as part of obtaining reasonable assurance about
whether the auditee's financial statements are free of material
misstatement, the auditor performed tests of the auditee's compli
ance with certain provisions of laws, regulations, contracts, and
grants, noncompliance with which could have a direct and mate
rial effect on the determination of financial statement amounts?
d. A statement that providing an opinion on compliance with those
provisions was not an objective of the audit and that, accordingly,
the auditor does not express such an opinion?
75

No

N/A

Yes
e.

A statement that notes whether the results of tests disclosed in
stances of noncompliance that are required to be reported under
Government Auditing Standards and, if they are, describes the in
stances of noncompliance or refers to the schedule of findings and
questioned costs in which they are described?

f.

If applicable, a statement that certain immaterial instances of
noncompliance were communicated to management in a separate
letter?

g. A statement that in planning and performing the audit, the auditor
considered the auditee's internal control over financial reporting
in order to determine the auditing procedures for the purpose of
expressing an opinion on the financial statements and not to
provide assurance on the internal control over financial reporting?

h. If applicable, a statement that reportable conditions were noted
and the definition of a reportable condition?

i.

If no reportable conditions are noted, a statement that the auditor's
consideration of the internal control over financial reporting
would not necessarily disclose all matters in the internal control
that might be material weaknesses; if reportable conditions are
noted, a statement that the auditor's consideration of the internal
control over financial reporting would not necessarily disclose all
matters in the internal control that might be reportable conditions
and, accordingly, would not necessarily disclose all reportable
conditions that are also considered to be material weaknesses?

If applicable, a description of the reportable condition noted or a
reference to the schedule of findings and questioned costs in which
the reportable conditions are described?
k. The definition of a material weakness?

j.

l.

If applicable, a statement about whether the auditor believes any
of the reportable conditions noted are material weaknesses and, if
they are, describes the material weaknesses noted or refers to the
schedule of findings and questioned costs in which they are de
scribed?

m. If reportable conditions are not noted, a statement that no material
weaknesses were noted?
n. If applicable, a statement that other matters involving the internal
control over financial reporting were communicated to manage
ment in a separate letter?

o. A statement that the report is intended for the information of the
audit committee, management, specified legislative or regulatory
bodies, federal awarding agencies, and (if applicable) passthrough entities?

Note: SAS 87, Restricting the Use of an Auditor's Report, provides guidance
to auditors in determining whether an engagement requires a restricteduse report and, if so, what elements to include in that report. SAS 87 is
effective for reports issued after December 31,1998.
p. If the report is a matter of public record, a statement that the report
is a matter of public record and its distribution is not limited?
q. The manual or printed signature of the auditor's firm?

r. The date of the auditor's report?
[SOP 98-3, par. 10.39]
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No

N/A

Yes

Reporting on a Compliance Audit of Major Federal Programs in
Accordance With Circular A-133
Material Instances of Noncompliance

14. If an audit of compliance with requirements applicable to a major
program detects material instances of noncompliance with those
requirements:
a. Is a qualified or adverse opinion expressed?
b. Does the report state the basis for such an opinion?
[SOP 98-3, par. 10.42]

15. If the scope of an audit of compliance with laws, regulations, and the
provisions of contracts or grant agreements is restricted so as to impair
the auditor's ability to form an opinion on compliance with require
ments governing each major program:
a. Is a qualified opinion or disclaimer of opinion expressed?
b. Are the reasons for such a qualification or disclaimer of opinion
described in the auditor's report?
[SOP 98-3, pars. 10.43 and 10.44]

16. When disclaiming an opinion because of a scope limitation, does the
auditor's report:
a. Include a separate paragraph that indicates all of the substantive
reasons for the disclaimer?
b. State that the scope of the audit was not sufficient to warrant the
expression of an opinion?

c. Exclude the scope paragraph (identification of the procedures that
were performed or a description of the characteristics of an audit)
so as not to overshadow the disclaimer?

d. Disclose any reservations the auditor has regarding compliance
with applicable laws and regulations?
[SOP 98-3, par. 10.45]
Report on Compliance With Requirements Applicable to Each Major
Program and on Internal Control Over Compliance in Accordance With
Circular A-133
17. Does the auditor's standard report on compliance with requirements
applicable to each major program and on the internal control over
compliance in accordance with Circular A-133 include:
a. A statement that the auditor has audited the compliance of the
auditee with the types of compliance requirements described in
the OMB Circular A-133 Compliance Supplement that are applicable
to each of its major programs?

b. A statement that the auditee's major programs are identified in the
summary of the auditor's results section of the accompanying
schedule of findings and questioned costs?

c. A statement that compliance with the requirements of laws, regu
lations, contracts, and grants applicable to each of the auditee's
major federal programs is the responsibility of the auditee's man
agement, and that the auditor's responsibility is to express an
opinion on the auditee's compliance based on the audit?
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No

N/A

Yes

d. A statement that the audit of compliance was conducted in accord
ance with GAAS, the standards applicable to financial audits
contained in Government Auditing Standards issued by the Comp
troller General of the United States, and Circular A-133?
e. A statement that those standards and Circular A-133 require that
the auditor plan and perform the audit to obtain reasonable assur
ance about whether noncompliance with the types of compliance
requirements that could have a direct and material effect on a
major federal program occurred?

f.

A statement that an audit includes the examining, on a test basis,
evidence about the auditee's compliance with those requirements
and performing of such other procedures as the auditor consid
ered necessary in the circumstances?

g. A statement that the auditor believes that the audit provides a
reasonable basis for the auditor's opinion?

h. A statement that the audit does not provide a legal determination
of the auditee's compliance with those requirements?
i.

If instances of noncompliance are noted that result in an opinion
modification, a reference to a description in the accompanying
schedule of findings and questioned costs, including:
(1) The reference number(s) of the finding(s)?

j.

(2)

An identification of the type(s) of compliance requirements
and related major program(s)?

(3)

A statement that compliance with such requirements is nec
essary, in the auditor's opinion, for the auditee to comply
with the requirements applicable to the program(s)?

An opinion on whether the auditee complied, in all material
respects, with the types of compliance requirements that are ap
plicable to each of its major federal programs?

k. If applicable, a statement that the results of the auditing proce
dures disclosed instances of noncompliance that are required to
be reported in accordance with Circular A-133 and a reference to
the schedule of findings and questioned costs in which they are
described?

l.

A statement that the auditee's management is responsible for
establishing and maintaining effective internal control over com
pliance with the requirements of laws, regulations, contracts, and
grants applicable to federal programs?

m. A statement that in planning and performing the audit, the auditor
considered the auditee's internal control over compliance with
requirements that could have a direct and material effect on a
major federal program, to determine the auditing procedures for
the purpose of expressing an opinion on compliance and to test
and report on the internal control over compliance in accordance
with Circular A-133?
n. If applicable, a statement that reportable conditions were noted
and the definition of a reportable condition?

o. If applicable, a reference to a description of reportable conditions
noted in the accompanying schedule of findings and questioned
costs, including the reference number of the finding(s)?
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No

N/A

Yes
p. If no reportable conditions are noted, a statement that the auditor's
consideration of the internal control over compliance would not
necessarily disclose all matters in internal control that might be
material weaknesses; if reportable conditions are noted, a state
ment that the auditor's consideration of the internal control over
compliance would not necessarily disclose all matters in the inter
nal control that might be reportable conditions and, accordingly,
would not necessarily disclose all reportable conditions that are
also considered to be material weaknesses?
q. The definition of a material weakness?
r. If applicable, a statement about whether the auditor believes any
of the reportable conditions noted are material weaknesses and, if
they are, a reference to a description of the material weaknesses in
the schedule of findings and questioned costs, including the refer
ence number of the finding(s)?

s. If there are no reportable conditions, a statement that no material
weaknesses were noted?
t.

A statement that the report is intended for the information of the
audit committee, management, specified legislative or regulatory
bodies, federal awarding agencies, and (if applicable) passthrough entities?

u. If the report is a matter of public record, a statement that the report
is a matter of public record and its distribution is not limited?

v. The manual or printed signature of the auditor's firm?
w. The date of the auditor's report?
[SOP 98-3, par. 10.46]
18. Are all audit findings required to be reported under Circular A-133
included in the schedule of findings and questioned costs?
[SOP 98-3, par. 10.48]

Other Reporting Considerations:
Dating of Reports

19. Do the report on the supplementary schedule of expenditures of
federal awards and the report on compliance and internal control over
financial reporting, as required by Government Auditing Standards,
carry the same date as that on the report on the basic financial
statements?
[SOP 98-3, par. 10.50]
20. Does the auditor's report on compliance and on the internal control
over compliance related to major programs, as required by Circular
A-133:
a. Carry the same date as that of other reports?
b. Because some of the audit work to satisfy Circular A-133 require
ments was done subsequent to the work on the financial state
ments, carry the date when the fieldwork required to support the
report on the audit of compliance is completed?
[SOP 98-3, par. 10.51]
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No

N/A

Yes
21. If the schedule of expenditures of federal awards is reported on in the
report on compliance and the internal control over compliance issued
to meet Circular A-133 requirements, but using the same dates for
reporting on the schedule and the report on the financial statements
is not possible, has the auditor:
a. Dual dated the report issued to meet Circular A-133 requirements?
b. Issued a separate report on the schedule of expenditures of federal
awards, dated the same date as that of the financial statement
report?
[SOP 98-3, par. 10.52]

____

____

Other Auditors
22. If the auditor is engaged to issue a stand-alone opinion on the sched
ule of expenditures of federal awards either as part of the report issued
to meet the requirements of Circular A-133 or separately (dated the
same as the Circular A-133 report), has the guidance in SAS No. 58
been followed?
[SOP 98-3, par. 10.52]

____

When the Audit of Federal Awards Does Not Encompass the Entirety of
the Auditee's Operations

23. If the audit of federal awards did not encompass the entirety of the
auditee's operations expending federal awards, were the operations
that were not included identified in a separate paragraph following
the first paragraph of the report on major programs?
[SOP 98-3, par. 10.54]

____

Schedule of Findings and Questioned Costs
24. Does the schedule of findings and questioned costs include the fol
lowing sections:

a. A summary of the auditor's results, including:
The type of report the auditor issued on the financial state
ments of the auditee (that is, unqualified opinion, qualified
opinion, adverse opinion, or disclaimer of opinion)?

____

Where applicable, a statement that reportable conditions in
internal control were disclosed by the audit of the financial
statements and whether any such conditions were material
weaknesses?

____

A statement on whether the audit disclosed any noncompli
ance that is material to the financial statement of the auditee?

____

(4) Where applicable, a statement that reportable conditions in
the internal control over major programs were disclosed by
the audit and whether any such conditions were material
weaknesses?

____

The type of report the auditor issued on compliance for major
programs (that is, unqualified opinion, qualified opinion,
adverse opinion, or disclaimer of opinion)?

____

A statement on whether the audit disclosed any audit find
ings that the auditor is required to report under section 510(a)
of Circular A-133?

____

(1)

(2)

(3)

(5)

(6)
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No

N/A

Yes

(7)

An identification of major programs?

(8) The dollar threshold used to distinguish between type A and
type B programs as described in section 520(b) of Circular
A-133?
(9)

A statement on whether the auditee qualified as a low-risk
auditee under section 530 of Circular A-133?
[SOP 98-3, par. 10.56]

b. Findings relating to the financial statements which are required to
be reported in accordance with Government Auditing Standards
including:

(1)

All reportable conditions in the internal control over financial
reporting and other findings relative to the audit of the finan
cial statements that are required to be reported by GAAS and
Government Auditing Standards, including those that do not
affect federal awards?

(2)

All but clearly inconsequential fraud and illegal acts that the
auditor concludes, based on the evidence obtained, either
occurred or are likely to have occurred?

(3)

Other noncompliance (for example, violations of the provi
sions of contract or grant agreements) that is material to the
financial statements?
[SOP 98-3, par. 10.57]

c. Findings and questioned costs for federal awards as defined in
section 510(a) of Circular A-133, that:
(1)

Present audit findings (for example, internal control findings,
compliance findings, questioned costs, or fraud) that relate to
the same issue as a single audit finding?

(2)

Where practical, are audit findings organized by federal
agency or pass-through entity?

(3)

Report audit findings that relate to both the financial state
ments and the federal awards in both sections of the sched
ule? (The reporting in one section of the schedule may be in
summary form, with a reference to a detailed reporting in the
other section of the schedule.)
[SOP 98-3, par. 10.56]

25. Are reportable conditions that are—individually or in the aggregate—
material weaknesses so identified?
[SOP 98-3, par. 10.58]
26. Do the findings identify at least the criteria (what should be), condi
tion (what is), and possible asserted effect (the difference between
what is and what should be) and, if known, the cause (why it
happened)?
[SOP 98-3, pars. 10.59-10.65]

27. In presenting reportable conditions, fraud, illegal acts, and other
noncompliance, were the report content standards in chapter 7 of
Government Auditing Standards that pertain to objectives, scope, and
methodology; audit results; the views of responsible officials; and the
reports presentation standards (as appropriate) followed?
[SOP 98-3, par. 10.61]
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No

N/A

Yes

28. With respect to uncorrected material findings and recommendations
from prior audits that affect the financial statement audit:
a. Have such uncorrected items been reported?
b. Have those material findings and recommendations from pre
vious audits that are repeated identified as repeat findings?

c. Has the status of uncorrected findings from previous audits that
are not repeated as current-year findings been reported?
[SOP 98-3, par. 10.62]
Audit Findings Reported—Federal Awards
29. As required by section 510(a) of Circular A-133, have the following
items been reported as audit findings in the schedule of findings and
questioned costs:

a. Reportable conditions in the internal control over major programs?
b. Reportable conditions that are individually or cumulatively ma
terial weaknesses?

c. Material noncompliance with the provisions of laws, regulations,
contracts, or grant agreements that are related to a major program?
d. Known questioned costs that are greater than $10,000 for a type of
compliance requirement for a major program?

e. Known questioned costs when likely questioned costs are greater
than $10,000 for a type compliance requirement for a major pro
gram, including information to provide proper perspective for
judging the prevalence and consequences of the questioned costs?
f.

Known questioned costs that are greater than $10,000 for pro
grams that are not audited as major, if the auditor becomes aware
of such questioned costs?

g. The circumstances concerning why the auditor's report on com
pliance for major programs is other than an unqualified opinion,
unless such circumstances are otherwise reported as audit find
ings in the schedule of findings and questioned costs for federal
awards (for example, a scope limitation that is not otherwise
reported as a finding)?
h. Known fraud affecting a federal award, unless such fraud is other
wise reported as an audit finding in the schedule of findings and
questioned costs for federal awards? (The auditor is not required to
make an additional reporting when the auditor confirms that the
fraud was reported outside of the auditor's reports under the direct
reporting requirements of Government Auditing Standards.)

i.

Instances where the results of audit follow-up procedures dis
closed that the summary schedule of prior audit findings prepared
by the auditee in accordance with section 315(b) of Circular A-133
materially misrepresents the status of any prior audit finding?
[SOP 98-3, par. 10.63]

Detail of Audit Findings—Federal Awards
30. In accordance with section 510(b) of Circular A-133, do audit findings
present:

a. Identification of the federal program and specific federal award
including the CFDA title and number, the federal award number
and year, the name of federal agency, and the name of the appli
cable pass-through entity or, if certain information is not available,
the best information available to describe the federal award?
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No

N/A

Yes
b. The criteria or specific requirement upon which the audit finding
is based, including the statutory, regulatory, or other citation?
c. The condition found, including facts that support the deficiency
identified in the audit finding?

d. Identification of questioned costs and how they were computed?

e. Information to provide a proper perspective for judging the preva
lence and consequences of the audit findings (for example,
whether the audit findings represent an isolated instance or a
systemic problem) and, where appropriate, the instances identi
fied are related to the universe and the number of cases examined
and quantified in terms of the dollar value?
f.

The possible asserted effect to provide sufficient information to
the auditee and federal agency (or pass-through entity, in the case
of a subrecipient) to permit them to determine the cause and effect,
to facilitate prompt and proper corrective action?

g. Recommendations to prevent future occurrences of the deficiency
identified in the audit finding?
h. To the extent practical, the views of responsible officials of the
auditee when there is disagreement with the audit findings?

i.

If the auditor does not agree with the auditee's position in the
corrective action plan, a statement of the auditor's reasons for
rejecting it?
[SOP 98-3, par. 10.64]

Other Preparation Guidance

31. Does each audit finding in the schedule of findings and questioned
costs include a reference number to allow for easy referencing of the
audit findings during follow-up?
[SOP 98-3, par. 10.65]

32. In a situation where there are no findings or questioned costs, has the
summary of auditor's results section of the schedule of findings and
questioned costs been prepared and indication been made in the other
required sections that no matters were reportable?
[SOP 98-3, par. 10.66]

Summary Schedule of Prior Audit Findings and Corrective
Action Plan
33. Has the auditor reported, as a current year audit finding, any in
stances where the auditor concludes that the summary schedule of
prior audit findings materially misrepresents the status of any prior
audit finding in accordance with the requirements of section 500(e) of
Circular A-133?
[SOP 98-3, par. 10.69]

Data Collection Form
34. With respect to the data collection form required by Circular A-133,
has the auditor:
a. Completed required sections of the form, including information
on the auditor and information on the results of the financial
statement audit and the audit of federal programs?
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No

N/A

Yes
b. Signed a statement in the form that indicates, at a minimum, the
source of the information included in the form, the auditor's
responsibility for the information, that the form is not a substitute
for the reporting package, and that the content of the form is
limited to the data elements prescribed by the OMB?

c. Dated the form as of the date on which he or she completes and
sign the form?
[SOP 98-3, par. 10.72]

Program-Specific Audits
Circular A-133 Requirements

35. Is the auditor's report in the form of either combined or separate
reports?
[SOP 98-3, par. 11.8]

____

36. Does the auditor's report state that the audit was conducted in accord
ance with GAAS, Government Auditing Standards, and Circular A-133?
[SOP 98-3, par. 11.8]

____

37. Does the auditor's report include the following:
a. An opinion (or disclaimer of opinion) on whether the financial
statement(s) of the federal program are presented fairly in all
material respects in conformity with the stated accounting poli
cies?

b. A report on the internal control related to the federal program,
which describes the scope of the testing of the internal control and
the results of the tests?

c. A report on compliance, which includes an opinion (or a dis
claimer of opinion) on whether the auditee complied with laws,
regulations, and the provisions of contracts or grant agreements
that could have a direct and material effect on the federal pro
gram?
d. A schedule of findings and questioned costs for the federal pro
gram, which includes a summary of the auditor's results relative
to the audit of the federal program in a format consistent with the
requirements for the summary of auditor's results in section
505(d)(1) of the circular, as well as findings and questioned costs
for federal awards consistent with the requirements of section
505(d)(3) of the circular?
[SOP 98-3, par. 11.8]

Note: The following auditor's reports are suggested for program specific
audits.
38. Are the following reports issued:

a. An opinion on the financial statement(s) of the federal program?

____

b. A report on compliance with requirements applicable to the fed
eral program and on the internal control over compliance in
accordance with the program-specific audit option under OMB
Circular A-133?

____
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No

N/A

c. If the financial statements of the program only present the activity
of the federal program, a separate Government Auditing Standards
report?
[SOP 98-3, pars. 11.8-11.10]
39. If the financial statements of the program present more than the
program's activity, is a separate Government Auditing Standards report,
modified so that it refers only to the financial statement(s) of the
federal program, issued?
[SOP 98-3, par. 11.10]
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Yes

No

____

___

____

___

N/A

FSP Section 11,500
Illustrative Financial Statements
.01 The following illustrative financial statements demonstrate the practical applications of the reporting
practices discussed in the June 1996 AICPA Audit and Accounting Guide Health Care Organizations (the
Guide). The checklists and illustrative financial statements do not include all disclosures and presentation
items promulgated. Pronouncements deemed remote for audits of health care providers are not included in
this document. Specific types of health care organizations have been selected to illustrate a wide diversity of
reporting practices; it is not intended that these illustrations represent either the only types of disclosure or
the only statement formats that would be appropriate. Health care providers are urged to develop financial
statement formats that are appropriate for their individual circumstances while being consistent with the
accounting and reporting practices discussed in the Guide.

The illustrative financial statements are reproduced from the May 1998 AICPA Audit and Accounting Guide
Health Care Organizations, and are in conformity with accounting standards issued up to and including FASB
Statement SFAS No. 132, Employers' Disclosures about Pensions and Other Postretirement Benefits. Preparers and
auditors of financial statements should refer to subsequent FASB Statements and other GAAP for additional
requirements.
This section contains illustrative financial statements for the following types of health care organizations:
•

Not-for-Profit Hospital

•

For-Profit Nursing Home

•

Not-for-Profit Continuing Care Retirement Community

•

Not-for-Profit Home Health Agency

•

Not-for-Profit Health Maintenance Organization

•

Not-for-Profit Ambulatory Care Organization
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The checklists and illustrative financial statements do not include all disclosures
and presentation items promulgated.

ILLUSTRATIVE FINANCIAL STATEMENTS FOR A NOT-FOR-PROFIT HOSPITAL
.02

Sample Not-for-Profit Hospital

Balance Sheets
December 31,19X7 and 19X6
(in thousands)
19X7

Assets
Current assets:
Cash and cash equivalents
Short-term investments
Assets limited as to use
Patient accounts receivable, net of allowance
for doubtful accounts of $2,500 in 19X7
and $2,400 in 19X6
Other current assets
Total current assets

Assets limited as to use:
Internally designated for capital acquisition
Held by trustee

Less amount required to meet current obligations
Long-term investments
Long-term investments restricted for capital acquisition
Property and equipment, net
Other assets
Total assets

$

4,758
15,836
970

19X6

$

15,100
2,670
39,334

5,877
10,740
1,300

14,194
2,856
34,967

12,000
6,949
18,949
(970)
17,979
4,680
320
51,038
1,695
$115,046

12,500
7,341
19,841
(1,300)
18,541
4,680
520
50,492
1,370
$110,570

$

$

Liabilities and Net Assets

Current liabilities:
Current portion of long-term debt
Accounts payable and accrued expenses
Estimated third-party payor settlements
Other current liabilities
Total current liabilities
Long-term debt, net of current portion
Other liabilities
Total liabilities
Net assets:
Unrestricted
Temporarily restricted
Permanently restricted
Total net assets
Total liabilities and net assets
See accompanying notes to financial statements.
88

1,470
5,818
2,143
1,969
11,400
23,144
3,953
38,497

1,750
5,382
1,942
2,114
11,188
24,014
3,166
38,368

70,846
2,115
3,588
76,549

66,199
2,470
3,533
72,202

$115,046

$110,570

.03

FORMAT A

Sample Not-for-Profit Hospital
Statements of Operations
Years Ended December 31,19X7 and 19X6
(in thousands)

Unrestricted revenues, gains and other support:
Net patient service revenue
Premium revenue
Other revenue
Net assets released from restrictions used for operations
Total revenues, gains and other support

Expenses:
Operating expenses
Depreciation and amortization
Interest
Provision for bad debts
Other
Total expenses

19X7

19X6

$85,156
11,150
2,601
300

$78,942
10,950
5,212

99,207

95,104

88,521
4,782
1,752
1,000
2,000

80,585
4,280
1,825
1,300
1,300

98,055

89,290

Operating income
Other income:
Investment income

1,152

5,814

3,900

3,025

Excess of revenues over expenses

5,052

8,839

300

375

Change in net unrealized gains and losses on other than
trading securities
Net assets released from restrictions used for purchase of
property and equipment
Contributions from Sample Hospital
Foundation for property acquisitions
Transfers to parent

Increase in unrestricted net assets, before extraordinary item

Extraordinary loss from extinguishment of debt
Increase in unrestricted net assets

200
235
(640)
5,147

89

6,699

(500)

$ 4,647

See accompanying notes to financial statements.
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(3,000)

$ 6,699

.04
FORMAT B

Sample Not-for-Profit Hospital
Statements of Operations
Years Ended December 31,19X7 and 19X6

(in thousands)
Unrestricted revenues, gains and other support:
Net patient service revenue
Premium revenue
Other, primarily investment income
Net assets released from restrictions used for operations
Total revenues, gains and other support
Expenses:
Salaries and benefits
Medical supplies and drugs
Insurance
Depreciation and amortization
Interest
Provision for bad debts
Other

Total expenses
Excess of revenues, gains, and other support over expenses

Change in net unrealized gains and losses on other than
trading securities
Net assets released from restrictions used for purchase of
property and equipment
Contributions from Sample Hospital
Foundation for property acquisitions
Transfers to parent
Increase in unrestricted net assets, before extraordinary item

Extraordinary loss from extinguishment of debt
Increase in unrestricted net assets

19X7

19X6

$85,156
11,150
6,501
300

$78,942
10,950
8,237

103,107

98,129

53,900
26,532
8,089
4,782
1,752
1,000
2,000

49,938
22,121
8,526
4,280
1,825
1,300
1,300

98,055

89,290

5,052

8,839

300

375

200
235
(640)
5,147

90

6,699

(500)

$ 4,647

See accompanying notes to financial statements.

485
(3,000)

$ 6,699

.05

Sample Not-for-Profit Hospital
Statements of Changes in Net Assets

Years Ended December 31,19X7 and 19X6
(in thousands)

Unrestricted net assets:
Excess of revenues over expenses
Net unrealized gains on investments, other than trading
securities
Contributions from Sample Hospital Foundation for
property acquisitions
Transfers to parent
Net assets released from restrictions used for purchase
of property and equipment
Increase in unrestricted net assets before
extraordinary item
Extraordinary loss from extinguishment of debt
Increase in unrestricted net assets

Temporarily restricted net assets:
Contributions for charity care
Net realized and unrealized gains on investments
Net assets released from restrictions
Increase (decrease) in temporarily restricted net assets

19X7

19X6

$ 5,052

$ 8,839

300

375

235
(640)

485
(3,000)

200
5,147
(500)

6,699

4,647

6,699

140
5
(500)

996
8

(355)

1,004

Permanently restricted net assets:
Contributions for endowment funds
Net realized and unrealized gains on investments

50
5

411
2

Increase in permanently restricted net assets

55

413

Increase in net assets

Net assets, beginning of year
Net assets, end of year
See accompanying notes to financial statements.
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4,347

8,116

72,202

64,086

$76,549

$72,202

.06

Sample Not-for-Profit Hospital
Statements of Cash Flows (Indirect Method)
Years Ended December 31,19X7 and 19X6

(in thousands)
Cash flows from operating activities:
Change in net assets
Adjustments to reconcile change in net assets to net
cash provided by operating activities:
Extraordinary loss from extinguishment of debt
Depreciation and amortization
Net realized and unrealized gains on investments,
other than trading
Transfers to parent
Provision for bad debts
Restricted contributions and investment income
received
(Increase) decrease in:
Patient accounts receivable
Trading securities
Other current assets
Other assets
Increase (decrease) in:
Accounts payable and accrued expenses
Estimated third-party payor settlements
Other current liabilities
Other liabilities
Net cash provided by operating activities
Cash flows from investing activities:
Purchase of investments
Capital expenditures
Net cash used in investing activities
Cash flows from financing activities:
Transfers to parent
Proceeds from restricted contributions and restricted
investment income
Payments on long-term debt
Payments on capital lease obligations
Proceeds from issuance of long-term debt
Net cash used in financing activities
Net (decrease) increase in cash and cash equivalents
Cash and cash equivalents, beginning of year
Cash and cash equivalents, end of year

19X7

19X6

$ 4,347

$ 8,116

500
4,782

4,280

(450)
640
1,000

(575)
3,000
1,300

(290)

(413)

(1,906)
215
186
(325)

(2,036)

436
201
(145)
787
9,978

679
305
(257)
(128)
11,549

(3,769)
(4,728)
(8,497)

(2,150)
(5,860)
(8,010)

(640)

(3,000)

290
(24,700)
(150)
22,600
(2,600)

413
(804)
(100)
500
(2,991)
548
5,329
$ 5,877

(1,119)
5,877
$ 4,758

(2,481)
(241)

Supplemental Disclosures of Cash Flow Information:

The Hospital entered into capital lease obligations in the amount of $600,000 for new
equipment in 19X7.
Cash paid for interest (net of amount capitalized) in 19X7 and 19X6 was $1,780,000
and $1,856,000, respectively.
See accompanying notes to financial statements.
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Sample Not-for-Profit Hospital
Notes to Financial Statements
December 31,19X7 and 19X6
1. Description of Organization and Summary of Significant Accounting Policies

Organization. The Sample Not-for-Profit Hospital (the Hospital), located in Tulsa, Oklahoma,
is a not-for-profit acute care hospital. The Hospital provides inpatient, outpatient and emergency
care services for residents of northeastern Oklahoma. Admitting physicians are primarily practi
tioners in the local area. The Hospital was incorporated in Oklahoma in 19X1 and is affiliated with
the Sample Health System.
Use of estimates. The preparation of financial statements in conformity with generally accepted
accounting principles requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the
date of the financial statements and the reported amounts of revenues and expenses during the
reporting period. Actual results could differ from those estimates.

Cash and cash equivalents. Cash and cash equivalents include certain investments in highly
liquid debt instruments with original maturities of three months or less.
The Hospital routinely invests its surplus operating funds in money market mutual funds. These
funds generally invest in highly liquid U.S. government and agency obligations.

Investments. Investments in equity securities with readily determinable fair values and all
investments in debt securities are measured at fair value in the balance sheet. Investment income
or loss (including realized gains and losses on investments, interest and dividends) is included in
the excess of revenues over expenses unless the income or loss is restricted by donor or law.
Unrealized gains and losses on investments are excluded from the excess of revenues over
expenses unless the investments are trading securities.

Assets limited as to use. Assets limited as to use primarily include assets held by trustees under
indenture agreements and designated assets set aside by the Board of Trustees for future capital
improvements, over which the Board retains control and may at its discretion subsequently use
for other purposes. Amounts required to meet current liabilities of the hospital have been
reclassified in the balance sheet at December 31,19X7 and 19X6.
Property and equipment. Property and equipment acquisitions are recorded at cost. Depreciation
is provided over the estimated useful life of each class of depreciable asset and is computed using
the straight-line method. Equipment under capital lease obligations is amortized on the straightline method over the shorter period of the lease term or the estimated useful life of the equipment.
Such amortization is included in depreciation and amortization in the financial statements.
Interest cost incurred on borrowed funds during the period of construction of capital assets is
capitalized as a component of the cost of acquiring those assets.

Gifts of long-lived assets such as land, buildings, or equipment are reported as unrestricted
support, and are excluded from the excess of revenues over expenses, unless explicit donor
stipulations specify how the donated assets must be used. Gifts of long-lived assets with explicit
restrictions that specify how the assets are to be used and gifts of cash or other assets that
must be used to acquire long-lived assets are reported as restricted support. Absent explicit
donor stipulations about how long those long-lived assets must be maintained, expirations of
donor restrictions are reported when the donated or acquired long-lived assets are placed in
service.
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Temporarily and permanently restricted net assets. Temporarily restricted net assets are those
whose use by the Hospital has been limited by donors to a specific time period or purpose.
Permanently restricted net assets have been restricted by donors to be maintained by the Hospital
in perpetuity.
Excess of revenues over expenses. The statement of operations includes excess of revenues over
expenses. Changes in unrestricted net assets which are excluded from excess of revenues over
expenses, consistent with industry practice, include unrealized gains and losses on investments
other than trading securities, permanent transfers of assets to and from affiliates for other than goods
and services, and contributions of long-lived assets (including assets acquired using contributions
which by donor restriction were to be used for the purposes of acquiring such assets).

Net patient service revenue. The Hospital has agreements with third-party payors that provide
for payments to the Hospital at amounts different from its established rates. Payment arrange
ments include prospectively determined rates per discharge, reimbursed costs, discounted
charges, and per diem payments. Net patient service revenue is reported at the estimated net
realizable amounts from patients, third-party payors, and others for services rendered, including
estimated retroactive adjustments under reimbursement agreements with third-party payors.
Retroactive adjustments are accrued on an estimated basis in the period the related services are
rendered and adjusted in future periods as final settlements are determined.
Premium revenue. The Hospital has agreements with various Health Maintenance Organiza
tions (HMOs) to provide medical services to subscribing participants. Under these agreements,
the Hospital receives monthly capitation payments based on the number of each HMO's participants,
regardless of services actually performed by the Hospital. In addition, the HMOs make fee-for-service
payments to the Hospital for certain covered services based upon discounted fee schedules.

Charity care. The Hospital provides care to patients who meet certain criteria under its charity care
policy without charge or at amounts less than its established rates. Because the Hospital does not
pursue collection of amounts determined to qualify as charity care, they are not reported as revenue.
Donor-restricted gifts. Unconditional promises to give cash and other assets to the Hospital are
reported at fair value at the date the promise is received. Conditional promises to give and
indications of intentions to give are reported at fair value at the date the gift is received. The gifts
are reported as either temporarily or permanently restricted support if they are received with
donor stipulations that limit the use of the donated assets. When a donor restriction expires, that
is, when a stipulated time restriction ends or purpose restriction is accomplished, temporarily
restricted net assets are reclassified as unrestricted net assets and reported in the statement of
operations as net assets released from restrictions. Donor-restricted contributions whose restric
tions are met within the same year as received are reported as unrestricted contributions in the
accompanying financial statements.
Estimated malpractice costs. The provision for estimated medical malpractice claims includes
estimates of the ultimate costs for both reported claims and claims incurred but not reported.
Income taxes. The Hospital is a not-for-profit corporation and has been recognized as tax-ex
empt pursuant to Sec. 501(c)(3) of the Internal Revenue Code.

2. Net Patient Service Revenue

The Hospital has agreements with third-party payors that provide for payments to the Hospital
at amounts different from its established rates. A summary of the payment arrangements with
major third-party payors follows:
•

Medicare. Inpatient acute care services rendered to Medicare program beneficiaries are
paid at prospectively determined rates per discharge. These rates vary according to a pa

94

tient classification system that is based on clinical, diagnostic, and other factors. Inpatient
nonacute services, certain outpatient services, and defined capital and medical education
costs related to Medicare beneficiaries are paid based on a cost reimbursement methodol
ogy. The Hospital is reimbursed for cost reimbursable items at a tentative rate with final
settlement determined after submission of annual cost reports by the Hospital and audits
thereof by the Medicare fiscal intermediary. Beginning in 19X3, the Hospital claimed
Medicare payments based on an interpretation of certain "disproportionate share" rules.
The intermediary disagreed and declined to pay the excess reimbursement claimed under
that interpretation. Through 1996, the Hospital has not included the claimed excess in net
patient revenues pending resolution of the matter. In 19X7, the intermediary accepted the
claims and paid the outstanding claims, including $950,000 applicable to 19X6 and $300,000
applicable to 19X5 and prior, which has been included in 19X7 net revenues.

•

Medicaid. Inpatient and outpatient services rendered to Medicaid program beneficiaries
are reimbursed under a cost reimbursement methodology. The Hospital is reimbursed at
a tentative rate with final settlement determined after submission of annual cost reports
by the Hospital and audits thereof by the Medicaid fiscal intermediary.

The Hospital also has entered into payment agreements with certain commercial insurance
carriers, health maintenance organizations, and preferred provider organizations. The basis for
payment to the Hospital under these agreements includes prospectively determined rates per
discharge, discounts from established charges, and prospectively determined daily rates.

3. Investments
Assets Limited as to Use

The composition of assets limited as to use at December 31,19X7 and 19X6, is set forth in the
following table. Investments are stated at fair value.
19X7

Internally designated for capital acquisition:
Cash
U.S. Treasury obligations
Interest receivable
Held by trustee under indenture agreement:
Cash and short-term investments
U.S. Treasury obligation
Interest receivable

$

545,000
11,435,000
20,000
12,000,000

352,000
6,505,000
92,000
6,949,000
$18,949,000

19X6

$

350,000
12,115,000
35,000
12,500,000

260,000
7,007,000
74,000
7,341,000
$19,841,000

Other Investments
Other investments, stated at fair value, at December 31,19X7 and 19X6, include:

Trading:
U.S. Corporate Bonds
Other:
U.S. Treasury obligations
Interest receivable
Less:
Long-term investments
Long-term investments restricted for capital
acquisitions
Short-term investments
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19X7

19X6

$ 1,260,000

$ 1,475,000

$19,266,000
310,000
20,836,000

$14,233,000
232,000
15,940,000

4,680,000

4,680,000

320,000
$15,836,000

520,000
$10,740,000

Investment income and gains for assets limited as to use, cash equivalents, and other invest
ments are comprised of the following for the years ending December 31,19X7 and 19X6:

Income:
Interest income
Realized gains on sales of securities
Unrealized gains on trading securities

Other Changes in Unrestricted Net Assets:
Unrealized gains on other than trading securities

19X7

19X6

$3,585,000
150,000
165,000
$3,900,000

$2,725,000
200,000
100,000
$3,025,000

$ 300,000

$ 375,000

4. Property and Equipment
A summary of property and equipment at December 31,19X7 and 19X6, follows:
19X7

Land
Land improvements
Buildings and improvements
Equipment
Equipment under capital lease obligations
Less accumulated depreciation and amortization

Construction in progress
Property and equipment, net

$ 3,000,000
472,000
46,852,000
29,190,000
2,851,000
82,365,000
34,928,000
47,437,000
3,601,000
$51,038,000

19X6
$ 3,000,000
472,000
46,636,000
26,260,000
2,752,000
79,120,000
30,661,000
48,459,000
2,033,000
$50,492,000

Depreciation expense for the years ended December 31,19X7 and 19X6 amounted to approxi
mately $4,782,000 and $4,280,000. Accumulated amortization for equipment under capital lease
obligations was $689,000 and $453,000 at December 31,19X7 and 19X6, respectively. Construction
contracts of approximately $7,885,000 exist for the remodeling of Hospital facilities. At December
31,19X7, the remaining commitment on these contracts approximated $4,625,000.

5. Long-Term Debt
A summary of long-term debt and capital lease obligations at December 31,19X7 and 19X6,
follows:
19X7

7.25 percent 19X7 Tax-Exempt Revenue Bonds, principal mat
uring in varying annual amounts, due November 1,20XX,
collateralized by a pledge of the Hospital's gross receipts

$21,479,000

8.50 percent 19X2 Tax-Exempt Revenue Bonds, principal
maturing in varying annual amounts, due June 1,19XX
7.75 percent mortgage loan, principal maturing in varying
annual amounts, due January 20XX, collateralized by a
mortgage on certain property and equipment
7.75 percent note payable, payable in monthly installments
of $12,000, including interest, due March 19XX, unsecured
Capital lease obligations, at varying rates of imputed interest from
6.8 percent to 9.3 percent collateralized by leased equipment
Less current portion
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19X6

$22,016,000

2,010,000

2,127,000

125,000

671,000

1,000,000

950,000

24,614,000
1,470,000

25,764,000
1,750,000

$23,144,000

$24,014,000

Under the terms of the 19X7 and 19X2 revenue bond indentures, the Hospital is required to
maintain certain deposits with a trustee. Such deposits are included with assets limited as to use.
The revenue note indenture also places limits on the incurrence of additional borrowings and
requires that the Hospital satisfy certain measures of financial performance as long as the notes
are outstanding.

Scheduled principal repayments on long-term debt and payments on capital lease obligations
are as follows:
Year Ending
December 31,

Long-Term
Debt

19X8
19X9
20Y0
20Y1
20Y2
Thereafter

$

Capital Leases
Obligations

970,000
912,000
983,000
1,060,000
1,143,000
18,546,000

$ 550,000
260,000
260,000
45,000
—
—

$23,614,000

1,115,000

Less amount representing interest under
capital leases obligations

115,000
$1,000,000

A summary of interest cost and investment income on borrowed funds held by the trustee under
the 19X7 and 19X2 revenue bond indentures during the years ended December 31,19X7 and 19X6,
follows:

Interest cost:
Capitalized
Charged to operations

Total
Investment income:
Capitalized
Credited to other revenue
Total

19X7

19X6

$ 740,000
1,752,000

$ 700,000
1,825,000

$2,492,000

$2,525,000

$ 505,000
330,000

$ 663,000
386,000

$ 835,000

$1,049,000

6. Temporarily and Permanently Restricted Net Assets

Temporarily restricted net assets are available for the following purposes or periods at Decem
ber 31,19X7 and 19X6:

Health care services
Purchase of equipment
Indigent care
Health education
For periods after December 31,19X9
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19X7

19X6

$ 320,000
840,000
350,000
605,000

$ 520,000
950,000
400,000
600,000

$2,115,000

$2,470,000

Permanently restricted net assets at December 31,19X7 and 19X6, are restricted to:

Investments to be held in perpetuity, the income
from which is expendable to support health care
services (reported as operating income)

Endowment requiring income to be added to
original gift until fund value is $1,500,000

19X7

19X6

$2,973,000

$2,923,000

615,000

610,000

$3,588,000

$3,533,000

During 19X7, net assets were released from donor restrictions by incurring expenses satisfying
the restricted purposes of indigent care and health care education in the amounts of $250,000 and
$50,000, respectively.
7. Medical Malpractice Claims
The Hospital purchases professional and general liability insurance to cover medical mal
practice claims. There are known claims and incidents that may result in the assertion of
additional claims, as well as claims from unknown incidents that may be asserted arising from
services provided to patients. The Hospital has employed independent actuaries to estimate
the ultimate costs, if any, of the settlement of such claims. Accrued malpractice losses have
been discounted at 7 percent and in management's opinion provide an adequate reserve for
loss contingencies.
On March 15,19X7, a patient filed a suit against the Hospital for malpractice during care received
as an inpatient. The Hospital believes it has meritorious defenses against the suit; however, the
ultimate resolution of the matter could result in a loss. The patient has claimed $16 million in
actual damages. Under state law, punitive damages are determined at trial. The Hospital main
tains insurance coverage for malpractice claims. The coverage does not include punitive damages
awards. Trial is scheduled to occur within the next year.

8. Pension and Other Postretirement Benefit Plans

The Hospital has a defined benefit pension plan covering substantially all of its employees. The
plan benefits are based on years of service and the employees' compensation during the last five
years of covered employment. Contributions are intended to provide not only for benefits
attributed to service to date but also for those expected to be earned in the future.
Note: The following paragraph is encouraged but not required.

The Hospital also sponsors two defined benefit postretirement plans that cover both salaried
and nonsalaried employees. One plan provides medical and dental benefits, and the other
provides for the payment of life insurance premiums. The postretirement health care plan is
contributory, with retiree contributions adjusted annually; the life insurance plan is noncontribu
tory. The accounting for the health care plan anticipates future cost-sharing changes to the written
plan that are consistent with the Hospital's expressed intent to increase retiree contributions each
year to 50 percent of the excess of the expected general inflation rate over 6 percent. Beginning in
19X7, the Hospital adopted a funding policy for its postretirement health care plan similar to its
funding policy for its life insurance plan—an amount equal to a level percentage of the employees'
salaries is contributed to the plan annually. For 19X7, that percentage was 4.25, and the aggregate
contribution for both plans was $34,000.
The following table sets forth the changes in benefit obligations, changes in plan assets and
components of net periodic benefit cost for both the pension plan and the other postretirement
benefit plans:
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Pension Benefits

Change in benefit obligation:
Benefit obligation at beginning of year
Service cost
Interest cost
Plan participants' contributions
Actuarial gain
Benefits paid

19X7

19X6

$500
15
44
34

(1,410)

$585
14
50
34
(7)
(66)

10,920

9,710

610

9,800
950
750

9,610
800
620

(1,230)

89
4
40
34
(67)

40
4
19
34
(8)

9,800

100

89

(510)
(30)
16
445

(496)
(40)
19
470

$ (79)

$ (47)

7.00%
6.60%

7.00%
6.60%

19X7

19X6

$ 9,710
905
700

$9,700
770
650

(20)
(375)

Benefit obligation at end of year
Change in plan assets:
Fair value of plan assets at beginning of year
Actual return on plan assets
Employer contribution
Plan participants' contributions
Benefits paid

(450)

11,050

Fair value of plan assets at end of year

Funded status
Unrecognized net actuarial gain
Unrecognized prior service cost
Unrecognized transition obligation
Unrecognized transition asset

$

Prepaid (accrued) benefit cost
Weighted-average assumptions as of December 31:
Discount rate
Expected return on plan assets
Rate of compensation increase

Other Benefits

130
(30)
50

90
(40)
55

(15)

(20)

135

7.00%
8.00%
6.00%

$

85

7.00%
8.00%
6.00%

(8)
585

For measurement purposes, a 7 percent annual rate of increase in the per capita cost of covered
health care benefits was assumed for 19X8. The rate was assumed to decrease gradually to 5
percent over the next five years.
Pension Benefits
Other Benefits
19X7
19X6 19X7
19X6

Components of net periodic benefit cost:
Service cost
Interest cost
Expected return on plan assets
Amortization of prior service cost
Recognized net actuarial gain
Amortization of transition obligation
Amortization of transition asset
Net periodic benefit cost

$906
700
(885)
7
(2)

$771
650
(725)
7
(2)

(1)

(1)
$700

$725

$14
50
(3)
2
(2)
25

$15
44
(4)
2
(1)
25

$86

$81

Assumed health care cost trend rates have a significant effect on the amounts reported for the
health care plans. A one-percentage-point change in assumed health care cost trend rates would
have the following effects:
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Effect on total of service and interest
cost components
Effect on postretirement benefit obligation
9.

1-PercentagePoint Increase

1-PercentagePoint Decrease

$13
73

$(11)
(67)

Concentrations of Credit Risk
The Hospital grants credit without collateral to its patients, most of whom are local residents
and are insured under third-party payor agreements. The mix of receivables from patients and
third-party payors at December 31,19X7 and 19X6, was as follows:

Medicare
Medicaid
Blue Cross
Other third-party payors
Patients

19X7

19X6

51%
17
18
7
7

53%
14
17
9
7

100%

100%

10. Commitments and Contingencies
Operating leases. The Hospital leases various equipment and facilities under operating leases
expiring at various dates through April 20X2. Total rental expense in 19X7 and 19X6 for all
operating leases was approximately $859,000 and $770,000, respectively.

The following is a schedule by year of future minimum lease payments under operating leases
as of December 31,19X7, that have initial or remaining lease terms in excess of one year.

Year Ending
December 31,

Amount

19X8
19X9
20Y0
20Y1
20Y2

$517,000
506,000
459,000
375,000
343,000

Litigation. The Hospital is involved in litigation and regulatory investigations arising in the
course of business. After consultation with legal counsel, management estimates that these
matters will be resolved without material adverse effect on the Hospital's future financial position
or results from operations.

Allowance for doubtful accounts. Beginning in 19X5, the Hospital has provided care under an
agreement with Associated HMO. The HMO currently owes the Hospital $950,000, substantially
all of which is overdue. The Hospital has notified the HMO that further services under the contract
cannot be provided without payment on the outstanding balance. The HMO has assured the
Hospital that additional funds are being obtained in order to pay the overdue balance and
continue service under the agreement, however, if the HMO is unable to make payments,
additional allowances for bad debts would need to be accrued.
11. Extraordinary Loss
In 19X7, the Hospital advance refunded its 19X2 Revenue Bonds in the amount of $22 million
by issuing 19X7 Revenue Bonds. As a result of this in-substance defeasance transaction, an
extraordinary loss totaling $500,000 was recorded. As of December 31, 19X7, $21 million of
advance refunded bonds, which are considered extinguished, remain outstanding.
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12. Related Party Transactions

During the years ended December 31,19X7 and 19X6, the Hospital contributed capital to Sample
Health System, an affiliate with some board members in common with the Hospital, in the
amounts of $640,000 and $3 million, respectively.
The Sample Hospital Foundation (the Foundation), which is controlled by Sample Health
System, was established to solicit contributions from the general public and to support the
Hospital. Funds are distributed to the Hospital as determined by the Foundation's Board of
Directors. A summary of the foundation's assets, liabilities, net assets, results of operations, and
changes in net assets follows.
December 31,

19X6

19X7

$521,000

$472,000

11,000
510,000

10,000
462,000

Total liabilities and net assets

$521,000

$472,000

Support and revenue
Expenses
Distributions to Sample Hospital for property acquisitions
Other

$269,000

$535,000

235,000
13,000

485,000
16,000

248,000

501,000

21,000
27,000
462,000

34,000
17,000
411,000

$510,000

$462,000

Assets, principally cash and cash equivalents
Liabilities
Net assets

Total expenses

Excess of support and revenue over expenses
Other changes in net assets
Net assets, beginning of year
Net assets, end of year

Liabilities include $10,000 payable at the end of each year to Sample Hospital. These amounts
were paid after the end of each year.
13. Functional Expenses

The Hospital provides general health care services to residents within its geographic location.
Expenses related to providing these services are as follows (in thousands):
December 31,

19X7
$86,000
12,055

Health care services
General and administrative

$98,055

19X6
$78,647
10,643
$89,290

14. Fair Value of Financial Instruments

The following methods and assumptions were used by the Hospital in estimating the fair value
of its financial instruments:

Cash and cash equivalents: The carrying amount reported in the balance sheet for cash and cash
equivalents approximates its fair value.
Investments: Fair values, which are the amounts reported in the balance sheet, are based on quoted
market prices, if available, or estimated using quoted market prices for similar securities.

Assets limited as to use: These assets consist primarily of cash and short-term investments and
interest receivable. The carrying amount reported in the balance sheet is fair value.
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Accounts payable and accrued expenses: The carrying amount reported in the balance sheet for
accounts payable and accrued expenses approximates its fair value.

Estimated third-party payor settlements: The carrying amount reported in the balance sheet for
estimated third-party payor settlements approximates its fair value.

Long-term debt: Fair values of the Hospital's revenue notes are based on current traded value.
The fair value of the Hospital's remaining long-term debt is estimated using discounted cash
flow analyses, based on the Hospital's current incremental borrowing rates for similar types
of borrowing arrangements.

The carrying amounts and fair values of the Hospital's financial instruments at December 31,19X7
and 19X6, are as follows (In thousands):
19X7

Cash and cash equivalents
Short-term investments
Assets limited as to use
Long-term investments
Long-term investments restricted
for capital acquisition
Accounts payable and
accrued expenses
Estimated third-party
payor settlements
Long-term debt

19X6

Carrying
Amount

Fair Value

Carrying
Amount

Fair Value

$ 4,758
15,836
18,949
4,680

$ 4,758
15,836
18,949
4,680

$ 5,877
10,740
19,841
4,680

$ 5,877
10,740
19,841
4,680

320

320

520

520

5,818

5,818

5,382

5,382

2,143
24,614

2,143
23,980

1,942
25,764

1,942
24,918

15. Promises to Contribute

At December 31,19X7, the Hospital had received $1,500,000 of conditional promises to contrib
ute to the building of a new facility for outpatient services. These contributions will be recorded
as temporarily restricted support when received. The Hospital had no material outstanding
unconditional promises of support at December 31,19X7.
16. Charity Care

The amount of charges foregone for services and supplies furnished under the Hospital's charity
care policy aggregated approximately $4,500,000 and $4,100,000 in 19X7 and 19X6, respectively.
17. Subsequent Event
On February 9,19X8, the Hospital signed a contract in the amount of $1,050,000 for the purchase
of certain real estate.
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ILLUSTRATIVE FINANCIAL STATEMENTS FOR A NURSING HOME
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Sample For-Profit Nursing Home, Inc.
Balance Sheets

December 31,19X5 and 19X4
19X5
Assets
Current assets:
Cash and cash equivalents
Investments
Assets limited as to use
Patient accounts receivable, net of allowance
for doubtful accounts of $6,700 in 19X5 and
$5,300 in 19X4
Estimated third-party payor settlements
Interest receivable
Supplies
Prepaid expenses
Deferred tax asset
Total current assets
Assets limited as to use, net of amount required
for current liabilities
Property and equipment:
Land
Land improvements
Buildings
Furniture, fixtures, and equipment
Less accumulated depreciation
Property and equipment, net
Other assets
Total assets

Liabilities and Shareholders' Equity
Current liabilities:
Current maturities of long-term debt
Accounts payable
Accrued expenses
Deposits from patients
Other current liabilities
Total current liabilities
Deferred tax liability
Long-term debt, net of current maturities
Shareholders' equity:
Common stock, $20 par value; authorized
5,000 shares; issued and outstanding
3,500 shares
Retained earnings
Total shareholders' equity
Total liabilities and shareholders' equity
See accompanying notes to financial statements.
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19X4

95,000
150,000
50,000

$ 129,000

162,000
71,000
7,000
47,000
3,000
12,000
597,000

152,000
62,000

43,000
2,000
14,000
452,000

173,000

150,000

205,000
37,000
1,399,000
228,000
1,869,000
210,000
1,659,000
150,000
$2,579,000

205,000
32,000
1,399,000
189,000
1,825,000
141,000
1,684,000
127,000
$2,413,000

$

$

$

50,000
78,000
175,000
50,000
74,000
427,000
6,000
1,700,000

70,000
376,000
446,000
$2,579,000

50,000

50,000
52,000
188,000
45,000
15,000
350,000
14,000
1,750,000

70,000
229,000
299,000
$2,413,000
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Sample For-Profit Nursing Home, Inc.
Statements of Income and Retained Earnings

Years Ended December 31,19X5 and 19X4

Revenue:
Net patient service revenue
Other revenue
Interest on investments held by trustee

Total revenue
Expenses:
Salaries and benefits
Medical supplies and drugs
Insurance and other
Provision for bad debts
Depreciation
Interest
Total expenses

Operating income
Nonoperating income:
Other interest income

19X5

19X4

$2,163,000
67,000
13,000

$1,949,000
22,000
7,000

2,243,000

1,978,000

969,000
511,000
216,000
92,000
69,000
164,000

919,000
499,000
176,000
83,000
57,000
172,000

2,021,000

1,906,000

222,000

72,000

5,000

Income before provision for income taxes

Provision for income taxes
Net income
Retained earnings, beginning of year
Retained earnings, end of year

See accompanying notes to financial statements.
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227,000

72,000

80,000

29,000

147,000

43,000

229,000

186,000

$ 376,000

$ 229,000
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Sample For-Profit Nursing Home, Inc.
Statements of Cash Flows
Years Ended December 31,19X5 and 19X4
Cash flows from operating activities:
Cash received from residents and third-party payors
Cash received from others
Cash paid to employees and suppliers
Interest and dividends received
Interest paid
Taxes paid
Deposits received from patients
Deposits refunded to patients

19X5

19X4

$2,019,000
67,000
(1,679,000)
10,000
(160,000)
(29,000)
35,000
(30,000)

$1,796,000
22,000
(1,495,000)
10,000
(170,000)
(30,000)
15,000
(20,000)

128,000

233,000

Net cash provided by operating activities
Cash flows from investing activities:
Purchase of investments
Proceeds from sale of property
Capital expenditures
Purchase of assets limited as to use

(150,000)

2,000
(79,000)

(44,000)
(23,000)

Net cash used in investing activities
Cash flows from financing activities:
Repayment of long-term debt

Net cash used in financing activities

Net increase (decrease) in cash and cash equivalents

Cash and cash equivalents, beginning of year
$

Cash and cash equivalents, end of year

(217,000)

(77,000)

(50,000)

(50,000)

(50,000)

(50,000)

(34,000)

1,000

129,000

128,000

95,000

$ 129,000

Reconciliation of net income to net cash
provided by operating activities:

Net income
Adjustments to reconcile net income to net cash
provided by operating activities:
Depreciation
Provision for bad debts
Loss on sale of property
Change in deferred income taxes
(Increase) decrease in:
Patient accounts receivable
Other current assets
Estimated third-party payor settlements
Interest receivable
Other assets
Increase (decrease) in:
Accounts payable and accrued expenses
Deposits from patients
Other current liabilities
Net cash provided by operating activities
See accompanying notes to financial statements.
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$ 147,000

$

43,000

69,000
92,000
—
(6,000)

57,000
83,000
11,000
(14,000)

(102,000)
(21,000)
(9,000)
(7,000)
(7,000)

(41,000)
(15,000)
(10,000)
(3,000)
(10,000)

13,000
5,000
59,000
$ 233,000

43,000
(5,000)
(11,000)
$ 128,000
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Sample For-Profit Nursing Home, Inc.

Notes to Financial Statements

December 31,19X5 and 19X4
1. Description of Organization and Summary of Significant Accounting Policies
Organization. The Sample Nursing Home, Inc. (the Company) was incorporated in New State
in 19X1 and operates a 128-bed nursing home in Abacus, New State. A summary of the Company's
significant accounting policies follows:
Use of estimates. The preparation of financial statements in conformity with generally accepted
accounting principles requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the
date of the financial statements and the reported amounts of revenues and expenses during the
reporting period. Actual results could differ from those estimates.
Cash and cash equivalents. Cash and cash equivalents include investments in highly liquid debt
instruments with an original maturity of three months or less, excluding amounts whose use is
limited by note indenture.

Investments. Investments in debt instruments, including assets limited as to use, are classified
as held-to-maturity because the Company has the positive intent and ability to hold the securities
until maturity. Held-to-maturity securities are carried at cost adjusted for amortization of premi
ums and accretion of discounts.

Assets limited as to use. Assets deposited with a trustee under terms of the note indenture and assets
set aside by the Board of Directors for capital improvements are classified as assets limited as to use.
Amounts required to meet current liabilities have been reclassified in the balance sheet.

Property and equipment. Property and equipment are recorded at cost. Depreciation is calculated
on the straight-line method over the estimated useful lives of depreciable assets.
Bond issuance costs. Costs incurred in issuing the Series 19X1 bonds are being amortized based
on the effective interest method.

Net patient service revenue. Net patient service revenue is reported at the estimated net realizable
amounts from residents, third-party payors, and others for service rendered.
Revenue under third-party payor agreements is subject to audit and retroactive adjustment.
Provisions for estimated third-party payor settlements are provided in the period the related
services are rendered. Differences between the estimated amounts accrued and interim and final
settlements are reported in operations in the year of settlement.

Income taxes. The provisions for income taxes are based on amounts estimated to be currently
payable and those deferred because of temporary differences between the financial statement and tax
bases of assets and liabilities. These differences consist principally of bad debts and depreciation.
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2. Assets Limited as to Use

Assets limited as to use include:
Assets held by trustee under the Series 19X1 note indenture agreement
at December 31,19X5 and 19X4.

19X5
$150,000
24,000
2,000

U.S. Government obligations
Cash
Accrued interest income

19X4

176,000

$130,000
21,000
2,000
153,000

$ 45,000
2,000
47,000

$ 45,000
2,000
47,000

$223,000

$200,000

Internally designated by the Board of
Directors for capital improvements
Certificate of deposit
Accrued interest

3. Investments

The amortized cost and approximate fair value of held-to-maturity securities at December 31,
19X5 and 19X4, are as follows:
December 31,19X5

U.S. Treasury obligations
U.S. Government agency
obligations
Other debt securities

Gross
Unrealized
(Losses)

Amortized
Cost

Gross
Unrealized
Gains

$150,000

$11,000

$(16,000)

$145,000
76,000
49,000

$11,000

(7,000)
(18,000)
$(41,000)

83,000
67,000
$300,000

Approximate
Fair Value

$270,000

December 31,19X4

Amortized
Cost

U.S. Treasury obligations
U.S. Government agency
obligations

Gross
Unrealized
Gains

$103,000

$

27,000
$130,000

2,000
$2,000

Gross
Unrealized
(Losses)

Approximate
Fair Value

$(10,000)

$ 93,000

$(10,000)

29,000
$122,000

Maturities of held-to-maturity securities at December 31,19X5, are as follows:

Amortized
Cost
One year or less
After one through five years
After five through ten years
After ten years
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Approximate
Fair Value

$131,000
31,000
68,000
70,000

$126,000
29,000
62,000
53,000

$300,000

$270,000

4. Long-Term Debt
Long-term debt at December 31,19X5 and 19X4, was as follows:

9.5 percent bonds payable to the City
of Abacus, maturing $50,000 annually
through November 1,19YY, with a
final maturity of $1 million on
November 1,19YY
Less current maturities

19X5

19X4

$1,750,000
50,000

$1,800,000
50,000

$1,700,000

$1,750,000

The notes are collateralized by a first-mortgage lien on all property and equipment of the
Company and a security interest in all of its receipts. The note indenture requires the maintenance
of certain deposits with a trustee, which are included in assets limited as to use.

Future maturities of long-term debt as of December 31,19X5, follow:

Year ending December 31,
19X6
19X7
19X8
19X9
19Y0
Thereafter
Total

Amount

$

50,000
50,000
50,000
50,000
50,000
1,500,000
$1,750,000

5. Income Taxes

The provisions for income taxes are as follows:
Current:
Federal
State
Total current

Deferred:
Federal
State
Total deferred

19X5

19X4

$72,000
2,000
74,000

$15,000

6,000

13,000
1,000
14,000
$29,000

6,000

Total provision for income taxes

$80,000

15,000

Deferred income taxes are provided for the temporary differences between the financial report
ing basis and the tax basis of the Company's assets and liabilities.
For the years ended December 31, 19X5 and 19X4, the effective tax rate approximated the
statutory rate of 34 percent and 40 percent, respectively.
The net current and noncurrent components of deferred income taxes recognized in the balance
sheet at December 31,19X5 and 19X4, follows:
19X5
19X4
Net current assets
$12,000
$14,000
Net noncurrent liabilities
6,000
14,000

$ 6,000

$____ 0

Management has determined that no valuation allowance related to deferred tax assets is
necessary at December 31,19X5 and 19X4, respectively.
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6. Concentration in State Medicaid Program

The Company has 100 of its 128 beds designated for care of patients under the state's Medicaid
program. The current funding of that program is 90 days behind filed claims. The current state
budget has no provision for reducing that lag and, while the proposed budget for 19X6 includes
additional funding, there is no assurance that the final budget will include the needed additional
funds.
7. Risks and Uncertainties Disclosures
*

8. Pension and Other Postretirement Benefit Plans
*
9. Fair Values of Financial Instruments
*
10. Concentrations of Credit Risk
*

The disclosures contained in these notes would be similar to the disclosures contained in the notes to the financial statements for
not-for-profit hospital and, therefore, are not repeated here.
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ILLUSTRATIVE FINANCIAL STATEMENTS
FOR A CONTINUING CARE RETIREMENT COMMUNITY
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Sample Not-for-Profit Continuing Care Retirement Community

Balance Sheets

December 31,19X5 and 19X4
19X5
Assets
Current assets:
Cash
Assets limited as to use
Accounts receivable, net of allowance for
doubtful accounts of $4,000 in 19X5 and
$5,000 in 19X4
Supplies
Prepaid expenses

$

$

330,000
170,000

187,000
40,000
115,000

197,000
21,000
73,000

982,000

791,000

1,865,000
14,893,000

1,583,000
15,280,000

83,000

90,000

$17,823,000

$17,744,000

$

$

Total current assets

Assets limited as to use, net of amount required
for current liabilities
Property and equipment, net
Deferred financing costs, net of accumulated
amortization of $28,000 in 19X5 and
$21,000 in 19X4

Total assets

375,000
265,000

19X4

Liabilities and Net Assets
Liabilities:
Current maturities of long-term debt
Accounts payable
Accrued expenses
Deposits on unoccupied units

Total current liabilities

Long-term debt, less current maturities
Refundable fees
Estimated obligation to provide future
services, in excess of amounts received
or to be received
Deferred revenue from advance fees
Total liabilities

Net assets:
Unrestricted
Temporarily restricted
Permanently restricted

Total net assets
Total liabilities and net assets
See accompanying notes to financial statements.
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90,000
180,000
161,000
22,000

77,000
174,000
178,000
40,000

453,000

469,000

8,871,000
59,000

8,935,000
144,000

88,000
6,304,000

100,000
6,585,000

15,775,000

16,233,000

1,286,000
311,000
451,000

833,000
294,000
384,000

2,048,000

1,511,000

$17,823,000

$17,744,000
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Sample Not-for-Profit Continuing Care Retirement Community

Statements of Operations
Years Ended December 31,19X5 and 19X4

Revenue, gains, and other support:
Resident services, including amortization
of advance fees of $935,000 in 19X5
and $915,000 in 19X4
Patient revenue from nonresidents
Change in obligation to provide future services
Contributions
Net assets released from restrictions used for
operations
Investment income
Other
Total revenue, gains, and other support

Expenses:
Salaries and benefits
Medical supplies and drugs
Insurance
Depreciation
Interest

Total expenses
Operating income (loss)
Net assets released from restriction—
purchase of equipment

Increase (decrease) in unrestricted net assets
See accompanying notes to financial statements.
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19X5

19X4

$3,946,000
249,000
12,000
54,000

$3,152,000
275,000
(82,000)
39,000

24,000
29,000
75,000

50,000
30,000
68,000

4,389,000

3,532,000

1,708,000
543,000
291,000
452,000
967,000

1,250,000
742,000
311,000
447,000
955,000

3,961,000

3,705,000

428,000

(173,000)

25,000

45,000

$ 453,000

$ (128,000)
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Sample Not-for-Profit Continuing Care Retirement Community

Statements of Changes in Net Assets
Years Ended December 31,19X5 and 19X4

Unrestricted net assets:
Operating income (loss)
Net assets released from restriction—
purchase of equipment

Increase (decrease) in unrestricted net assets
Temporarily restricted net assets:
Contributions
Net assets released from restrictions used
for operations
Net assets released from restriction—
purchase of equipment
Investment income

Increase (decrease) in temporarily restricted
net assets
Permanently restricted net assets:
Contributions

Increase in permanently restricted net assets
Increase (decrease) in net assets
Net assets, beginning of year
Net assets, end of year
See accompanying notes to financial statements.
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19X5

19X4

$ 428,000

$ (173,000)

25,000

45,000

453,000

(128,000)

40,000

15,000

(24,000)

(50,000)

(25,000)
26,000

(45,000)
15,000

17,000

(65,000)

67,000

52,000

67,000

52,000

537,000

(141,000)

1,511,000

1,652,000

$2,048,000

$1,511,000
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Sample Not-for-Profit Continuing Care Retirement Community

Statements of Cash Flows
Years Ended December 31,19X5 and 19X4
19X5
Cash flows from operating activities:
Cash received from residents and
third-party payors
Advance fees received
Other receipts from operations
Investment income received
Contributions received
Cash paid to employees and suppliers
Interest paid
Net cash provided by operating activities
Cash flows from investing activities:
Purchase of property and equipment
Purchase of assets limited as to use
Net cash used in investing activities
Cash flows from financing activities:
Permanently restricted funds received
Refunds of deposits and refundable fees
Proceeds from issuance of long-term debt
Principal payments of long-term debt
Net cash used in financing activities
Net increase in cash
Cash, beginning of year
Cash, end of year

$3,252,000
654,000
75,000
68,000
51,000
(2,576,000)
(950,000)
574,000

19X4

$2,341,000
857,000
68,000
53,000
44,000
(2,040,000)
(945,000)
378,000

(65,000)
(377,000)

(250,000)
229,000

(442,000)

(21,000)

67,000
(103,000)
26,000
(77,000)
(87,000)
45,000
330,000

52,000
(52,000)

(307,000)
(307,000)
50,000
280,000

$ 375,000

$ 330,000

$ 537,000

$ (141,000)

Reconciliation of change in net assets to
net cash provided by operating activities:

Change in net assets
Adjustments to reconcile change in net assets
to net cash provided by operating activities:
Advance fees received
Restricted net assets received
Amortization of advance fees
Loss (gain) on obligation to provide
future services
Depreciation
Amortization of deferred financing costs
Provision for bad debts
(Increase) decrease in:
Accounts receivable
Other assets
Increase (decrease) in:
Accounts payable and accrued expenses
Net cash provided by operating
activities
See accompanying notes to financial statements.
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654,000
(67,000)
(935,000)

857,000
(52,000)
(915,000)

(12,000)
452,000
7,000
3,000

82,000
447,000
34,000
3,000

7,000
(61,000)

(33,000)
(4,000)

(11,000)

100,000

$ 574,000

$ 378,000
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Sample Not-for-Profit Continuing Care Retirement Community

Notes to Financial Statements

December 31,19X5 and 19X4
1. Description of Organization and Summary of Significant Accounting Policies1

Organization. The Sample Continuing Care Retirement Community (the CCRC) is a nonprofit
organization that principally provides housing, health care, and other related services to residents
through the operation of a retirement facility containing 249 apartments and a 78-bed health care
facility located in Evergreen Park, Illinois. The CCRC was incorporated in Illinois in 19X1. A
summary of significant accounting policies follows.
Use of estimates. The preparation of financial statements in conformity with generally accepted
accounting principles requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the
date of the financial statements and the reported amounts of revenues and expenses during the
reporting period. Actual results could differ from those estimates.
Investments. Investments, which consist of U.S. Treasury obligations, are measured at fair value
in the balance sheet. Investment income (including realized gains and losses on investments,
interest, and dividends) is included in operating income (loss) unless restricted by donor or law.
Unrealized gains and losses on investments, if any, are excluded from operating income (loss).

Deferred financing costs. Deferred financing costs are amortized using the effective interest
method over the term of the related financing agreement.
Advance fees. Fees paid by a resident upon entering into a continuing care contract, net of the
portion thereof that is refundable to the resident, are recorded as deferred revenue and are
amortized to income using the straight-line method over the estimated remaining life expectancy
of the resident.
Obligation to provide future services. The CCRC annually calculates the present value of the net
cost of future services and the use of facilities to be provided to current residents and compares
that amount with the balance of deferred revenue from advance fees. If the present value of the
net cost of future services and the use of facilities exceeds the deferred revenue from advance fees,
a liability is recorded (obligation to provide future services and use of facilities) with the
corresponding charge to income. The obligation is discounted at 9 percent, based on the expected
long-term rate of return on government obligations.

Donor restrictions. The CCRC reports gifts of cash and other assets as restricted support if they
are received with donor stipulations that limit the use of the donated assets. When a donor
restriction expires (that is, when a stipulated time restriction ends or a purpose restriction is
accomplished), temporarily restricted net assets are reclassified as unrestricted net assets and
reported in the statement of operations as net assets released from restrictions. Donor-restricted
contributions whose restrictions are met within the same year as received are reflected as
unrestricted contributions in the accompanying financial statements.

The CCRC reports gifts of property and equipment (or other long-lived assets) as unrestricted
support unless explicit donor stipulations specify how the donated assets must be used. Gifts of
long-lived assets with explicit restrictions that specify how the assets are to be used and gifts of
cash or other assets that must be used to acquire long-lived assets are reported as restricted
support. Absent explicit donor stipulations about how long those long-lived assets must be
maintained, the CCRC reports expirations of donor restrictions when the donated or acquired
long-lived assets are placed in service.
1 Does not include all disclosures common to all health care entities.
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Income taxes. The CCRC has been recognized by the Internal Revenue Service as a not-for-profit
corporation as described in Sec. 501(c)(3) of the Internal Revenue Code (IRC) and is exempt from
federal income taxes pursuant to Sec. 501(a) of the IRC.

Property and equipment. Property and equipment are stated at cost. Donated property is re
corded at its estimated fair value at the date of receipt. Depreciation is computed on the
straight-line method based on the following estimated useful lives:
Land improvements
Buildings and improvements
Furniture and equipment

20 years
40 years
5-15 years

Operating income (loss). The statement of operations includes operating income (loss). Changes in
unrestricted net assets which are excluded from operating income (loss), consistent with industry
practice, include unrealized gains and losses on investments other than trading securities,
permanent transfers of assets to and from affiliates for other than goods and services, and
contributions of long-lived assets (including assets acquired using contributions which by donor
restriction were to be used for the purposes of acquiring such assets).

2. Property and Equipment
A summary of property and equipment at December 31,19X5 and 19X4, follows:

19X5
19X4
557,000 $ 557,000
205,000
203,000
14,573,000
14,564,000
752,000
698,000
16,022,000
16,087,000
(1,194,000)
(742,000)
$14,893,000 $15,280,000

Land
Land improvements
Buildings and improvements
Furniture and equipment

$

Less: accumulated depreciation

3. Temporarily Restricted Net Assets
Temporarily restricted net assets are available for the following purposes:
19X5
$169,000
142,000
$311,000

Purchase of equipment
Charity care

19X4
$152,000
142,000
$294,000

Net assets were released from donor restrictions by incurring expenses satisfying the restricted
purposes or by occurrence of other events specified by donors:
19X5
$24,000
$25,000

Charity care
Purchase of equipment

19X4

$50,000
$45,000

4. Permanently Restricted Net Assets
Permanently restricted net assets are restricted to investment in perpetuity, the income from
which is expendable to support:
19X5
19X4
Charity care
$168,000
$168,000
Community activities
283,000
216,000
$451,000
$384,000
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5. Long-Term Debt

Long-term debt at December 31,19X5 and 19X4, is as follows:
10.75 percent mortgage note payable
Notes payable to bank—unsecured
Other

Less current maturities

19X5
$8,901,000
34,000
26,000
8,961,000
90,000
$8,871,000

19X4
$8,965,000
14,000
33,000
9,012,000
77,000
$8,935,000

The mortgage note is payable in consecutive monthly installments of principal and interest of
$85,425 to May 20XX. The note is collateralized by a first mortgage on property and equipment with
a depreciated cost at December 31,19X5, of $14,893,000 and by a pledge of all operating revenue.
As required by the mortgage note agreement, the CCRC established an initial debt service
reserve fund of $1,000,000 at April 15,19X3. All resident fees received thereafter, net of resident
fee refunds and debt service payments not to exceed $300,000 annually in the first four years and
$200,000 annually thereafter, are to be added to the debt service reserve fund until the total sum
of $2,050,000 is accumulated. Since June 1,19X4, the CCRC has been required to deliver to the
trustee $5,500 per month to establish maintenance reserves until the aggregate of such payments
equals a residential unit reserve and a health care center reserve of $240,000 and $90,000,
respectively. At December 31,19X5 and 19X4, the trustee held investments aggregating $2,130,000
and $1,753,000, respectively. Such amount has been classified as assets limited as to use.
Scheduled annual principal maturities of long-term debt for the next five years are as follows:

Year ending December 31,
19X6
19X7
19X8
19X9
20Y0

Amount
$ 90,000
90,000
95,000
105,000
105,000

6. Classification of Expenses

Program activities
General and administrative

19X5
3,368,000
593,000

19X4
3,135,000
570,000

$3,961,000

$3,705,000

7. Assets Limited as to Use
*

8. Risks and Uncertainties Disclosures*
9. Pension and Other Postretirement Benefit Plans
*
10. Fair Values of Financial Instruments"

11. Concentrations of Credit Risk
*
12. Investments
*
* The disclosures contained in these notes would be similar to the disclosures contained in the notes to the financial statements for
the not-for-profit hospital and, therefore, are not repeated here.
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Sample Not-for-Profit Home Health Agency
Balance Sheets
December 31,19X5 and 19X4
19X5

19X4

Assets

Current assets:
Cash and cash equivalents
Investments
Accounts receivable, net of allowance for doubtful
accounts of $61,000 in 19X5 and $30,000 in 19X4
Other receivables

74,000
147,000

$ 41,000
137,000

752,000
27,000

476,000
22,000

1,000,000

676,000

100,000

100,000

56,000
50,000

39,000
37,000

106,000
(45,000)

76,000
(24,000)

61,000

52,000

20,000

25,000

$1,181,000

$853,000

$

13,000
40,000
496,000
28,000
70,000

$ 13,000
21,000
352,000
31,000
66,000

647,000

483,000

105,000

118,000

752,000

601,000

330,000
9,000
90,000

167,000
5,000
80,000

429,000

252,000

$1,181,000

$853,000

$

Total current assets

Investments
Equipment:
Medical and office equipment
Vehicles
Less accumulated depreciation

Equipment, net

Deferred finance charges, net of accumulated amort
ization of $15,000 in 19X5 and $10,000 in 19X4
Total assets
Liabilities and Net Assets

Current liabilities:
Current maturities of long-term debt
Accounts payable
Accrued payroll and vacation costs
Estimated third-party payor settlements
Advances from third-party payors

Total current liabilities

Long-term debt, less current maturities
Total liabilities
Net assets:
Unrestricted
Temporarily restricted
Permanently restricted
Total net assets

Total liabilities and net assets
See accompanying notes to financial statements.
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FORMAT A

Sample Not-for-Profit Home Health Agency
Statements of Operations
Years Ended December 31,19X5 and 19X4

Revenue, gains, and other support:
Net patient service revenue
Contributions
Net assets released from restrictions
Investment income
Other revenue
Total revenue, gains, and other support

Expenses:
Salaries and benefits
Medical supplies and drugs
Insurance and other
Provision for bad debts
Depreciation
Interest
Total expenses

Excess of revenue over expenses and
change in unrestricted net assets

19X5

19X4

$4,042,000
5,000
5,000
13,000
27,000

$2,687,000
22,000
—
6,000
32,000

4,092,000

2,747,000

2,714,000
1,042,000
90,000
46,000
21,000
16,000

1,835,000
675,000
83,000
21,000
15,000
19,000

3,929,000

2,648,000

$ 163,000

See accompanying notes to financial statements.
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FORMAT B

Sample Not-for-Profit Home Health Agency

Statements of Operations
Years Ended December 31,19X5 and 19X4

19X5

19X4

$4,042,000
5,000
5,000
27,000

$2,687,000
22,000
—
32,000

4,079,000

2,741,000

2,714,000
1,042,000
90,000
46,000
21,000
16,000

1,835,000
675,000
83,000
21,000
15,000
19,000

Total expenses

3,929,000

2,648,000

Operating income

150,000

93,000

13,000

6,000

Revenue, gains, and other support:
Net patient service revenue
Contributions
Net assets released from restrictions
Other revenue
Total revenue, gains, and other support

Expenses:
Salaries and benefits
Medical supplies and drugs
Insurance and other
Provision for bad debts
Depreciation
Interest

Other income:
Investment income

Excess of revenue over expenses and
change in unrestricted net assets

$ 163,000

See accompanying notes to financial statements.
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Sample Not-for-Profit Home Health Agency

Statements of Changes in Net Assets

Years Ended December 31,19X5 and 19X4
19X5

19X4

$163,000

$ 99,000

163,000

99,000

Unrestricted net assets:
Excess of revenue over expenses

Increase in unrestricted net assets
Temporarily restricted net assets:
Contributions
Net assets released from restrictions

9,000
(5,000)

5,000
—

4,000

5,000

10,000

6,000

10,000

6,000

Increase in net assets

177,000

110,000

Net assets, beginning of year

252,000

142,000

$429,000

$252,000

Increase in temporarily restricted net assets
Permanently restricted net assets:
Contributions

Increase in permanently restricted net assets

Net assets, end of year
See accompanying notes to financial statements.
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Sample Not-for-Profit Home Health Agency

Statements of Cash Flows

Years Ended December 31,19X5 and 19X4
19X4

19X5

Cash flows from operating activities:
Cash received from patients and
third-party payors
Other receipts from operations
Cash paid to employees and suppliers
Interest paid
Nonoperating revenue

$3,721,000
22,000
(3,679,000)
(11,000)
23,000

$2,542,000
32,000
(2,541,000)
(14,000)
22,000

76,000

41,000

(30,000)
(10,000)

(19,000)
(15,000)

Net cash used in investing activities

(40,000)

(34,000)

Cash flows from financing activities:
Proceeds from contributions restricted for:
Endowment

10,000

6,000

Net cash provided by operating activities

Cash flows from investing activities:
Purchase of equipment
Purchase of investments

Other financing activities:
Payment of long-term debt

—

(13,000)

Net cash provided by (used in) financing activities

(3,000)

6,000

Net increase in cash and cash equivalents

33,000

13,000

Cash and cash equivalents, beginning of year

41,000

28,000

Cash and cash equivalents, end of year

$

74,000

$

41,000

Reconciliation of change in net assets to net
cash provided by operating activities:
Change in net assets
Adjustments to reconcile change in net assets
to net cash provided by operating activities:
Increase in permanently restricted net assets
Provision for bad debts
Depreciation
Amortization of deferred financing charges
(Increase) decrease in:
Accounts receivable
Other receivables

$ 177,000

Increase (decrease) in:
Accounts payable, accrued payroll, and
vacation costs
Estimated third-party payor settlements

Net cash provided by operating activities
See accompanying notes to financial statements.
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$

$ 110,000

(10,000)
46,000
21,000
5,000

(6,000)
21,000
15,000
5,000

(322,000)
(5,000)

(150,000)
4,000

163,000
1,000

38,000
4,000

76,000

$

41,000
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Sample Not-for-Profit Home Health Agency

Notes to Financial Statements

Years Ended December 31,19X5 and 19X4
1. Description of Organization and Summary of Significant Accounting Policies

Organization. The Sample Home Health Agency (the Agency) was incorporated in 19X0 in New
State as a not-for-profit corporation. The Agency provides health and supportive services to
individuals at their homes, primarily in the New State area.
Use of estimates. The preparation of financial statements in conformity with generally accepted
accounting principles requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the
date of the financial statements and the reported amounts of revenues and expenses during the
reporting period. Actual results could differ from those estimates.

Cash and cash equivalents. Cash and cash equivalents include investments in highly liquid debt
instruments with an original maturity of three months or less.
Investments. Investments, which consist of U.S. Treasury obligations, are measured at fair value
in the balance sheet. Investment income (including realized gains and losses on investments,
interest and dividends) is included in excess of revenues over expenses unless restricted by donor
or law. Unrealized gains and losses on investments, if any, are excluded from excess of revenues
over expenses.

Equipment. Equipment is recorded at cost. Depreciation is computed using the straight-line
method over the estimated useful lives of the assets.
Deferredfinancing costs. Deferred financing costs are being amortized using the effective interest
method over the term of the related financing agreement.

Donor restrictions. The Agency reports gifts of cash and other assets as restricted support if they
are received with donor stipulations that limit the use of the donated assets. When a donor
restriction expires, that is, when a stipulated time restriction ends or purpose restriction is
accomplished, temporarily restricted net assets are reclassified as unrestricted net assets and
reported in the statement of operations as net assets released from restrictions. When long-lived
assets are placed in service, thus satisfying purpose restrictions, the amount is included as a
change in net assets, restricted and unrestricted. Donor-restricted contributions whose restrictions
are met within the same year as received are reflected as unrestricted contributions in the
accompanying financial statements.

The Agency reports gifts of equipment (or other long-lived assets) as unrestricted support unless
explicit donor stipulations specify how the donated assets must be used. Gifts of long-lived assets
with explicit restrictions that specify how the assets are to be used and gifts of cash or other assets
that must be used to acquire long-lived assets are reported as restricted support. Absent explicit
donor stipulations about how long those long-lived assets must be maintained, the Agency
reports expirations of donor restrictions when the donated or acquired long-lived assets are
placed in service.
Net patient service revenue. Net patient service revenue represents the estimated net realizable
amounts from patients, third-party payors, and others for services rendered.

Charity care. The Agency has a policy of providing charity care to patients who are unable to
pay. Such patients are identified based on financial information obtained from the patient and
subsequent analysis. Since the Agency does not expect payment, estimated charges for charity
care are not included in revenue.
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Income taxes. The Agency has been recognized by the Internal Revenue Service as a not-forprofit corporation as described in Sec. 501(c)(3) of the Internal Revenue Code (IRC) and is exempt
from federal income taxes on related income pursuant to Sec. 501(a) of the IRC.
Excess of revenue over expenses. The statement of operations includes excess of revenue over
expenses. Changes in unrestricted net assets which are excluded from excess of revenue over
expenses, consistent with industry practice, include unrealized gains and losses on investments
other than trading securities, permanent transfers of assets to and from affiliates for other than goods
and services, and contributions of long-lived assets (including assets acquired using contributions
which by donor restriction were to be used for the purposes of acquiring such assets).

2. Temporarily Restricted Net Assets
Temporarily restricted net assets are available for the following purposes:

19X5
$ 9,000
$9,000

Charity care
Purchase of equipment

19X4
$5,000
—
$5,000

Net assets were released from donor restrictions by incurring expenses satisfying the restricted
purposes or by occurrence of other events specified by donors:
19X5
19X4

$5,000

Charity care expenditures

$ —

3. Permanently Restricted Net Assets
Permanently restricted net assets are restricted in perpetuity, the income from which is expendable to support:
19X4
19X5
$10,000 $ —
Program A activities
80,000
80,000
Any activities of the Agency
$90,000 $80,000

4. Third-Party Rate Adjustments and Revenue

Approximately 38 percent in 19X5 and 37 percent in 19X4 of net patient service revenue was
derived under federal and state third-party reimbursement programs. These revenues are based,
in part, on cost reimbursement principles and are subject to audit and retroactive adjustment by
the respective third-party fiscal intermediaries. In the opinion of management, retroactive adjust
ments, if any, would not be material to the financial position or results of operations of the Agency.
5. Internally-Designated Assets

The Board of Directors has designated investments aggregating $135,000 to be used for future
major capital improvements. Those assets are classified in the balance sheet as investments.

6. Long-Term Debt
Long-term debt at December 31,19X5 and 19X4, is as follows:

Note payable to bank, interest at 15 percent,
payable in monthly installments of $2,200 per
month, including interest, collateralized by
equipment with a depreciated cost of $42,000
Less current maturities
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19X5

19X4

$118,000
13,000

$131,000
13,000

$105,000

$118,000

Scheduled maturities of long-term debt at December 31,19X5, are as follows:
Year ending December 31,

Amount

19X6
19X7
19X8
19X9
20Y0
Thereafter
Total

$ 13,000
13,000
13,000
13,000
13,000
53,000
$118,000

7. Classification of Expenses
Program

Expenses incurred for the
year ended December 31,
19X5, were for:
Salaries and benefits
Medical supplies and drugs
Insurance and other
Provision for bad debts
Depreciation
Interest
Total expenses
Expenses incurred for the
year ended December 31,
19X4, were for:
Salaries and benefits
Medical supplies and drugs
Insurance and other
Provision for bad debts
Depreciation
Interest
Total expenses

Total

A

B

C

$2,714,000
1,042,000
90,000
46,000
21,000
16,000
$3,929,000

$1,363,000
511,000
58,000
16,000
5,000
10,000
$1,963,000

$699,000
246,000

$363,000
285,000

3,000
$978,000

$648,000

$1,835,000
675,000
83,000
21,000
15,000
19,000
$2,648,000

$ 915,000
335,000
64,000
21,000
6,000
12,000
$1,353,000

$463,000
211,000

$216,000
129,000

General and
Administrative

$289,000
32,000

30,000

16,000
3,000
$340,000

$241,000
19,000

5,000
$679,000

$345,000

9,000
2,000
$271,000

(The preparer of the financial statements may wish to include a brief description of the types of programs.)

8. Charity Care
Charity care represented approximately 3 percent and 4 percent of visits in 19X5 and 19X4,
respectively.

9. Risks and Uncertainties Disclosures
*
10. Pension and Other Postretirement Benefit Plans’
11. Fair Value of Financial Statements
*

12. Concentrations of Credit Risk
*
13. Investments
*
* The disclosures contained in these notes would be similar to the disclosures contained in the notes to the financial statements for
the not-for-profit hospital and, therefore, are not repeated here.
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Sample Not-for-Profit Health Maintenance Organization
Balance Sheets
June 30,19X5 and 19X4
19X5

19X4

$2,937,000

$1,021,000

358,000
263,000
190,000
197,000

407,000
261,000
184,000
99,000

3,945,000

1,972,000

5,756,000

5,626,000

150,000

150,000

18,000

21,000

$9,869,000

$7,769,000

Assets
Current assets:
Cash and cash equivalents
Premiums receivable, net of allowance for
doubtful accounts of $36,000 in 19X5
and $42,000 in 19X4
Other receivables
Supplies
Prepaid expenses
Total current assets

Property and equipment, net

State guaranty fund deposit

Debt issuance costs, net of accumulated
amortization of $42,000 in 19X5 and
$39,000 in 19X4
Total assets

Liabilities and Net Assets

Current liabilities:
Unsecured 12 percent note payable to a bank
Current maturities of long-term debt
Accounts payable—medical services
Other accounts payable and accrued expenses
Unearned premium revenue
Total current liabilities

$

241,000
2,245,000
829,000
141,000
3,456,000

Long-term debt, less current maturities
Total liabilities

Net assets—unrestricted
Total liabilities and net assets
See accompanying notes to financial statements.
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$

44,000
109,000
1,471,000
661,000
202,000
2,487,000

4,295,000

2,382,000

7,751,000

4,869,000

2,118,000

2,900,000

$9,869,000

$7,769,000
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Sample Not-for-Profit Health Maintenance Organization

Statements of Operations and Changes in Net Assets
Years Ended June 30,19X5 and 19X4

Revenue:
Premiums earned
Coinsurance
Interest and other income
Total revenue
Expenses:
Salaries and benefits
Medical supplies and drugs
Insurance
Provision for bad debts
Depreciation
Interest

Total expenses

19X5

19X4

$27,682,000
689,000
242,000

$22,500,000
500,000
100,000

28,613,000

23,100,000

16,154,000
8,507,000
3,963,000
19,000
367,000
385,000

13,328,000
5,988,000
2,463,000
20,000
336,000
375,000

29,395,000

22,510,000

Operating income (loss)

(782,000)

590,000

Net assets, beginning of year

2,900,000

2,310,000

$ 2,118,000

$ 2,900,000

Net assets, end of year

See accompanying notes to financial statements.
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Sample Not-for-Profit Health Maintenance Organization

Statements of Cash Flows

Years Ended June 30,19X5 and 19X4
Cash flows from operating activities:
Cash received from premiums,
stop-loss insurance recoveries,
and coinsurance
Cash paid to employees and to
providers of health care services
Interest and other income received
Interest paid

Net cash provided by operating activities
Cash flows from investing activities:
Capital expenditures
Net cash used in investing activities

Cash flows from financing activities:
Proceeds from long-term debt
Principal payments on long-term debt
Principal payments on note payable
Net cash provided by (used in)
financing activities

Net increase in cash and cash equivalents
Cash and cash equivalents, beginning of year
Cash and cash equivalents, end of year

19X5

19X4

$28,969,000

$24,410,000

(28,405,000)
230,000
(382,000)

(22,818,000)
90,000
(372,000)

412,000

1,310,000

(497,000)

(121,000)

(497,000)

(121,000)

2,300,000
(255,000)
(44,000)

—
(1,000,000)
—

2,001,000

(1,000,000)

1,916,000
1,021,000

189,000
832,000

$ 2,937,000

$ 1,021,000

Reconciliation of change in net assets to net cash
provided by operating activities:
Change in net assets
Adjustments to reconcile change in net assets to
net cash provided by operating activities:

Depreciation and amortization
Provision for bad debts

(Increase) decrease in:
Premiums receivables
Other current assets
Increase (decrease) in:
Accounts payable—medical services
Other accounts payable and accrued expenses
Unearned premium revenue
Net cash provided by operating activities
See accompanying notes to financial statements.
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$ (782,000) $

590,000

370,000
19,000

339,000
20,000

30,000
230,000

64,000
(93,000)

774,000
(168,000)
(61,000)

335,000
(60,000)
115,000

$412,000

$ 1,310,000
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Sample Not-for-Profit Health Maintenance Organization
Notes to Financial Statements
June 30,19X5 and 19X4
1. Organization

The Sample Health Maintenance Organization (the HMO) was incorporated in 19X0 in New
State as a not-for-profit corporation for the purpose of providing comprehensive health care
services on a prepaid basis and for the purpose of establishing and operating organized health
maintenance and health care delivery systems.
The HMO has been determined to be a qualified health maintenance organization under Title
XIII of the Public Health Service Act.

2. Summary of Significant Accounting Policies

Use of estimates. The preparation of financial statements in conformity with generally accepted
accounting principles requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the
date of the financial statements and the reported amounts of revenues and expenses during the
reporting period. Actual results could differ from those estimates.
Cash and cash equivalents. Cash and cash equivalents include investments in highly liquid debt
instruments with an original maturity of three months or less.

Supplies. Inventories of drugs and other supplies are stated at the lower of cost (first-in,
first-out) or market.
Property and equipment. Property and equipment are recorded at cost. Maintenance and repairs
are charged to expense, and betterments are capitalized. Property and equipment costing approxi
mately $700,000 was financed by health maintenance organization initial development grants
received in 19X1 and 19X2 from the U.S. Department of Health and Human Services (HHS). This
property will be owned by the HMO as long as the equipment and facilities are used for projects
related to the objectives of the Public Health Service Act.

Depreciation is computed using the straight-line method over the estimated useful lives of the
related assets as follows:

40 years
20-25 years

Building
Improvements
Data processing and laboratory
equipment and automobiles
Medical equipment
Office equipment

3-7 years
10 years
5-10 years

Amortization of debt issuance costs. Debt issuance costs are deferred and amortized using the
effective interest method over the term of the related debt.

Health care service cost recognition. The HMO contracts with various health care providers for
the provision of certain medical care services to its members. The HMO compensates these
providers on a capitation basis. As part of a cost control incentive program, the HMO retains up
to 20 percent of the capitation as a risk-sharing fund. In the event of hospital utilization in excess
of budget, those providers bear the risk to the extent of 15 percent of the capitation fee. Operating
expenses include all amounts incurred by the HMO under the aforementioned contracts.
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The cost of other health care services provided or contracted for is accrued in the period in which
it is provided to a member based in part on estimates, including an accrual for medical services
provided but not reported to the HMO.

Premiums revenue. Membership contracts are on a yearly basis subject to cancellation by the
employer group or the HMO upon 30 days written notice. Premiums are due monthly and are
recognized as revenue during the period in which the HMO is obligated to provide services to
members.
Reinsurance (stop-loss insurance). Reinsurance premiums are reported as health care costs, and
reinsurance recoveries are reported as a reduction of related health care costs.
Federal income tax. The HMO is exempt from federal income taxes under Sec. 501(c)(4) of the
Internal Revenue Code; accordingly, no provision for federal income taxes has been made in the
accompanying financial statements.

3. Property and Equipment
Property and equipment at June 30,19X5 and 19X4, consists of the following:

19X5

19X4

Land
Buildings and improvements
Furniture and equipment

$ 300,000
5,473,000
1,786,000

$ 300,000
5,459,000
1,303,000

Less accumulated depreciation

7,559,000
(1,803,000)

7,062,000
(1,436,000)

$5,756,000

$5,626,000

4. Long-Term Debt
Long-term debt is collateralized by assets with a depreciated cost of $4,943,000. A summary of
long-term debt at June 30,19X5 and 19X4, follows.

HHS loan, interest at 7.5 percent,
payable in monthly installments
of $50,000, including interest
HHS loan, interest at 9.25 percent,
payable in monthly installments
of $10,000, including interest
Secured equipment loans, payable
in monthly installments of $15,000,
including interest
Less current maturities

19X5

19X4

$2,020,000

$ 111,000

1,658,000

1,694,000

858,000

686,000

4,536,000
241,000

2,491,000
109,000

$4,295,000

$2,382,000

Scheduled principal payments on long-term debt are as follows:
Year ending December 31,

Amount

19X6
19X7
19X8
19X9
20Y0

$ 241,000
259,000
280,000
800,000
2,956,000
$4,536,000
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5. State Guarantee Fund Deposit
In August 19X4 the state in which the HMO is domiciled enacted legislation specifically
governing HMOs. Under this legislation, the corporation is required to maintain a deposit of
$150,000 with the director of the division of insurance of the state.
6. Employee Retirement Plan

The HMO has a contributory defined contribution retirement plan covering substantially all
employees. Expense determined in accordance with the plan formula (4 percent to 10 percent of
eligible covered compensation) was $354,000 and $275,000 for the years ended June 30,19X5 and
19X4, respectively.
7. Stop-Loss Insurance

The HMO entered into a stop-loss insurance agreement with an insurance company to limit its
losses on individual claims. Under the terms of this agreement, the insurance company will
reimburse the HMO approximately 25 percent of the cost of each member's annual hospital
services, in excess of a $1,000 deductible, up to a lifetime limitation of $500,000 per member. In
the event the HMO ceases operations, (a) plan benefits will continue for members who are
confined in an acute care hospital on the date of insolvency until their discharge, and (b) plan
benefits will continue for any other member until the end of the contract period for which
premiums have been paid.
Stop-loss insurance premiums of approximately $700,000 and $500,000 are included in insurance
expense (Note 9) in 19X5 and 19X4, respectively. Approximately $600,000 and $400,000 in stop-loss
insurance recoveries are deducted from insurance expense in 19X5 and 19X4, respectively.
Included in other receivables is approximately $50,000 recoverable from insurers.

8. Malpractice Claims
Malpractice claims have been asserted against the HMO by various claimants. The claims are in
various stages of processing, and some may ultimately be brought to trial. In the opinion of counsel,
the outcome of these actions will not have a significant effect on the financial position or the operating
income of the HMO. Incidents occurring through June 30, 19X5, may result in the assertion of
additional claims. Other claims may be asserted arising from past services provided. Management
believes that these claims, if asserted, would be settled within the limits of insurance coverage.
9. Classification of Expenses

Program activities
General and administrative

19X5

19X4

26,921,000
2,474,000

20,909,000
1,601,000

$29,395,000

$22,510,000

10. Risks and Uncertainties Disclosures
*
11. Pension and Other Postretirement Benefit Plans
*
12. Fair Value of Financial Instruments
*
13. Concentrations of Credit Risk
*
The disclosures contained in these notes would be similar to the disclosures contained in the notes to the financial statements for
the not-for-profit hospital and, therefore, are not repeated here.
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Sample Not-for-Profit Ambulatory Care, Inc.

Balance Sheets

December 31,19X5 and 19X4
19X5

19X4

Assets
Current assets:
Cash
Patient accounts receivable, net of allowance for
doubtful accounts of $15,000 in 19X5 and
$5,000 in 19X4
Estimated retroactive adjustments—third-party payors
Accounts receivable—other
Supplies
Prepaid expenses and deposits

$

65,000

$

76,000

290,000
19,000
13,000
21,000
5,000

278,000
32,000
8,000
18,000
9,000

413,000

421,000

Property and equipment, at cost:
Land
Land improvements
Buildings
Equipment

100,000
322,000
682,000
1,390,000

100,000
322,000
682,000
1,389,000

Less accumulated depreciation

2,494,000
217,000

2,493,000
100,000

Property and equipment, net

2,277,000

2,393,000

14,000

5,000

$2,704,000

$2,819,000

$ 138,000
52,000
33,000
30,000
—

$ 144,000
87,000
22,000
24,000
1,000

253,000

278,000

Total current assets

Other assets:
Advances receivable
Total assets
Liabilities and Net Assets

Current liabilities:
Notes payable
Accounts payable
Accrued payroll, benefits, and taxes
Estimated retroactive adjustments—third-party payors
Financing advance from third-party payors
Total current liabilities
Net assets—unrestricted
Total liabilities and net assets

See accompanying notes to financial statements.
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2,451,000

2,541,000

$2,704,000

$2,819,000

.28

Sample Not-for-Profit Ambulatory Care, Inc.
Statements of Operations and Changes in Net Assets
Years Ended December 31,19X5 and 19X4
Revenue and gains:
Net patient service revenue
Other

Total revenue and gains
Expenses:
Salaries and benefits
Medical supplies and drugs
Insurance
Provision for bad debts
Depreciation
Interest

Total expenses

19X5

19X4

$ 860,000
29,000

$ 357,000
15,000

889,000

372,000

485,000
189,000
154,000
14,000
117,000
20,000

243,000
66,000
98,000
4,000
100,000
18,000

979,000

529,000

(90,000)

Operating loss

Net assets, beginning of year
Net assets, end of year
See accompanying notes to financial statements.
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(157,000)

2,541,000

2,698,000

$2,451,000

$2,541,000

.29

Sample Not-for-Profit Ambulatory Care, Inc.

Statements of Cash Flows
Years Ended December 31,19X5 and 19X4
Cash flows from operating activities:
Cash received from patients and third-party payors
Cash received from others
Interest received
Interest paid
Cash paid to employees and suppliers

19X5

19X4

$866,000
21,000
3,000
(15,000)
(870,000)

$ 368,000
6,000
11,000
(16,000)
(432,000)

Net cash provided by (used in) operating activities

Cash flows from investing activities:
Purchase of equipment
Advances made to XYZ Affiliate
Net cash used in investing activities

Cash flows from financing activities:
Proceeds from notes payable
Payments on notes payable

Net cash provided by (used in) financing activities
Net increase (decrease) in cash

(63,000)

(1,000)
(9,000)

(4,000)
(5,000)

(10,000)

(9,000)

__
(6,000)

144,000
—

(6,000)

144,000

(11,000)

72,000

76,000

4,000

$ 65,000

$ 76,000

$(90,000)

$(157,000)

117,000
14,000

100,000
4,000

(12,000)
1,000

(19,000)
(2,000)

Cash, beginning of year
Cash, end of year

5,000

Reconciliation of change in net assets
to net cash provided by (used in)
operating activities:
Change in net assets
Adjustments to reconcile change in net
assets to net cash provided by (used in)
operating activities:
Depreciation
Provision for bad debts

(Increase) decrease in:
Patient accounts receivable
Other current assets
Increase (decrease) in:
Accounts payable and accrued payroll,
benefits, and taxes
Other current liabilities
Net cash provided by (used in)
operating activities

(24,000)
(1,000)

$

See accompanying notes to financial statements.
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5,000

10,000
1,000
$ (63,000)

.30

Sample Not-for-Profit Ambulatory Care, Inc.

Notes to Financial Statements

December 31,19X5 and 19X4
1. Description of Organization and Summary of Significant Accounting Policies

Organization. Ambulatory Care, Inc. was incorporated on September 7,19X3, in New State, to
operate an ambulatory care health facility to treat or prevent injury and disease, to provide funds
or to expend funds to further the treatment or prevention of injury or disease, and to develop and
participate in activities designed to promote the general health of the community.

Three area hospitals—ABC Hospital and Health Center, DEF Hospital, and GHI Hospital—en
tered into a members' agreement to develop this ambulatory care center. In accordance with this
agreement, each hospital contributed capital of $947,000 to Ambulatory Care, Inc. Ambulatory
Care, Inc. began operations in October 19X3.

Use of estimates. The preparation of financial statements in conformity with generally accepted
accounting principles requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the
date of the financial statements and the reported amounts of revenues and expenses during the
reporting period. Actual results could differ from those estimates.
Supplies. Supplies are stated at the lower of cost (first-in, first-out) or net realizable value.

Depreciation. Depreciation of property and equipment is computed on the straight-line method
over the estimated lives of depreciable assets.

Third-party contractual adjustments. Retroactively calculated third-party contractual adjust
ments are accrued on an estimated basis in the period the related services are rendered. Net patient
service revenue is adjusted as required in subsequent periods based on final settlements.
Net patient service revenue. Patient service revenue is reported at the estimated net realizable
amounts from patients, third-party payors, and others for services rendered.

Charity care. Ambulatory Care, Inc. has a policy of providing charity care to patients who are
unable to pay. Such patients are identified and related charges are estimated, based on financial
information obtained from the patient and subsequent analysis. Since management does not
expect payment for charity care, the estimated charges are excluded from revenue.
Income taxes. Ambulatory Care, Inc. has been recognized by the Internal Revenue Service as a
not-for-profit corporation as described in Sec. 501(c)(3) of the Internal Revenue Code (IRC) and
is exempt from federal income taxes on related income pursuant to Sec. 501(a) of the IRC.

2. Advances Receivable
In May 19X4, Ambulatory Care, Inc. entered into a five-year agreement with XYZ Affiliates
(XYZ). Under this agreement, XYZ is to provide emergency medical services as well as charge
and bill each patient treated at Ambulatory Care, Inc. Ambulatory Care, Inc. has guaranteed that XYZ
will collect at least $18,000 per month during the term of this agreement. In any month in which XYZ
does not collect the minimum guarantee, Ambulatory Care, Inc. advances funds to XYZ to cover the
deficiency. Such advances are to be repaid to the extent XYZ's net cash collections exceed the minimum
guarantee amount. Management estimates that the advances will be fully recovered in 19X8.

3. Related-Party Transactions
During 19X3, Ambulatory Care, Inc. entered into a contract with one of the member hospitals
(the managing hospital) for the management of the business and affairs of Ambulatory Care, Inc.
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Under this agreement, Ambulatory Care, Inc. pays $4,000 per month to the managing hospital.
The agreement with the managing hospital was to remain in effect through December 31,19X5,
but has been extended on a month-to-month basis.
In addition, during 19X4 each hospital loaned $48,000 to Ambulatory Care, Inc. in the form of
promissory notes at an interest rate of prime rate plus 1 percent (effective rates of 10 percent and
9 percent in 19X5 and 19X4, respectively). Of the total $144,000 liability, $48,000 is payable on
demand after November 28,19X5, to one member hospital, with the remaining portion ($96,000)
payable on demand after December 8,19X5, to the other two member hospitals. During 19X5,
Ambulatory Care, Inc. paid $2,000 to each member hospital, thereby reducing the obligation to
$138,000.
4. Revenue From Contracting Agencies
Ambulatory Care, Inc. participates as a provider of health care services to Blue Cross, Medicare,
and County Indigent Plan patients. Reimbursement for covered services is based on tentative
payment rates. Final reimbursement is determined after submission of annual cost reports and
audits thereof by the fiscal intermediaries. Provisions for estimated reimbursement adjustments
are reported in the financial statements in the period that the services are rendered.

5. Charity Care
Ambulatory Care, Inc. has a policy of providing charity care to indigent patients in emergency
situations. These services, which are excluded from revenues, amounted to $27,000 and $13,000
in 19X5 and 19X4, respectively, when measured at Ambulatory Care, Inc.'s established rates.

6. Classification of Expenses
Program
Expenses incurred for the
year ended December 31,
19X5, were for:
Salaries and benefits
Medical supplies and drugs
Insurance
Provision for bad debts
Depreciation
Interest
Total expenses
Expenses incurred for the
year ended December 31,
19X4, were for:
Salaries and benefits
Medical supplies and drugs
Insurance
Provision for bad debts
Depreciation
Interest
Total expenses

Total

A

B

C

General and
Administrative

$485,000
189,000
154,000
14,000
117,000
20,000
$979,000

$216,000
98,000
79,000
9,000
100,000
9,000
$511,000

$102,000
43,000
45,000
—
—
—
$190,000

$121,000
48,000
14,000
5,000
17,000
—
$205,000

$46,000
—
16,000
—
—
11,000
$73,000

$243,000
66,000
98,000
4,000
100,000
18,000
$529,000

$111,000
31,000
45,000
—
56,000
7,000
$250,000

$ 46,000
15,000
19,000
4,000
—
—
$ 84,000

$ 57,000
20,000
26,000
—
44,000
—
$147,000

$29,000
—
8,000
—
—
11,000
$48,000

(The preparer of the financial statements may wish to include a brief description of the types of
programs.)
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7. Risks and Uncertainties Disclosures
*

8. Pension and Other Postretirement Benefit Plans’

9. Fair Value of Financial Instruments’

10. Concentrations of Credit Risk’

The disclosures contained in these notes would be similar to the disclosures contained in the notes to the financial statements for
the not-for-profit hospital and, therefore, are not repeated here.
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Comment Letter
We welcome any comments and suggestions you have regarding this Checklist. Please send this
completed form to: AICPA Accounting and Auditing Publications Team, Harborside Financial Center,
201 Plaza Three, Jersey City, NJ, 07311-3881. Thank you.

Checklist Title:_______________________________________________________________________________

Comments and Suggestions:

TECHNICAL HOTLINE
The AICPA Technical Hotline answers
inquiries about specific audit or accounting problems.

Call Toll Free
(888)777-7077
This service is free to AICPA members.

www.aicpa.org
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